array(1) { [0]=> object(Apache_Solr_Document)#24 (3) { ["_documentBoost":protected]=> bool(false) ["_fields":protected]=> array(6) { ["content_id"]=> array(1) { [0]=> string(14) "DIRECTORY_3483" } ["content_title"]=> array(1) { [0]=> string(14) "WILLIAM ARCESE" } ["description"]=> array(1) { [0]=> string(274745) " a:257:{i:0;a:14:{s:9:"citazione";s:259:"Buccisano, F., Palmieri, R., Piciocchi, A., Arena, V., Candoni, A., Melillo, L., et al. (2021). ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol. BLOOD ADVANCES [10.1182/bloodadvances.2021005717].";s:4:"data";s:10:"2021-11-03";s:2:"id";s:20:"PUBBLICAZIONE_427433";s:6:"handle";s:11:"2108/281270";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:111:"ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol";s:9:"metadata6";s:328:"Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, MI; Paterno, G; Irno Consalvo, MA; Ottone, T; Lavorgna, S; Voso, MT; Fazi, P; Vignetti, M; Arcese, W; Venditti, A";s:9:"metadata7";s:32:"10.1182/bloodadvances.2021005717";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:1;a:14:{s:9:"citazione";s:419:"Bekadja, M., Boumendil, A., Blaise, D., Chevallier, P., Peggs, K.S., Salles, G., et al. (2021). Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry. CYTOTHERAPY, 23(6), 483-487-487 [10.1016/j.jcyt.2020.12.016].";s:4:"data";s:7:"2021-06";s:2:"id";s:20:"PUBBLICAZIONE_424345";s:6:"handle";s:11:"2108/278408";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:255:"Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation ...";s:9:"metadata6";s:137:"Bekadja, M; Boumendil, A; Blaise, D; Chevallier, P; Peggs, KS; Salles, G; Giebel, S; Marks, R; Arcese, W; Milpied, N; Finel, H; Gorin, NC";s:9:"metadata7";s:26:"10.1016/j.jcyt.2020.12.016";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:2;a:14:{s:9:"citazione";s:218:"Mikulska, M., Tridello, G., Hoek, J., Gil, L., Yañez, L., Labussière-Wallet, H., et al. (2021). Legionellosis after hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION [10.1038/s41409-021-01333-7].";s:4:"data";s:10:"2021-05-22";s:2:"id";s:20:"PUBBLICAZIONE_424349";s:6:"handle";s:11:"2108/278400";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:59:"Legionellosis after hematopoietic stem cell transplantation";s:9:"metadata6";s:274:"Mikulska, M; Tridello, G; Hoek, J; Gil, L; Yañez, L; Labussière-Wallet, H; Passweg, J; Xhaard, A; Pioltelli, P; Caillot, D; Michel, G; Veelken, H; Blaise, D; Bruno, B; Garcia, CB; Itälä-Remes, M; Crawley, C; Bourhis, JH; Kaare, A; Arcese, W; Parody, R; Styczynski, J";s:9:"metadata7";s:26:"10.1038/s41409-021-01333-7";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:3;a:14:{s:9:"citazione";s:265:"Hayden, P.J., Eikema, D., de Wreede, L.C., Koster, L., Kröger, N., Einsele, H., et al. (2021). Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party. BONE MARROW TRANSPLANTATION [10.1038/s41409-021-01286-x].";s:4:"data";s:10:"2021-05-11";s:2:"id";s:20:"PUBBLICAZIONE_424343";s:6:"handle";s:11:"2108/278410";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:109:"Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party";s:9:"metadata6";s:356:"Hayden, PJ; Eikema, D; de Wreede, LC; Koster, L; Kröger, N; Einsele, H; Minnema, M; Dominietto, A; Potter, M; Passweg, J; Bermúdez, A; Nguyen-Quoc, S; Platzbecker, U; Tischer, J; Ciceri, F; Veelken, JH; Ljungman, P; Schaap, N; Forcade, E; Carella, AM; Gandemer, V; Arcese, W; Bloor, A; Olivieri, A; Vincent, L; Beksac, M; Schönland, S; Yakoub-Agha, I";s:9:"metadata7";s:26:"10.1038/s41409-021-01286-x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:4;a:14:{s:9:"citazione";s:265:"Buccisano, F., Palmieri, R., Piciocchi, A., Maurillo, L., Del Principe, M.I., Paterno, G., et al. (2021). Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation. CANCERS [10.3390/cancers13051083].";s:4:"data";s:10:"2021-03-03";s:2:"id";s:20:"PUBBLICAZIONE_414161";s:6:"handle";s:11:"2108/269150";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:123:"Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation";s:9:"metadata6";s:255:"Buccisano, F; Palmieri, R; Piciocchi, A; Maurillo, L; Del Principe, MI; Paterno, G; Soddu, S; Cerretti, R; De Angelis, G; Mariotti, B; Irno Consalvo, MA; Conti, C; Fraboni, D; Divona, M; Ottone, T; Lavorgna, S; Panetta, P; Voso, MT; Arcese, W; Venditti, A";s:9:"metadata7";s:23:"10.3390/cancers13051083";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:5;a:14:{s:9:"citazione";s:328:"Cesaro, S., Tridello, G., Knelange, N.S., Blijlevens, N., Martin, M., Snowden, J.A., et al. (2021). Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT. BONE MARROW TRANSPLANTATION [10.1038/s41409-021-01212-1].";s:4:"data";s:10:"2021-01-29";s:2:"id";s:20:"PUBBLICAZIONE_409482";s:6:"handle";s:11:"2108/264916";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:169:"Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT";s:9:"metadata6";s:370:"Cesaro, S; Tridello, G; Knelange, NS; Blijlevens, N; Martin, M; Snowden, JA; Malladi, R; Ljungman, P; Deconinck, E; Gedde-Dahl, T; Byrne, J; Xhaard, A; Chevallier, P; Maertens, J; Zuckerman, T; Lioure, B; Petersen, E; Cornelissen, JJ; Arcese, W; Blaise, D; Milpied, N; Cahn, JY; Aljurf, M; de Wreede, L; Mauro, M; de la Camara, R; Averbuch, D; Mikulska, M; Styczynski, J";s:9:"metadata7";s:26:"10.1038/s41409-021-01212-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:6;a:14:{s:9:"citazione";s:346:"Domingo-Domenech, E., Duarte, R.F., Boumedil, A., Onida, F., Gabriel, I., Finel, H., et al. (2021). Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. BONE MARROW TRANSPLANTATION.";s:4:"data";s:10:"2021-01-08";s:2:"id";s:20:"PUBBLICAZIONE_409479";s:6:"handle";s:11:"2108/264914";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:216:"Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation";s:9:"metadata6";s:291:"Domingo-Domenech, E; Duarte, RF; Boumedil, A; Onida, F; Gabriel, I; Finel, H; Arcese, W; Browne, P; Beelen, D; Kobbe, G; Veelken, H; Arranz, R; Greinix, H; Lenhoff, S; Poiré, X; Ribera, JM; Thompson, J; Zuckerman, T; Mufti, GJ; Cortelezzi, A; Olavarria, E; Dreger, P; Sureda, A; Montoto, S";s:9:"metadata7";s:26:"10.1038/s41409-020-01197-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:7;a:14:{s:9:"citazione";s:395:"Battipaglia, G., Mauff, K., Wendel, L., Angelucci, E., Mohty, M., Arcese, W., et al. (2021). Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT. BONE MARROW TRANSPLANTATION, 56(7), 1593-1602-1602 [10.1038/s41409-021-01222-z].";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_424347";s:6:"handle";s:11:"2108/278402";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:220:"Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT";s:9:"metadata6";s:321:"Battipaglia, G; Mauff, K; Wendel, L; Angelucci, E; Mohty, M; Arcese, W; Santarone, S; Rubio, MT; Kroger, N; Fox, ML; Blaise, D; Iori, AP; Fanin, R; Chalandon, Y; Pioltelli, P; Marotta, G; Chiusolo, P; Sever, M; Solano, C; Contentin, N; de Wreede, LC; Czerw, T; Hernandez-Boluda, JC; Hayden, P; McLornan, D; Yakoub-Agha, I";s:9:"metadata7";s:26:"10.1038/s41409-021-01222-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:8;a:14:{s:9:"citazione";s:217:"Fabiani, E., Cicconi, L., Nardozza, A.M., Cristiano, A., Rossi, M., Ottone, T., et al. (2021). Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia. CANCER MEDICINE, 10(12), 3839-3847 [10.1002/cam4.3904].";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_424346";s:6:"handle";s:11:"2108/278404";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:65:"Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia";s:9:"metadata6";s:242:"Fabiani, E; Cicconi, L; Nardozza, AM; Cristiano, A; Rossi, M; Ottone, T; Falconi, G; Divona, M; Testi, AM; Annibali, O; Castelli, R; Lazarevic, V; Rego, E; Montesinos, P; Esteve, J; Venditti, A; Della Porta, M; Arcese, W; Lo-Coco, F; Voso, MT";s:9:"metadata7";s:17:"10.1002/cam4.3904";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:9;a:14:{s:9:"citazione";s:333:"Nagler, A., Kanate, A.S., Labopin, M., Ciceri, F., Angelucci, E., Koc, Y., et al. (2021). Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia. HAEMATOLOGICA, 106(6), 1591-1598 [10.3324/haematol.2020.247296].";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_397491";s:6:"handle";s:11:"2108/254171";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:177:"Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia";s:9:"metadata6";s:199:"Nagler, A; Kanate, AS; Labopin, M; Ciceri, F; Angelucci, E; Koc, Y; Gülbas, Z; Arcese, W; Tischer, J; Pioltelli, P; Ozdogu, H; Afanasyev, B; Wu, D; Arat, M; Peric, Z; Giebel, S; Savani, B; Mohty, M";s:9:"metadata7";s:28:"10.3324/haematol.2020.247296";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:10;a:14:{s:9:"citazione";s:543:"Picardi, A., Sacchi, N., Miotti, V., Lorentino, F., Oldani, E., Rambaldi, A., et al. (2021). Allelic HLA matching and pair origin are favorable prognostic factors for unrelated hematopoietic stem cell transplantation in neoplastic hematologic diseases: an Italian analysis by the Gruppo italiano trapianto di cellule staminali e terapie cellulari, Italian bone marrow donor registry, and Associazione Italiana di immunogenetica e biologia dei trapianti. TRANSPLANTATION AND CELLULAR THERAPY, 27(5), 406.e1-406.e11 [10.1016/j.jtct.2020.11.021].";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_424341";s:6:"handle";s:11:"2108/278412";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:255:"Allelic HLA matching and pair origin are favorable prognostic factors for unrelated hematopoietic stem cell transplantation in neoplastic hematologic diseases: an Italian analysis by the Gruppo italiano trapianto di cellule staminali e terapie cellular...";s:9:"metadata6";s:509:"Picardi, A; Sacchi, N; Miotti, V; Lorentino, F; Oldani, E; Rambaldi, A; Sessa, M; Bruno, B; Cerno, M; Vago, L; Bernasconi, P; Arcese, W; Benedetti, F; Pioltelli, P; Russo, D; Farina, L; Fagioli, F; Guidi, S; Saporiti, G; Zallio, F; Chiusolo, P; Borghero, C; Papalinetti, G; La Rocca, U; Milone, G; Lamparelli, T; Carella, AM; Luppi, M; Olivieri, A; Martino, M; Carluccio, P; Celeghini, I; Andreani, M; Gallina, AM; Patriarca, F; Pollichieni, S; Mammoliti, S; Miccichè, S; Mangione, I; Ciceri, F; Bonifazi, F";s:9:"metadata7";s:26:"10.1016/j.jtct.2020.11.021";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:11;a:14:{s:9:"citazione";s:247:"De Bellis, E., Ottone, T., Mercante, L., Falconi, G., Cugini, E., Consalvo, M.I., et al. (2020). Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia. LEUKEMIA RESEARCH, 99, 106462.";s:4:"data";s:7:"2020-12";s:2:"id";s:20:"PUBBLICAZIONE_405905";s:6:"handle";s:11:"2108/261781";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:118:"Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia";s:9:"metadata6";s:186:"De Bellis, E; Ottone, T; Mercante, L; Falconi, G; Cugini, E; Consalvo, MI; Travaglini, S; Paterno, G; Piciocchi, A; Rossi, ELL; Gurnari, C; Maurillo, L; Buccisano, F; Arcese, W; Voso, MT";s:9:"metadata7";s:29:"10.1016/j.leukres.2020.106462";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:12;a:14:{s:9:"citazione";s:244:"Castagna, L., Busca, A., Bramanti, S., Raiola Anna, M., Malagola, M., Ciceri, F., et al. (2020). Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients. BMC CANCER, 20(1), 1140.";s:4:"data";s:10:"2020-11-24";s:2:"id";s:20:"PUBBLICAZIONE_409480";s:6:"handle";s:11:"2108/264918";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:121:"Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients";s:9:"metadata6";s:322:"Castagna, L; Busca, A; Bramanti, S; Raiola Anna, M; Malagola, M; Ciceri, F; Arcese, W; Vallisa, D; Patriarca, F; Specchia, G; Raimondi, R; Devillier, R; Furst, S; Giordano, L; Sarina, B; Mariotti, J; Olivieri, A; Bouabdallah, R; Carlo-Stella, C; Rambaldi, A; Santoro, A; Corradini, P; Bacigalupo, A; Bonifazi, F; Blaise, D";s:9:"metadata7";s:26:"10.1186/s12885-020-07602-w";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:13;a:14:{s:9:"citazione";s:237:"Travaglini, S., Angelini, D.F., Alfonso, V., Guerrera, G., Lavorgna, S., Divona, M., et al. (2020). Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells. BLOOD CANCER JOURNAL, 10(8), 85.";s:4:"data";s:10:"2020-08-25";s:2:"id";s:20:"PUBBLICAZIONE_397490";s:6:"handle";s:11:"2108/254167";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:103:"Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells";s:9:"metadata6";s:316:"Travaglini, S; Angelini, DF; Alfonso, V; Guerrera, G; Lavorgna, S; Divona, M; Nardozza, AM; Consalvo, MI; Fabiani, E; De Bardi, M; Neri, B; Forghieri, F; Marchesi, F; Paterno, G; Cerretti, R; Barragan, E; Fiori, V; Dominici, S; Del Principe, MI; Venditti, A; Battistini, L; Arcese, W; Lo-Coco, F; Voso, MT; Ottone, T";s:9:"metadata7";s:26:"10.1038/s41408-020-00352-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:14;a:14:{s:9:"citazione";s:262:"Gurnari, C., Breccia, M., Di Giuliano, F., Scalzulli, E., Divona, M., Piciocchi, A., et al. (2020). Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. BRITISH JOURNAL OF HAEMATOLOGY.";s:4:"data";s:10:"2020-08-10";s:2:"id";s:20:"PUBBLICAZIONE_397492";s:6:"handle";s:11:"2108/254169";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:129:"Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters";s:9:"metadata6";s:178:"Gurnari, C; Breccia, M; Di Giuliano, F; Scalzulli, E; Divona, M; Piciocchi, A; Cicconi, L; De Bellis, E; Venditti, A; Del Principe, MI; Arcese, W; Lo-Coco, F; Garaci, F; Voso, MT";s:9:"metadata7";s:17:"10.1111/bjh.17018";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:15;a:14:{s:9:"citazione";s:281:"Meconi, F., Provenzano, I., Nasso, D., Mariotti, B., Pupo, L., Secchi, R., et al. (2020). A case of metachronous peripheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin. CLINICAL CASE REPORTS, 8(8), 1353-1356.";s:4:"data";s:7:"2020-08";s:2:"id";s:20:"PUBBLICAZIONE_397489";s:6:"handle";s:11:"2108/254165";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:150:"A case of metachronous peripheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin";s:9:"metadata6";s:118:"Meconi, F; Provenzano, I; Nasso, D; Mariotti, B; Pupo, L; Secchi, R; Cerretti, R; Anemona, L; Arcese, W; Cantonetti, M";s:9:"metadata7";s:17:"10.1002/ccr3.2898";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:16;a:14:{s:9:"citazione";s:334:"Arcese, W., Cerretti, R., Sarmati, L., Cudillo, L., De Angelis, G., Mariotti, B., et al. (2020). MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2020.02.005].";s:4:"data";s:10:"2020-02-14";s:2:"id";s:20:"PUBBLICAZIONE_372948";s:6:"handle";s:11:"2108/232692";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:77:"Haplo vs Identical Sibling; Matched pair analysis; hematological malignancies";s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:162:"MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES";s:9:"metadata6";s:325:"Arcese, W; Cerretti, R; Sarmati, L; Cudillo, L; De Angelis, G; Mariotti, B; Bruno, A; Mangione, I; Rapanotti, C; Andreani, M; De Fabritiis, P; Dentamaro, T; Cupelli, L; Mengarelli, A; Marchesi, F; Tirindelli, MC; Annibali, O; Tafuri, A; Ferrari, A; Cedrone, M; Anaclerico, B; Adorno, G; Miccichè, S; Andreoni, M; Picardi, A";s:9:"metadata7";s:26:"10.1016/j.bbmt.2020.02.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:17;a:14:{s:9:"citazione";s:319:"Gilleece, M.H., Labopin, M., Savani, B.N., Yakoub-Agha, I., Socie, G., Gedde-Dahl, T., et al. (2020). Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT. LEUKEMIA, 34(1), 87-99 [10.1038/s41375-019-0527-4].";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_372951";s:6:"handle";s:11:"2108/232688";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:164:"Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT";s:9:"metadata6";s:195:"Gilleece, MH; Labopin, M; Savani, BN; Yakoub-Agha, I; Socie, G; Gedde-Dahl, T; Blaise, D; Byrne, JL; Craddock, C; Cornelissen, JJ; Arcese, W; Forcade, E; Crawley, C; Polge, E; Mohty, M; Nagler, A";s:9:"metadata7";s:25:"10.1038/s41375-019-0527-4";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:18;a:14:{s:9:"citazione";s:464:"Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(12), 2388-2397-2397 [10.1016/j.bbmt.2019.07.037].";s:4:"data";s:7:"2019-12";s:2:"id";s:20:"PUBBLICAZIONE_372953";s:6:"handle";s:11:"2108/232686";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:255:"Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transpla...";s:9:"metadata6";s:561:"Candoni, A; Rambaldi, A; Fanin, R; Velardi, A; Arcese, W; Ciceri, F; Lazzarotto, D; Lussana, F; Olivieri, J; Grillo, G; Parma, M; Bruno, B; Sora, F; Bernasconi, P; Saccardi, R; Foa, R; Sessa, M; Bresciani, P; Giglio, F; Picardi, A; Busca, A; Sica, S; Perruccio, K; Zucchetti, E; Diral, E; Iori, AP; Colombo, AA; Tringali, S; Santarone, S; Irrera, G; Mancini, S; Zallio, F; Malagola, M; Albano, F; Carella, AM; Olivieri, A; Tecchio, C; Dominietto, A; Vacca, A; Sorasio, R; Orciuolo, E; Risitano, AM; Leotta, S; Cortelezzi, A; Mammoliti, S; Oldani, E; Bonifazi, F";s:9:"metadata7";s:26:"10.1016/j.bbmt.2019.07.037";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:19;a:14:{s:9:"citazione";s:352:"Del Principe, M.i., Venditti, A., Arcese, W., Cantonetti, M., Buccisano, F., Maurillo, L., et al. (2019). DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 11(1), 1-8.";s:4:"data";s:7:"2019-11";s:2:"id";s:20:"PUBBLICAZIONE_359534";s:6:"handle";s:11:"2108/221457";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:172:"DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE";s:9:"metadata6";s:280:"Del Principe, Mi; Venditti, A; Arcese, W; Cantonetti, M; Buccisano, F; Maurillo, L; De Fabritiis, P; Rogliani, P; Zizzari, Ag; Casciani, P; Laureana, R; Meconi, F; Buzzatti, E; Palmieri, R; De Bellis, E; Pane, G; Nassa, D; Fontana, C; Paterno, G; Sarmati, L; Puxeddu, E; Cefalo, M";s:9:"metadata7";s:22:"10.4084/mjhid.2019.065";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:20;a:14:{s:9:"citazione";s:267:"Noguera, N.I., Catalano, G., Banella, C., Divona, M., Faraoni, I., Ottone, T., et al. (2019). Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies. CANCERS, 11(10), 1591 [10.3390/cancers11101591].";s:4:"data";s:7:"2019-10";s:2:"id";s:20:"PUBBLICAZIONE_385914";s:6:"handle";s:11:"2108/244036";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/06";s:9:"metadata4";N;s:9:"metadata5";s:123:"Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies";s:9:"metadata6";s:91:"Noguera, NI; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, MT";s:9:"metadata7";s:23:"10.3390/cancers11101591";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:21;a:14:{s:9:"citazione";s:243:"Venditti, A., Piciocchi, A., Candoni, A., Melillo, L., Calafiore, V., Cairoli, R., et al. (2019). GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia. BLOOD, 134(12), 935-945.";s:4:"data";s:10:"2019-09-19";s:2:"id";s:20:"PUBBLICAZIONE_357889";s:6:"handle";s:11:"2108/220032";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:119:"GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia";s:9:"metadata6";s:462:"Venditti, A; Piciocchi, A; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; de Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Mazza, P; Martelli, MP; Cuneo, A; Albano, F; Fabbiano, F; Tafuri, A; Chierichini, A; Tieghi, A; Fracchiolla, NS; Capelli, D; Foà, R; Alati, C; La Sala, E; Fazi, P; Vignetti, M; Maurillo, L; Buccisano, F; Del Principe, MI; Irno-Consalvo, M; Ottone, T; Lavorgna, S; Voso, MT; Lo-Coco, F; Arcese, W; Amadori, S";s:9:"metadata7";s:24:"10.1182/blood.2018886960";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:22;a:14:{s:9:"citazione";s:237:"Iaccarino, L., Ottone, T., Alfonso, V., Cicconi, L., Divona, M., Lavorgna, S., et al. (2019). Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse. AMERICAN JOURNAL OF HEMATOLOGY, 94(10), 1091-1097.";s:4:"data";s:10:"2019-07-10";s:2:"id";s:20:"PUBBLICAZIONE_355167";s:6:"handle";s:11:"2108/217754";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:91:"Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse";s:9:"metadata6";s:223:"Iaccarino, L; Ottone, T; Alfonso, V; Cicconi, L; Divona, M; Lavorgna, S; Travaglini, S; Ferrantini, A; Falconi, G; Baer, C; Usai, M; Forghieri, F; Venditti, A; Del Principe, MI; Arcese, W; Voso, MT; Haferlach, T; Lo-Coco, F";s:9:"metadata7";s:17:"10.1002/ajh.25573";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:23;a:14:{s:9:"citazione";s:346:"Derenzini, E., Risso, A., Ruella, M., Spatola, T., Milone, G., Pioltelli, P., et al. (2019). INFLUENCE OF DONOR AND RECIPIENT GENDER ON TELOMERE MAINTENANCE FOLLOWING UMBILICAL CORD BLOOD CELL TRANSPLANTATION: A STUDY BY GITMO (GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2019.03.026].";s:4:"data";s:10:"2019-03-29";s:2:"id";s:20:"PUBBLICAZIONE_347687";s:6:"handle";s:11:"2108/212184";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:178:"INFLUENCE OF DONOR AND RECIPIENT GENDER ON TELOMERE MAINTENANCE FOLLOWING UMBILICAL CORD BLOOD CELL TRANSPLANTATION: A STUDY BY GITMO (GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO)";s:9:"metadata6";s:155:"Derenzini, E; Risso, A; Ruella, M; Spatola, T; Milone, G; Pioltelli, P; Iori, Ap; Santarone, S; Bosi, A; Rambaldi, A; Bacigalupo, Ap; Arcese, W; Tarella, C";s:9:"metadata7";s:26:"10.1016/j.bbmt.2019.03.026";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:24;a:14:{s:9:"citazione";s:344:"Bazarbachi, A., Labopin, M., Battipaglia, G., Djabali, A., Passweg, J., Socié, G., et al. (2019). Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of EBMT acute leukemia Working Party. HAEMATOLOGICA, 104(9), haematol.2018.211615 [10.3324/haematol.2018.211615].";s:4:"data";s:10:"2019-02-21";s:2:"id";s:20:"PUBBLICAZIONE_347683";s:6:"handle";s:11:"2108/212186";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:167:"Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of EBMT acute leukemia Working Party";s:9:"metadata6";s:241:"Bazarbachi, A; Labopin, M; Battipaglia, G; Djabali, A; Passweg, J; Socié, G; Forcade, E; Blaise, D; Chevallier, P; Orvain, C; Cornelissen, JJ; Arcese, W; Chantepie, S; Hashaishi, K; El Cheikh, J; Medinger, M; Esteve, J; Nagler, A; Mohty, M";s:9:"metadata7";s:28:"10.3324/haematol.2018.211615";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:25;a:14:{s:9:"citazione";s:225:"Alfonso, V., Iaccarino, L., Ottone, T., Cicconi, L., Lavorgna, S., Divona, M., et al. (2019). Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia. LEUKEMIA.";s:4:"data";s:10:"2019-01-16";s:2:"id";s:20:"PUBBLICAZIONE_343453";s:6:"handle";s:11:"2108/208550";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:120:"Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia";s:9:"metadata6";s:192:"Alfonso, V; Iaccarino, L; Ottone, T; Cicconi, L; Lavorgna, S; Divona, M; Cairoli, R; Cristiano, A; Ciardi, C; Travaglini, S; Falconi, G; Hasan, SK; Venditti, A; Arcese, W; Voso, MT; Lo-Coco, F";s:9:"metadata7";s:25:"10.1038/s41375-018-0298-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:26;a:14:{s:9:"citazione";s:198:"Amadori, S., Arcese, W., Avvisati, G., Gale, R.P., & Lo-Coco, F. (2019). Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018. LEUKEMIA, 33(2), 285-286 [10.1038/s41375-018-0352-1].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_372968";s:6:"handle";s:11:"2108/232696";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:70:"Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018";s:9:"metadata6";s:56:"Amadori, S; Arcese, W; Avvisati, G; Gale, RP; Lo-Coco, F";s:9:"metadata7";s:25:"10.1038/s41375-018-0352-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:27;a:14:{s:9:"citazione";s:301:"Bove, P., Iacovelli, V., Tirindelli, M.c., Bianchi, D., Flammia, G.p., Cipriani, C., et al. (2019). Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: A single cohort pilot study. JOURNAL OF ENDOUROLOGY, 33(2), 93-98 [10.1089/end.2018.0028].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_347642";s:6:"handle";s:11:"2108/212126";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:25:"Settore MED/24 - Urologia";s:9:"metadata4";N;s:9:"metadata5";s:138:"Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: A single cohort pilot study";s:9:"metadata6";s:154:"Bove, P; Iacovelli, V; Tirindelli, Mc; Bianchi, D; Flammia, Gp; Cipriani, C; Ferraro, As; Ferro, M; Arcese, W; Ingrosso, G; Vespasiani, G; Finazzi Agro, E";s:9:"metadata7";s:21:"10.1089/end.2018.0028";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:28;a:14:{s:9:"citazione";s:368:"Marchesi, F., Pimpinelli, F., Di Domenico, E.G., Renzi, D., Gallo, M.T., Regazzo, G., et al. (2019). Association between CMV and invasive fungal infections after autologous stem cell transplant in lymphoproliferative malignancies: Opportunistic partnership or cause-effect relationship?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(6), 1373 [10.3390/ijms20061373].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_372966";s:6:"handle";s:11:"2108/232698";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:473:"CMV infection; autologous stem cell transplant; gram negative bacteria; gram positive bacteria; invasive fungal disease; lymphoma; multiple myeloma; skin commensals; Adolescent; Adult; Aged; Cohort Studies; Cytomegalovirus Infections; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoproliferative Disorders; Male; Middle Aged; Multivariate Analysis; Opportunistic Infections; Risk Factors; Transplantation, Autologous; Young Adult";s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:185:"Association between CMV and invasive fungal infections after autologous stem cell transplant in lymphoproliferative malignancies: Opportunistic partnership or cause-effect relationship?";s:9:"metadata6";s:293:"Marchesi, F; Pimpinelli, F; Di Domenico, EG; Renzi, D; Gallo, MT; Regazzo, G; Rizzo, MG; Gumenyuk, S; Toma, L; Marino, M; Cordone, I; Cantonetti, M; Liberati, AM; Montanaro, M; Ceribelli, A; Prignano, G; Palombi, F; Romano, A; Papa, E; Pisani, F; Spadea, A; Arcese, W; Ensoli, F; Mengarelli, A";s:9:"metadata7";s:20:"10.3390/ijms20061373";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:29;a:14:{s:9:"citazione";s:282:"Meconi, F., Ciangola, G., Mariotti, B., Cerretti, R., Cudillo, L., Arcese, W., et al. (2019). Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor. CASE REPORT IN INFECTIOUS DISEASES, 2019, 4603130.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_372949";s:6:"handle";s:11:"2108/232690";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:136:"Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor";s:9:"metadata6";s:83:"Meconi, F; Ciangola, G; Mariotti, B; Cerretti, R; Cudillo, L; Arcese, W; Picardi, A";s:9:"metadata7";s:20:"10.1155/2019/4603130";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:30;a:14:{s:9:"citazione";s:298:"Piemontese, S., Boumendil, A., Labopin, M., Schmid, C., Ciceri, F., Arcese, W., et al. (2019). Leukemia relapse following unmanipulated haploidentical transplantation: A risk factor analysis on behalf of the ALWP of the EBMT. JOURNAL OF HEMATOLOGY & ONCOLOGY, 12(1), 68 [10.1186/s13045-019-0751-4].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_372965";s:6:"handle";s:11:"2108/232700";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:40:"Leukemia relapse; Survival after relapse";s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:129:"Leukemia relapse following unmanipulated haploidentical transplantation: A risk factor analysis on behalf of the ALWP of the EBMT";s:9:"metadata6";s:197:"Piemontese, S; Boumendil, A; Labopin, M; Schmid, C; Ciceri, F; Arcese, W; Koc, Y; Gulbas, Z; Tischer, J; Bruno, B; Wu, D; Blaise, D; Beelen, D; Irrera, G; Ruggeri, A; Houhou, M; Mohty, M; Nagler, A";s:9:"metadata7";s:25:"10.1186/s13045-019-0751-4";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:31;a:14:{s:9:"citazione";s:281:"Santoro, N., Labopin, M., Ciceri, F., Van Lint, M.t., Nasso, D., Blaise, D., et al. (2019). Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age and over. CANCER [10.1002/cncr.31941].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_347688";s:6:"handle";s:11:"2108/212182";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:159:"Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age and over";s:9:"metadata6";s:192:"Santoro, N; Labopin, M; Ciceri, F; Van Lint, Mt; Nasso, D; Blaise, D; Arcese, W; Tischer, J; Bruno, B; Ehninger, G; Koc, Y; Santarone, S; Huang, X-; Savani, Bn; Mohty, M; Ruggeri, A; Nagler, A";s:9:"metadata7";s:18:"10.1002/cncr.31941";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:32;a:14:{s:9:"citazione";s:324:"Tendas, A., Marchesi, F., Mengarelli, A., Annibali, O., Tomarchio, V., Saltarelli, D., et al. (2019). Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions. SUPPORTIVE CARE IN CANCER, 27(3), 793-803 [10.1007/s00520-018-4594-2].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_372963";s:6:"handle";s:11:"2108/232694";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:150:"Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions";s:9:"metadata6";s:242:"Tendas, A; Marchesi, F; Mengarelli, A; Annibali, O; Tomarchio, V; Saltarelli, D; Chierichini, A; Di Venanzio, M; Sollazzo, F; Piedimonte, M; Cupelli, L; Bruno, A; De Angelis, G; Delbono, L; Niscola, P; Perrotti, AP; de Fabritiis, P; Arcese, W";s:9:"metadata7";s:25:"10.1007/s00520-018-4594-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:33;a:14:{s:9:"citazione";s:214:"Ottone, T., Alfonso, V., Iaccarino, L., Hasan, S.K., Mancini, M., Divona, M., et al. (2018). Longitudinal detection of DNMT3AR882Htranscripts in patients with acute myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY.";s:4:"data";s:10:"2018-02-08";s:2:"id";s:20:"PUBBLICAZIONE_326554";s:6:"handle";s:11:"2108/194347";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:88:"Longitudinal detection of DNMT3AR882Htranscripts in patients with acute myeloid leukemia";s:9:"metadata6";s:323:"Ottone, T; Alfonso, V; Iaccarino, L; Hasan, SK; Mancini, M; Divona, M; Lavorgna, S; Cicconi, L; Panetta, P; Maurillo, L; Del Principe, MI; Irno Consalvo, M; Franceschini, L; Angelini, DF; Battistini, L; Guerrera, G; De Bardi, M; Fabiani, E; Falconi, G; Arcese, W; Amadori, S; Buccisano, F; Venditti, A; Voso, MT; Lo-Coco, F";s:9:"metadata7";s:17:"10.1002/ajh.25061";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:34;a:14:{s:9:"citazione";s:261:"Bove, P., Iacovelli, V., Cipriani, C., Tirindelli Maria, C., Flammia Gerardo, P., Cindolo, L., et al. (2018). ENDOSCOPIC INTRAVESICAL FIBRIN GLUE APPLICATION IN THE TREATMENT OF REFRACTORY HAEMORRHAGIC RADIATION CYSTITIS. Paper presented at Anticancer Research.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_347969";s:6:"handle";s:11:"2108/212371";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:25:"Settore MED/24 - Urologia";s:9:"metadata4";N;s:9:"metadata5";s:110:"ENDOSCOPIC INTRAVESICAL FIBRIN GLUE APPLICATION IN THE TREATMENT OF REFRACTORY HAEMORRHAGIC RADIATION CYSTITIS";s:9:"metadata6";s:185:"Bove, P; Iacovelli, V; Cipriani, C; Tirindelli Maria, C; Flammia Gerardo, P; Cindolo, L; Ferraro Angelo, S; Bianchi, D; Ferro, M; Arcese, W; Ingrosso, G; Vespasiani, G; FINAZZI AGRO', E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:35;a:14:{s:9:"citazione";s:264:"Buccisano, F., Maurillo, L., Del Principe, M.I., Di Veroli, A., De Bellis, E., Biagi, A., et al. (2018). Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia. EXPERT REVIEW OF HEMATOLOGY, 11(4), 307-313.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_331616";s:6:"handle";s:11:"2108/198737";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:113:"Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia";s:9:"metadata6";s:175:"Buccisano, F; Maurillo, L; Del Principe, MI; Di Veroli, A; De Bellis, E; Biagi, A; Zizzari, A; Rossi, V; Rapisarda, V; Amadori, S; Voso, MT; Lo-Coco, F; Arcese, W; Venditti, A";s:9:"metadata7";s:29:"10.1080/17474086.2018.1447378";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:36;a:14:{s:9:"citazione";s:394:"Canaani, J., Labopin, M., Huang, X.-., Arcese, W., Ciceri, F., Blaise, D., et al. (2018). T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 93(6), 736-744 [10.1002/ajh.25082].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_347701";s:6:"handle";s:11:"2108/212170";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:235:"T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation";s:9:"metadata6";s:169:"Canaani, J; Labopin, M; Huang, X-; Arcese, W; Ciceri, F; Blaise, D; Irrera, G; Corral, Ll; Bruno, B; Santarone, S; Van Lint, Mt; Vitek, A; Esteve, J; Mohty, M; Nagler, A";s:9:"metadata7";s:17:"10.1002/ajh.25082";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:37;a:14:{s:9:"citazione";s:285:"Canaani, J., Savani, B.n., Labopin, M., Huang, X.-., Ciceri, F., Arcese, W., et al. (2018). Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 93(2), 246-253 [10.1002/ajh.24963].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_347706";s:6:"handle";s:11:"2108/212168";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:124:"Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation";s:9:"metadata6";s:154:"Canaani, J; Savani, Bn; Labopin, M; Huang, X-; Ciceri, F; Arcese, W; Koc, Y; Tischer, J; Blaise, D; Gulbas, Z; Van Lint, Mt; Bruno, B; Mohty, M; Nagler, A";s:9:"metadata7";s:17:"10.1002/ajh.24963";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:38;a:14:{s:9:"citazione";s:243:"Del Principe, M.I., Buccisano, F., Soddu, S., Maurillo, L., Cefalo, M., Piciocchi, A., et al. (2018). Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome. SEMINARS IN HEMATOLOGY.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_331627";s:6:"handle";s:11:"2108/198747";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:116:"Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome";s:9:"metadata6";s:265:"Del Principe, MI; Buccisano, F; Soddu, S; Maurillo, L; Cefalo, M; Piciocchi, A; Consalvo, MI; Paterno, G; Sarlo, C; De Bellis, E; Zizzari, A; De Angelis, G; Fraboni, D; Divona, M; Voso, MT; Sconocchia, G; Del Poeta, G; Lo-Coco, F; Arcese, W; Amadori, S; Venditti, A";s:9:"metadata7";s:34:"10.1053/j.seminhematol.2018.02.006";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:39;a:14:{s:9:"citazione";s:333:"Gagelmann, N., Eikema, D., Iacobelli, S., Koster, L., Nahi, H., Stoppa, A., et al. (2018). Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the Chronic Malignancies Working Party of the EBMT. HAEMATOLOGICA [10.3324/haematol.2017.178434].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_330184";s:6:"handle";s:11:"2108/197413";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:34:"Settore MED/01 - Statistica Medica";s:9:"metadata4";N;s:9:"metadata5";s:195:"Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the Chronic Malignancies Working Party of the EBMT";s:9:"metadata6";s:297:"Gagelmann, N; Eikema, D; Iacobelli, S; Koster, L; Nahi, H; Stoppa, A; Masszi, T; Caillot, D; Lenhoff, S; Udvardy, M; Crawley, C; Arcese, W; Mariette, C; Hunter, A; Leleu, X; Schipperus, M; Delforge, M; Pioltelli, P; Snowden, J; Itälä-Remes, M; Musso, M; van Biezen, A; Garderet, L; Kröger, N";s:9:"metadata7";s:28:"10.3324/haematol.2017.178434";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:40;a:14:{s:9:"citazione";s:330:"Picardi, A., Sacchi, N., Miotti, V., Lorentino, F., Oldani, E., Rambaldi, A., et al. (2018). High resolution donor/recipient HLA matching level in unrelated hematopoietic stem cell transplantation and impact on the transplant outcome: the Italian experience on behalf of GITMO, IBMDR and Aibt. BLOOD, 132(Supplement 1), 4642-4642.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_384396";s:6:"handle";s:11:"2108/242730";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:199:"High resolution donor/recipient HLA matching level in unrelated hematopoietic stem cell transplantation and impact on the transplant outcome: the Italian experience on behalf of GITMO, IBMDR and Aibt";s:9:"metadata6";s:435:"Picardi, A; Sacchi, N; Miotti, V; Lorentino, F; Oldani, E; Rambaldi, A; Sessa, M; Bruno, B; Cerno, M; Bernasconi, P; Vago, L; Arcese, W; Benedetti, F; Pioltelli, P; Farina, L; Saporiti, G; Chiusolo, P; Zallio, F; Fagioli, F; Papalinetti, G; Borghero, C; Carella, AM; Narni, F; Russo, D; Olivieri, A; Lamparelli, T; Specchia, G; Guidi, S; Iori, AP; Milone, G; Andreani, M; Gallina, AM; Patriarca, F; Mammoliti, S; Ciceri, F; Bonifazi, F";s:9:"metadata7";s:28:"10.1182/blood-2018-99-114486";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:41;a:14:{s:9:"citazione";s:502:"Salvatore, D., Labopin, M., Ruggeri, A., Battipaglia, G., Ghavamzadeh, A., Ciceri, F., et al. (2018). Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation. HAEMATOLOGICA, 103(8), 1317-1328 [10.3324/haematol.2018.189258].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_347694";s:6:"handle";s:11:"2108/212178";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute l...";s:9:"metadata6";s:207:"Salvatore, D; Labopin, M; Ruggeri, A; Battipaglia, G; Ghavamzadeh, A; Ciceri, F; Blaise, D; Arcese, W; Socie, G; Bourhis, Jh; Van Lint, Mt; Bruno, B; Huynh, A; Santarone, S; Deconinck, E; Mohty, M; Nagler, A";s:9:"metadata7";s:28:"10.3324/haematol.2018.189258";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:42;a:14:{s:9:"citazione";s:373:"Saraceni, F., Beohou, E., Labopin, M., Arcese, W., Bonifazi, F., Stepensky, P., et al. (2018). Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY, 93(10), 1211-1219 [10.1002/ajh.25225].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_347682";s:6:"handle";s:11:"2108/212188";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:206:"Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia";s:9:"metadata6";s:202:"Saraceni, F; Beohou, E; Labopin, M; Arcese, W; Bonifazi, F; Stepensky, P; Aljurf, M; Bruno, B; Pioltelli, P; Passweg, J; Socie, G; Santarone, S; Yakoub-Agha, I; Lanza, F; Savani, Bn; Mohty, M; Nagler, A";s:9:"metadata7";s:17:"10.1002/ajh.25225";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:43;a:14:{s:9:"citazione";s:293:"Tendas, A., Malandruccolo, L., Venditti, D., Costa, A., Volta, L., Annibali, O., et al. (2018). Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series. ANNALS OF PALLIATIVE MEDICINE, 7(4), 484-486 [10.21037/apm.2018.04.03].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_347700";s:6:"handle";s:11:"2108/212172";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:124:"Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series";s:9:"metadata6";s:167:"Tendas, A; Malandruccolo, L; Venditti, D; Costa, A; Volta, L; Annibali, O; Marchesi, F; Saltarelli, D; de Fabritiis, P; Arcese, W; Bondanini, F; Niscola, P; Palumbo, R";s:9:"metadata7";s:23:"10.21037/apm.2018.04.03";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:44;a:14:{s:9:"citazione";s:251:"Vago, L., Toffalori, C., Ahci, M., Lange, V., Lang, K., Todaro, S., et al. (2018). Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study. BLOOD, 132(Supplement 1), 818-818.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_384397";s:6:"handle";s:11:"2108/242732";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:132:"Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study";s:9:"metadata6";s:644:"Vago, L; Toffalori, C; Ahci, M; Lange, V; Lang, K; Todaro, S; Lorentino, F; Stempelmann, K; Heinold, A; Stoelzel, F; Waterhouse, M; Claus, R; Gendzekhadze, K; Onozawa, M; Devillier, R; Tang, R; Ulman, M; Kwon, M; Gojo, I; Ruggeri, L; Imovilli, A; Facchini, L; Lazarevic, D; Lupo Stanghellini, MT; Peccatori, J; Steckel, NK; Horn, PA; Picardi, A; Manetta, S; Busca, A; Pinana, JL; Sanz, J; Martínez-Laperche, C; Ciurea, SO; Luznik, L; Velardi, A; Arcese, W; Sanz, G; Pini, M; Bruno, B; Kobbe, G; Al Malki, M; Teshima, T; Kroeger, N; Finke, J; Nagler, A; Blaise, D; Mohty, M; Bornhäuser, M; Beelen, DW; Schmidt, AH; Ciceri, F; Fleischhauer, K";s:9:"metadata7";s:28:"10.1182/blood-2018-99-112142";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:45;a:14:{s:9:"citazione";s:277:"Lorentino, F., Labopin, M., Fleischhauer, K., Ciceri, F., Mueller, C.r., Ruggeri, A., et al. (2017). The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis. BLOOD ADVANCES, 1(11), 669-680 [10.1182/bloodadvances.2017006429].";s:4:"data";s:10:"2017-04-25";s:2:"id";s:20:"PUBBLICAZIONE_347712";s:6:"handle";s:11:"2108/212166";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:108:"The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis";s:9:"metadata6";s:231:"Lorentino, F; Labopin, M; Fleischhauer, K; Ciceri, F; Mueller, Cr; Ruggeri, A; Shimoni, A; Bornhäuser, M; Bacigalupo, A; Gülbas, Z; Koc, Y; Arcese, W; Bruno, B; Tischer, J; Blaise, D; Messina, G; Beelen, Dw; Nagler, A; Mohty, M";s:9:"metadata7";s:32:"10.1182/bloodadvances.2017006429";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:46;a:14:{s:9:"citazione";s:337:"Buccisano, F., Maurillo, L., Piciocchi, A., Del Principe, M.i., Picardi, A., Cerretti, R., et al. (2017). Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia. BONE MARROW TRANSPLANTATION, 52(3), 473-475 [10.1038/bmt.2016.308].";s:4:"data";s:7:"2017-03";s:2:"id";s:20:"PUBBLICAZIONE_302675";s:6:"handle";s:11:"2108/173310";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:162:"Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia";s:9:"metadata6";s:278:"Buccisano, F; Maurillo, L; Piciocchi, A; Del Principe, Mi; Picardi, A; Cerretti, R; Cudillo, L; De Angelis, G; Sarlo, C; Cefalo, M; Ditto, C; Di Veroli, A; Mariotti, B; Nasso, D; De Bellis, E; Del Poeta, G; Voso, Mt; Sconocchia, G; Lo Coco, F; Arcese, W; Amadori, S; Venditti, A";s:9:"metadata7";s:20:"10.1038/bmt.2016.308";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:47;a:14:{s:9:"citazione";s:348:"Canaani, J., Savani, B., Labopin, M., Huang, X., Ciceri, F., Arcese, W., et al. (2017). Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT. HAEMATOLOGICA, 102(6), 1066-1074 [10.3324/haematol.2016.160804].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_308103";s:6:"handle";s:11:"2108/177692";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:194:"Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT";s:9:"metadata6";s:166:"Canaani, J; Savani, B; Labopin, M; Huang, X; Ciceri, F; Arcese, W; Tischer, J; Koc, Y; Bruno, B; Gülbas, Z; Blaise, D; Maertens, J; Ehninger, G; Mohty, M; Nagler, A";s:9:"metadata7";s:28:"10.3324/haematol.2016.160804";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:48;a:14:{s:9:"citazione";s:309:"Cefalo, M., DEL PRINCIPE, M.I., Buccisano, F., Di Piazza, F., OTTAVIANI, L., Maurillo, L., et al. (2017). Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients. ANNALS OF HEMATOLOGY & ONCOLOGY, 4(4), 1-5.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_331620";s:6:"handle";s:11:"2108/198741";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:158:"Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients";s:9:"metadata6";s:262:"Cefalo, M; DEL PRINCIPE, MI; Buccisano, F; Di Piazza, F; OTTAVIANI, L; Maurillo, L; Sarlo, C; De Santis, G; Consalvo, M; De Bellis, E; De Angelis, G; Zizzari, A; Paterno, G; Divona, M; Postorino, M; Del Poeta, G; Sconocchia, G; Arcese, W; Amadori, S; Venditti, A";s:9:"metadata7";s:34:"10.26420/annhematoloncol.2017.1145";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:49;a:14:{s:9:"citazione";s:239:"De Bellis, E., Fianchi, L., Buccisano, F., Criscuolo, M., Maurillo, L., Cicconi, L., et al. (2017). Treatment of low-blast count AML using hypomethylating agents. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 9(1), e2017045.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_319174";s:6:"handle";s:11:"2108/187799";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:61:"Treatment of low-blast count AML using hypomethylating agents";s:9:"metadata6";s:180:"De Bellis, E; Fianchi, L; Buccisano, F; Criscuolo, M; Maurillo, L; Cicconi, L; Brescini, M; Del Principe, MI; Di Veroli, A; Venditti, A; Amadori, S; Arcese, W; Lo Coco, F; Voso, MT";s:9:"metadata7";s:22:"10.4084/mjhid.2017.045";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:50;a:14:{s:9:"citazione";s:360:"Eder, S., Beohou, E., Labopin, M., Sanz, J., Finke, J., Arcese, W., et al. (2017). Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 92(1), 18-22 [10.1002/ajh.24567].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_308052";s:6:"handle";s:11:"2108/177682";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:210:"Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation";s:9:"metadata6";s:145:"Eder, S; Beohou, E; Labopin, M; Sanz, J; Finke, J; Arcese, W; Or, R; Bonifazi, F; Aljurf, M; Socie, G; Passweg, J; Giebel, S; Mohty, M; Nagler, A";s:9:"metadata7";s:17:"10.1002/ajh.24567";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:51;a:14:{s:9:"citazione";s:446:"Eder, S., Canaani, J., Beohou, E., Labopin, M., Sanz, J., Arcese, W., et al. (2017). Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 92(10), 997-1003 [10.1002/ajh.24823].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_347691";s:6:"handle";s:11:"2108/212180";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Societ...";s:9:"metadata6";s:194:"Eder, S; Canaani, J; Beohou, E; Labopin, M; Sanz, J; Arcese, W; Or, R; Finke, J; Cortelezzi, A; Beelen, D; Passweg, J; Socie, G; Gurman, G; Aljurf, M; Stelljes, M; Giebel, S; Mohty, M; Nagler, A";s:9:"metadata7";s:17:"10.1002/ajh.24823";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:52;a:14:{s:9:"citazione";s:364:"Girmenia, C., Bertaina, A., Piciocchi, A., Perruccio, K., Algarotti, A., Busca, A., et al. (2017). Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. CLINICAL INFECTIOUS DISEASES, 65(11), 1884-1896 [10.1093/cid/cix690].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_327896";s:6:"handle";s:11:"2108/195487";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:194:"Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey";s:9:"metadata6";s:2094:"Girmenia, C; Bertaina, A; Piciocchi, A; Perruccio, K; Algarotti, A; Busca, A; Cattaneo, C; Raiola, Am; Guidi, S; Iori, Ap; Candoni, A; Irrera, G; Milone, G; Marcacci, G; Scime, R; Musso, M; Cudillo, L; Sica, S; Castagna, L; Corradini, P; Marchesi, F; Pastore, D; Alessandrino, Ep; Annaloro, C; Ciceri, F; Santarone, S; Nassi, L; Farina, C; Viscoli, C; Rossolini, Gm; Bonifazi, F; Rambaldi, A; Capria, S; Bertaina, A; Mastronuzzi, A; Pagliara, D; Bernaschi, P; Amico, L; Carotti, A; Mencacci, A; Busca, A; Bruno, B; Costa, C; Passi, A; Ravizzola, G; Angelucci, E; Marchese, A; Pecile, P; Candoni, A; Ventura, G; Fanin, R; Scarparo, C; Barbaro, A; Milone, G; Leotta, S; Marchese, Ae; Marcacci, G; Becchimanzi, C; Donnarumma, D; Tringali, S; Baldi, Mt; Scalone, R; Picardi, A; Arcese, W; Fontana, C; Sica, S; Giammarco, S; Spanu, T; Castagna, L; Crocchiolo, R; Casari, E; Mussetti, A; Conte, E; Ensoli, F; Miragliotta, G; Marone, P; Arghittu, M; Greco, R; Forcina, A; Chichero, P; Santarone, S; Di Bartolomeo, P; Fazii, P; Kroumova, V; Decembrino, N; Zecca, M; Pisapia, G; Palazzo, G; Lanino, E; Faraci, M; Castagnola, E; Bandettini, R; Pastano, R; Sammassimo, S; Passerini, R; Stefani, Pm; Gherlinzoni, F; Rigoli, R; Prezioso, L; Cambo, B; Calderaro, A; Carella, Am; Cascavilla, N; Labonia, Mt; Celeghini, I; Mordini, N; Piana, F; Vacca, A; Sanna, M; Podda, G; Corsetti, Mt; Rocchetti, A; Cilloni, D; De Gobbi, M; Bianco, O; Fagioli, F; Carraro, F; De Intinis, G; Severino, A; Proia, A; Parisi, G; Vallisa, D; Confalonieri, M; Russo, D; Malagola, M; Galieni, P; Falcioni, S; Travaglini, V; Raimondi, R; Borghero, C; Pavan, G; Prete, A; Belotti, T; Ambretti, S; Imola, M; Mianulli, Am; Pedna, Mf; Cesaro, S; Lo Cascio, G; Ferrari, A; Piedimonte, M; Santino, I; Calandrelli, M; Olivieri, A; Orecchioni, F; Mirabile, M; Centurioni, R; Gironacci, L; Caravelli, D; Gallo, S; De Filippi, M; Cupelli, L; Dentamaro, T; Falco, S; Eugenio, Os; Marotta, S; Risitano, A; Lula, D; Musto, P; Pietrantuono, G; Traficante, A; Cerchiara, E; Tirindelli, Mc; Dicuonzo, G; Chierichini, A; Anaclerico, B; Placanica, P";s:9:"metadata7";s:18:"10.1093/cid/cix690";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:53;a:14:{s:9:"citazione";s:442:"Gorin, N., Labopin, M., Czerw, T., Pabst, T., Blaise, D., Dumas, P., et al. (2017). Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission—Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). CANCER, 123(5), 824-831 [10.1002/cncr.30400].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_308049";s:6:"handle";s:11:"2108/177673";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission—Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the E...";s:9:"metadata6";s:209:"Gorin, N; Labopin, M; Czerw, T; Pabst, T; Blaise, D; Dumas, P; Nemet, D; Arcese, W; Trisolini, S; Wu, D; Huynh, A; Zuckerman, T; Meijer, E; Cagirgan, S; Cornelissen, J; Houhou, M; Polge, E; Mohty, M; Nagler, A";s:9:"metadata7";s:18:"10.1002/cncr.30400";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:54;a:14:{s:9:"citazione";s:343:"Marchesi, F., Tendas, A., Giannarelli, D., Viggiani, C., Gumenyuk, S., Renzi, D., et al. (2017). Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study. BONE MARROW TRANSPLANTATION, 52(1), 154-156 [10.1038/bmt.2016.207].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_290628";s:6:"handle";s:11:"2108/162746";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:177:"Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study";s:9:"metadata6";s:238:"Marchesi, F; Tendas, A; Giannarelli, D; Viggiani, C; Gumenyuk, S; Renzi, D; Franceschini, L; Caffarella, G; Rizzo, M; Palombi, F; Pisani, F; Romano, A; Spadea, A; Papa, E; Canfora, M; Pignatelli, A; Cantonetti, M; Arcese, W; Mengarelli, A";s:9:"metadata7";s:20:"10.1038/bmt.2016.207";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:55;a:14:{s:9:"citazione";s:276:"Paviglianiti, A., Ruggeri, A., Volt, F., Sanz, G., Milpied, N., Furst, S., et al. (2017). Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies. BRITISH JOURNAL OF HAEMATOLOGY [10.1111/bjh.14962].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_321692";s:6:"handle";s:11:"2108/190176";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:133:"Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies";s:9:"metadata6";s:229:"Paviglianiti, A; Ruggeri, A; Volt, F; Sanz, G; Milpied, N; Furst, S; Esquirol, A; Arcese, W; Picardi, A; Ferra, C; Ifrah, N; Bourhis, Jh; Raj, K; Von Dem Borne, Pa; Sica, S; Menard, A-L; Bloor, A; Kenzey, C; Gluckman, E; Rocha, V";s:9:"metadata7";s:17:"10.1111/bjh.14962";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:56;a:14:{s:9:"citazione";s:334:"Picardi, A., Arcese, W., Pollichieni, S., Di Piazza, F., Mangione, I., Gallina, A.m., et al. (2017). The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy. TRANSFUSION, 57(7), 1734-1743 [10.1111/trf.14131].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_318500";s:6:"handle";s:11:"2108/187183";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:181:"The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy";s:9:"metadata6";s:240:"Picardi, A; Arcese, W; Pollichieni, S; Di Piazza, F; Mangione, I; Gallina, Am; Cerretti, R; Cudillo, L; De Angelis, G; Mengarelli, A; Dentamaro, T; Tirindelli, Mc; Chierichini, A; Ferrari, A; Marciano, R; Andreani, M; Bonifazi, F; Sacchi, N";s:9:"metadata7";s:17:"10.1111/trf.14131";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:57;a:14:{s:9:"citazione";s:332:"Picardi, A., Ferraro, A.S., Miranda, M., Meconi, F., Lanti, A., Adorno, G., et al. (2017). Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation. ORAL & IMPLANTOLOGY, 10(4), 398-405 [10.11138/orl/2017.10.4.398].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_384392";s:6:"handle";s:11:"2108/242729";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:174:"Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation";s:9:"metadata6";s:90:"Picardi, A; Ferraro, AS; Miranda, M; Meconi, F; Lanti, A; Adorno, G; Arcese, W; Bollero, P";s:9:"metadata7";s:26:"10.11138/orl/2017.10.4.398";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:58;a:14:{s:9:"citazione";s:319:"Picardi, A., Miranda, M., Liciani, F., Paterno, G., Arcese, W., & Bollero, P. (2017). Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation. ORAL & IMPLANTOLOGY, 10(4), 390-397 [10.11138/orl/2017.10.4.390].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_384391";s:6:"handle";s:11:"2108/242728";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:166:"Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation";s:9:"metadata6";s:69:"Picardi, A; Miranda, M; Liciani, F; Paterno, G; Arcese, W; Bollero, P";s:9:"metadata7";s:26:"10.11138/orl/2017.10.4.390";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:59;a:14:{s:9:"citazione";s:308:"Piemontese, S., Ciceri, F., Labopin, M., ARCESE, W., Kyrcz Krzemien, S., Santarone, S., et al. (2017). A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia. JOURNAL OF HEMATOLOGY & ONCOLOGY, 10(1), 1-8 [10.1186/s13045-017-0394-2].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_308102";s:6:"handle";s:11:"2108/177688";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:130:"A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia";s:9:"metadata6";s:171:"Piemontese, S; Ciceri, F; Labopin, M; ARCESE, W; Kyrcz Krzemien, S; Santarone, S; Huang, H; Beelen, D; Gorin, N; Craddock, C; Gulbas, Z; Bacigalupo, A; Mohty, M; Nagler, A";s:9:"metadata7";s:25:"10.1186/s13045-017-0394-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:60;a:14:{s:9:"citazione";s:291:"Ruggeri, A., Sun, Y., Labopin, M., Bacigalupo, A., Lorentino, F., Arcese, W., et al. (2017). Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. HAEMATOLOGICA, 102(2), 401-410 [10.3324/haematol.2016.151779].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_308054";s:6:"handle";s:11:"2108/177680";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:134:"Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant";s:9:"metadata6";s:212:"Ruggeri, A; Sun, Y; Labopin, M; Bacigalupo, A; Lorentino, F; Arcese, W; Santarone, S; Gulbas, Z; Blaise, D; Messina, G; Ghavamzadeh, A; Malard, F; Bruno, B; Diez-Martin, Jl; Koc, Y; Ciceri, F; Mohty, M; Nagler, A";s:9:"metadata7";s:28:"10.3324/haematol.2016.151779";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:61;a:14:{s:9:"citazione";s:325:"Saraceni, F., Bruno, B., Lemoli, R.m., Meloni, G., Arcese, W., Falda, M., et al. (2017). Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission. BONE MARROW TRANSPLANTATION, 52(1), 163-166 [10.1038/bmt.2016.233].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_308055";s:6:"handle";s:11:"2108/177677";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:167:"Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission";s:9:"metadata6";s:203:"Saraceni, F; Bruno, B; Lemoli, Rm; Meloni, G; Arcese, W; Falda, M; Ciceri, F; Alessandrino, Ep; Specchia, G; Scime, R; Raimondi, R; Bacigalupo, A; Bosi, A; Onida, F; Rambaldi, A; Bonifazi, F; Olivieri, A";s:9:"metadata7";s:20:"10.1038/bmt.2016.233";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:62;a:14:{s:9:"citazione";s:416:"Sarmati, L., Andreoni, M., Antonelli, G., Arcese, W., Bruno, R., Coppola, N., et al. (2017). Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper. CLINICAL MICROBIOLOGY AND INFECTION, 23(12), 935-940 [10.1016/j.cmi.2017.06.023].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_347699";s:6:"handle";s:11:"2108/212174";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:240:"Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper";s:9:"metadata6";s:208:"Sarmati, L; Andreoni, M; Antonelli, G; Arcese, W; Bruno, R; Coppola, N; Gaeta, Gb; Galli, M; Girmenia, C; Mikulska, M; Pane, F; Perno, Cf; Picardi, M; Puoti, M; Rambaldi, A; Svicher, V; Taliani, G; Gentile, G";s:9:"metadata7";s:25:"10.1016/j.cmi.2017.06.023";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:63;a:14:{s:9:"citazione";s:324:"Scarlata, S., Annibali, O., Santangelo, S., Tomarchio, V., Ferraro, S., Armiento, D., et al. (2017). Pulmonary complications and survival after autologous stem cell transplantation: Predictive role of pulmonary function and pneumotoxic medications. EUROPEAN RESPIRATORY JOURNAL, 49(3), 1601902 [10.1183/13993003.01902-2016].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_347716";s:6:"handle";s:11:"2108/212164";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:146:"Pulmonary complications and survival after autologous stem cell transplantation: Predictive role of pulmonary function and pneumotoxic medications";s:9:"metadata6";s:129:"Scarlata, S; Annibali, O; Santangelo, S; Tomarchio, V; Ferraro, S; Armiento, D; Scardocci, A; Arcese, W; Incalzi, Ra; Avvisati, G";s:9:"metadata7";s:27:"10.1183/13993003.01902-2016";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:64;a:14:{s:9:"citazione";s:283:"Shouval, R., Ruggeri, A., Labopin, M., Mohty, M., Sanz, G., Michel, G., et al. (2017). An integrative scoring system for survival prediction following umbilical cord blood transplantation in acute leukemia. CLINICAL CANCER RESEARCH, 23(21), 6478-6486 [10.1158/1078-0432.CCR-17-0489].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_347697";s:6:"handle";s:11:"2108/212176";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:118:"An integrative scoring system for survival prediction following umbilical cord blood transplantation in acute leukemia";s:9:"metadata6";s:229:"Shouval, R; Ruggeri, A; Labopin, M; Mohty, M; Sanz, G; Michel, G; Kuball, J; Chevallier, P; Al-Seraihy, A; Milpied, N-; De Heredia, Cd; Arcese, W; Blaise, D; Rocha, V; Fein, J; Unger, R; Baron, F; Bader, P; Gluckman, E; Nagler, A";s:9:"metadata7";s:29:"10.1158/1078-0432.CCR-17-0489";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:65;a:14:{s:9:"citazione";s:321:"Todisco, E., Ciceri, F., Boschini, C., Giglio, F., Bacigalupo, A., Patriarca, F., et al. (2017). Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO). BONE MARROW TRANSPLANTATION [10.1038/bmt.2016.325].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_308104";s:6:"handle";s:11:"2108/177690";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:171:"Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)";s:9:"metadata6";s:258:"Todisco, E; Ciceri, F; Boschini, C; Giglio, F; Bacigalupo, A; Patriarca, F; Donnini, I; Alessandrino, Ep; Arcese, W; Iori, Ap; Marenco, P; Cavattoni, I; Chiusolo, P; Terruzzi, E; Castagna, L; Santoro, A; Bosi, A; Oldani, E; Bruno, B; Bonifazi, F; Rambaldi, A";s:9:"metadata7";s:20:"10.1038/bmt.2016.325";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:66;a:14:{s:9:"citazione";s:329:"Del Principe, M.I., Buccisano, F., Maurillo, L., Sconocchia, G., Cefalo, M., Consalvo, M., et al. (2016). Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 8(1), e2016052 [10.4084/MJHID.2016.052].";s:4:"data";s:10:"2016-10-20";s:2:"id";s:20:"PUBBLICAZIONE_303233";s:6:"handle";s:11:"2108/173741";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/06 - Oncologia Medica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications";s:9:"metadata6";s:265:"Del Principe, MI; Buccisano, F; Maurillo, L; Sconocchia, G; Cefalo, M; Consalvo, M; Sarlo, C; Conti, C; De Santis, G; De Bellis, E; Di Veroli, A; Palomba, P; Attrotto, C; Zizzari, A; Paterno, G; Voso, MT; Del Poeta, G; Lo Coco, F; Arcese, W; Amadori, S; Venditti, A";s:9:"metadata7";s:22:"10.4084/MJHID.2016.052";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:67;a:14:{s:9:"citazione";s:401:"Cerva, C., Colagrossi, L., Maffongelli, G., Salpini, R., Di Carlo, D., Malagnino, V., et al. (2016). Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. CLINICAL MICROBIOLOGY AND INFECTION, 22(11), 946.e1-946.e8 [10.1016/j.cmi.2016.07.021].";s:4:"data";s:10:"2016-07-27";s:2:"id";s:20:"PUBBLICAZIONE_290349";s:6:"handle";s:11:"2108/164129";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:211:"Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor";s:9:"metadata6";s:254:"Cerva, C; Colagrossi, L; Maffongelli, G; Salpini, R; Di Carlo, D; Malagnino, V; Battisti, A; Ricciardi, A; Pollicita, M; Bianchi, A; Picardi, A; Cudillo, L; Cerretti, R; Angelis, G; Cantonetti, M; Andreoni, M; Perno, CF; Arcese, W; Svicher, V; Sarmati, L";s:9:"metadata7";s:25:"10.1016/j.cmi.2016.07.021";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:68;a:14:{s:9:"citazione";s:322:"Rocha, V., Ruggeri, A., Spellman, S., Wang, T., Sobecks, R., Locatelli, F., et al. (2016). Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(7), 1284-1289 [10.1016/j.bbmt.2016.04.007].";s:4:"data";s:7:"2016-07";s:2:"id";s:20:"PUBBLICAZIONE_290626";s:6:"handle";s:11:"2108/162748";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:138:"Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia";s:9:"metadata6";s:165:"Rocha, V; Ruggeri, A; Spellman, S; Wang, T; Sobecks, R; Locatelli, F; Askar, M; Michel, G; Arcese, W; Iori, Ap; Purtill, D; Danby, R; Sanz, Gf; Gluckman, E; Eapen, M";s:9:"metadata7";s:26:"10.1016/j.bbmt.2016.04.007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:69;a:14:{s:9:"citazione";s:341:"De Felice, L., AGOSTINI, F., Suriano, C., Fraboni, D., Gregorj, C., Tirindelli, M., et al. (2016). Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2016.06.024].";s:4:"data";s:10:"2016-06-24";s:2:"id";s:20:"PUBBLICAZIONE_290618";s:6:"handle";s:11:"2108/162738";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:167:"Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors";s:9:"metadata6";s:145:"De Felice, L; AGOSTINI, F; Suriano, C; Fraboni, D; Gregorj, C; Tirindelli, M; PICARDI, A; Santarone, S; Di Piazza, F; Di Bartolomeo, P; ARCESE, W";s:9:"metadata7";s:26:"10.1016/j.bbmt.2016.06.024";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:70;a:14:{s:9:"citazione";s:244:"Tendas, A., Cupelli, L., Mauroni, M.r., Sollazzo, F., Di Piazza, F., Saltarelli, D., et al. (2016). Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy?. CANCER, 122(9), 1461-1462 [10.1002/cncr.29943].";s:4:"data";s:10:"2016-05-01";s:2:"id";s:20:"PUBBLICAZIONE_290629";s:6:"handle";s:11:"2108/162740";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:95:"Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy?";s:9:"metadata6";s:260:"Tendas, A; Cupelli, L; Mauroni, Mr; Sollazzo, F; Di Piazza, F; Saltarelli, D; Carli, I; Chierichini, A; Melfa, C; Surano, Ma; Annibali, O; Piedimonte, M; Conte, E; Marchesi, F; Viggiani, C; Pignatelli, Ac; Dentamaro, T; de Fabritiis, P; Perrotti, Ap; Arcese, W";s:9:"metadata7";s:18:"10.1002/cncr.29943";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:71;a:14:{s:9:"citazione";s:318:"Gratwohl, A., Iacobelli, S., Bootsman, N., van Biezen, A., Baldomero, H., Arcese, W., et al. (2016). Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. ANNALS OF HEMATOLOGY, 95(6), 967-972 [10.1007/s00277-016-2638-6].";s:4:"data";s:7:"2016-05";s:2:"id";s:20:"PUBBLICAZIONE_290620";s:6:"handle";s:11:"2108/163034";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:69:"CML; HSCT; Long-term follow-up; Randomized trial; Splenic irradiation";s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";s:1268:"In the context of discussions on the reproducibility of clinical studies, we reanalyzed a prospective randomized study on the role of splenic irradiation as adjunct to the conditioning for hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML). Between 1986 and 1989, a total of 229 patients with CML were randomized; of these, 225 (98 %; 112 with, 113 without splenic irradiation) could be identified in the database and their survival updated. Results confirmed the early findings with no significant differences in all measured endpoints (overall survival at 25 years: 42.7 %, 32.0-52.4 % vs 52.9 %, 43.2-62.6 %; p = 0.355, log rank test). Additional splenic irradiation failed to reduce relapse incidence. It did not increase non-relapse mortality nor the risk of late secondary malignancies. Comforting are the long-term results from this predefined consecutive cohort of patients: more than 60 % were alive at plus 25 years when they were transplanted with a low European Society for Blood and Marrow Transplantation (EBMT) risk sore. This needs to be considered today when treatment options are discussed for patients who failed initial tyrosine kinase inhibitor therapy and have an available low risk HLA-identical donor.";s:9:"metadata5";s:150:"Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study";s:9:"metadata6";s:314:"Gratwohl, A; Iacobelli, S; Bootsman, N; van Biezen, A; Baldomero, H; Arcese, W; Arnold, R; Bron, D; Cordonnier, C; Ernst, P; Ferrant, A; Frassoni, F; Gahrton, G; Richard, C; Kolb, Hj; Link, H; Niederwieser, D; Ruutu, T; Schattenberg, A; Schmitz, N; Torres-Gomez, A; Zwaan, F; Apperley, J; Olavarria, E; Kröger, N";s:9:"metadata7";s:25:"10.1007/s00277-016-2638-6";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:72;a:14:{s:9:"citazione";s:325:"Tendas, A., Cupelli, L., Mauroni, M.R., Sollazzo, F., Di Piazza, F., Saltarelli, D., et al. (2016). Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network. BONE MARROW TRANSPLANTATION, 51(5), 638-639 [10.1038/bmt.2015.341].";s:4:"data";s:10:"2016-01-11";s:2:"id";s:20:"PUBBLICAZIONE_254764";s:6:"handle";s:11:"2108/239780";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:156:"Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network";s:9:"metadata6";s:271:"Tendas, A; Cupelli, L; Mauroni, MR; Sollazzo, F; Di Piazza, F; Saltarelli, D; Carli, I; Chierichini, A; Melfa, C; Surano, M; Annibali, O; Piedimonte, M; Conte, E; Marchesi, F; Viggiani, C; Pignatelli, AC; Dentamaro, T; Niscola, P; de Fabritiis, P; Perrotti, AP; Arcese, W";s:9:"metadata7";s:20:"10.1038/bmt.2015.341";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:73;a:14:{s:9:"citazione";s:287:"Piñana, J.l., Sanz, J., Esquirol, A., Martino, R., Picardi, A., Barba, P., et al. (2016). Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease. EUROPEAN JOURNAL OF HAEMATOLOGY [10.1111/ejh.12557].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_254716";s:6:"handle";s:11:"2108/212112";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:141:"Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease";s:9:"metadata6";s:193:"Piñana, Jl; Sanz, J; Esquirol, A; Martino, R; Picardi, A; Barba, P; Parody, R; Gayoso, J; Montesinos, P; Guidi, S; Terol, Mj; Moscardó, F; Solano, C; Arcese, W; Sanz, Ma; Sierra, J; Sanz, G";s:9:"metadata7";s:17:"10.1111/ejh.12557";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:74;a:14:{s:9:"citazione";s:398:"Renzi, D., Marchesi, F., De Angelis, G., Elia, L., Salvatorelli, E., Gumenyuk, S., et al. (2016). Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant. CHEMOTHERAPY, 62(1), 58-61 [10.1159/000448750].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_308000";s:6:"handle";s:11:"2108/177686";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:251:"Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant";s:9:"metadata6";s:167:"Renzi, D; Marchesi, F; De Angelis, G; Elia, L; Salvatorelli, E; Gumenyuk, S; Palombi, F; Pisani, F; Romano, A; Spadea, A; Papa, E; Canfora, M; Arcese, W; Mengarelli, A";s:9:"metadata7";s:17:"10.1159/000448750";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:75;a:14:{s:9:"citazione";s:333:"Rubio, M.t., Savani, B.n., Labopin, M., Piemontese, S., Polge, E., Ciceri, F., et al. (2016). Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT. JOURNAL OF HEMATOLOGY & ONCOLOGY, 9(1), 25 [10.1186/s13045-016-0248-3].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_290621";s:6:"handle";s:11:"2108/162753";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:166:"Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT";s:9:"metadata6";s:217:"Rubio, Mt; Savani, Bn; Labopin, M; Piemontese, S; Polge, E; Ciceri, F; Bacigalupo, A; Arcese, W; Koc, Y; Beelen, D; Gülbas, Z; Wu, D; Santarone, S; Tischer, J; Afanasyev, B; Schmid, C; Giebel, S; Mohty, M; Nagler, A";s:9:"metadata7";s:25:"10.1186/s13045-016-0248-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:76;a:14:{s:9:"citazione";s:383:"Saraceni, F., Labopin, M., Gorin, N., Blaise, D., Tabrizi, R., Volin, L., et al. (2016). Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT. JOURNAL OF HEMATOLOGY & ONCOLOGY, 9(1), 79 [10.1186/s13045-016-0314-x].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_290624";s:6:"handle";s:11:"2108/162751";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:221:"Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT";s:9:"metadata6";s:168:"Saraceni, F; Labopin, M; Gorin, N; Blaise, D; Tabrizi, R; Volin, L; Cornelissen, J; Cahn, J; Chevallier, P; Craddock, C; Wu, D; Huynh, A; Arcese, W; Mohty, M; Nagler, A";s:9:"metadata7";s:25:"10.1186/s13045-016-0314-x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:77;a:14:{s:9:"citazione";s:277:"Mengarelli, A., Annibali, O., Pimpinelli, F., Riva, E., Gumenyuk, S., Renzi, D., et al. (2015). Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. JOURNAL OF INFECTION, 72(2), 265-268 [10.1016/j.jinf.2015.11.005].";s:4:"data";s:10:"2015-12-12";s:2:"id";s:20:"PUBBLICAZIONE_254814";s:6:"handle";s:11:"2108/239782";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:113:"Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant";s:9:"metadata6";s:213:"Mengarelli, A; Annibali, O; Pimpinelli, F; Riva, E; Gumenyuk, S; Renzi, D; Cerchiara, E; Piccioni, L; Palombi, F; Pisani, F; Romano, A; Spadea, A; Papa, E; Cordone, I; Canfora, M; Arcese, W; Ensoli, F; Marchesi, F";s:9:"metadata7";s:26:"10.1016/j.jinf.2015.11.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:78;a:14:{s:9:"citazione";s:404:"Rambaldi, A., Grassi, A., Masciulli, A., Boschini, C., Micò, M.c., Busca, A., et al. (2015). Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. THE LANCET ONCOLOGY, 16(15), 1525-36 [10.1016/S1470-2045(15)00200-4].";s:4:"data";s:7:"2015-11";s:2:"id";s:20:"PUBBLICAZIONE_254706";s:6:"handle";s:11:"2108/203476";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:238:"Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial";s:9:"metadata6";s:419:"Rambaldi, A; Grassi, A; Masciulli, A; Boschini, C; Micò, Mc; Busca, A; Bruno, B; Cavattoni, I; Santarone, S; Raimondi, R; Montanari, M; Milone, G; Chiusolo, P; Pastore, D; Guidi, S; Patriarca, F; Risitano, Am; Saporiti, G; Pini, M; Terruzzi, E; Arcese, W; Marotta, G; Carella, Am; Nagler, A; Russo, D; Corradini, P; Alessandrino, Ep; Torelli, Gf; Scimè, R; Mordini, N; Oldani, E; Marfisi, Rm; Bacigalupo, A; Bosi, A";s:9:"metadata7";s:29:"10.1016/S1470-2045(15)00200-4";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:79;a:14:{s:9:"citazione";s:307:"Marchand, T., Lamy, T., Finel, H., Arcese, W., Choquet, S., Finke, J., et al. (2015). Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. LEUKEMIA, 30(5), 1201-1204 [10.1038/leu.2015.256].";s:4:"data";s:10:"2015-09-22";s:2:"id";s:20:"PUBBLICAZIONE_254738";s:6:"handle";s:11:"2108/239787";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:169:"Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation";s:9:"metadata6";s:215:"Marchand, T; Lamy, T; Finel, H; Arcese, W; Choquet, S; Finke, J; Huynh, A; Irrera, G; Karakasis, D; Konopacki, J; Lambert, J; Michieli, M; Schouten, HC; Schroyens, W; Sucak, G; Tischer, J; Vandenberghe, E; Dreger, P";s:9:"metadata7";s:20:"10.1038/leu.2015.256";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:80;a:14:{s:9:"citazione";s:284:"Ruggeri, A., Labopin, M., Sanz, G., Piemontese, S., Arcese, W., Bacigalupo, A., et al. (2015). Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. LEUKEMIA, 29(9), 1891-1900 [10.1038/leu.2015.98].";s:4:"data";s:7:"2015-09";s:2:"id";s:20:"PUBBLICAZIONE_254800";s:6:"handle";s:11:"2108/239796";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:138:"Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia";s:9:"metadata6";s:273:"Ruggeri, A; Labopin, M; Sanz, G; Piemontese, S; Arcese, W; Bacigalupo, A; Blaise, D; Bosi, A; Huang, H; Karakasis, D; Koc, Y; Michallet, M; Picardi, A; Sanz, J; Santarone, S; Sengelov, H; Sierra, J; Vincent, L; Volt, F; Nagler, A; Gluckman, E; Ciceri, F; Rocha, V; Mohty, M";s:9:"metadata7";s:19:"10.1038/leu.2015.98";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:81;a:14:{s:9:"citazione";s:264:"Ringdén, O., Labopin, M., Ciceri, F., Velardi, A., Bacigalupo, A., Arcese, W., et al. (2015). Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?. LEUKEMIA, 30(2), 447-455 [10.1038/leu.2015.232].";s:4:"data";s:10:"2015-08-21";s:2:"id";s:20:"PUBBLICAZIONE_254799";s:6:"handle";s:11:"2108/239799";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:118:"Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?";s:9:"metadata6";s:135:"Ringdén, O; Labopin, M; Ciceri, F; Velardi, A; Bacigalupo, A; Arcese, W; Ghavamzadeh, A; Hamladji, RM; Schmid, C; Nagler, A; Mohty, M";s:9:"metadata7";s:20:"10.1038/leu.2015.232";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:82;a:14:{s:9:"citazione";s:249:"Tendas, A., Niscola, P., Perrotti, A., Dentamaro, T., de Fabritiis, P., & Arcese, W. (2015). Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need. SUPPORTIVE CARE IN CANCER, 23(8), 2211-2211 [10.1007/s00520-015-2711-z].";s:4:"data";s:7:"2015-08";s:2:"id";s:20:"PUBBLICAZIONE_254781";s:6:"handle";s:11:"2108/239802";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:82:"Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need";s:9:"metadata6";s:76:"Tendas, A; Niscola, P; Perrotti, A; Dentamaro, T; de Fabritiis, P; Arcese, W";s:9:"metadata7";s:25:"10.1007/s00520-015-2711-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:83;a:14:{s:9:"citazione";s:308:"Arcese, W., Picardi, A., Santarone, S., De Angelis, G., Cerretti, R., Cudillo, L., et al. (2015). Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update. BONE MARROW TRANSPLANTATION, 50 Suppl 2, S24-S30 [10.1038/bmt.2015.91].";s:4:"data";s:7:"2015-06";s:2:"id";s:20:"PUBBLICAZIONE_254798";s:6:"handle";s:11:"2108/239805";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:137:"Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update";s:9:"metadata6";s:236:"Arcese, W; Picardi, A; Santarone, S; De Angelis, G; Cerretti, R; Cudillo, L; Pennese, E; Bavaro, P; Olioso, P; Dentamaro, T; Cupelli, L; Chierichini, A; Ferrari, A; Mengarelli, A; Tirindelli, MC; Testi, M; Di Piazza, F; Di Bartolomeo, P";s:9:"metadata7";s:19:"10.1038/bmt.2015.91";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:84;a:14:{s:9:"citazione";s:260:"Piemontese, S., Ciceri, F., Labopin, M., Bacigalupo, A., Huang, H., Santarone, S., et al. (2015). A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia. LEUKEMIA, 29(5), 1069-1075 [10.1038/leu.2014.336].";s:4:"data";s:7:"2015-05";s:2:"id";s:20:"PUBBLICAZIONE_254717";s:6:"handle";s:11:"2108/239814";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:110:"A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia";s:9:"metadata6";s:168:"Piemontese, S; Ciceri, F; Labopin, M; Bacigalupo, A; Huang, H; Santarone, S; Gorin, N; Koc, Y; Wu, D; Beelen, D; Tischer, J; Ehninger, G; Arcese, W; Nagler, A; Mohty, M";s:9:"metadata7";s:20:"10.1038/leu.2014.336";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:85;a:14:{s:9:"citazione";s:295:"Gorin, N., Labopin, M., Piemontese, S., Arcese, W., Santarone, S., Huang, H., et al. (2015). T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis. HAEMATOLOGICA, 100(4), 558-564 [10.3324/haematol.2014.111450].";s:4:"data";s:7:"2015-04";s:2:"id";s:20:"PUBBLICAZIONE_254769";s:6:"handle";s:11:"2108/239824";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:138:"T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis";s:9:"metadata6";s:172:"Gorin, N; Labopin, M; Piemontese, S; Arcese, W; Santarone, S; Huang, H; Meloni, G; Ferrara, F; Beelen, D; Sanz, M; Bacigalupo, A; Ciceri, F; Mailhol, A; Nagler, A; Mohty, M";s:9:"metadata7";s:28:"10.3324/haematol.2014.111450";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:86;a:14:{s:9:"citazione";s:431:"Marchesi, F., Cerchiara, E., Dessanti, M.L., Gumenyuk, S., Franceschini, L., Palombi, F., et al. (2015). Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network. BRITISH JOURNAL OF HAEMATOLOGY, 169(2), 293-296 [10.1111/bjh.13199].";s:4:"data";s:7:"2015-04";s:2:"id";s:20:"PUBBLICAZIONE_254649";s:6:"handle";s:11:"2108/239821";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:255:"Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Net...";s:9:"metadata6";s:175:"Marchesi, F; Cerchiara, E; Dessanti, ML; Gumenyuk, S; Franceschini, L; Palombi, F; Pisani, F; Romano, A; Spadea, A; Pupo, L; Annibali, O; La Malfa, A; Arcese, W; Mengarelli, A";s:9:"metadata7";s:17:"10.1111/bjh.13199";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:87;a:14:{s:9:"citazione";s:458:"Eder, S., Labopin, M., Arcese, W., Or, R., Majolino, I., Bacigalupo, A., et al. (2015). Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY, 96(1), 90-97 [10.1111/ejh.12553].";s:4:"data";s:10:"2015-03-21";s:2:"id";s:20:"PUBBLICAZIONE_254714";s:6:"handle";s:11:"2108/239829";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:255:"Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the E...";s:9:"metadata6";s:171:"Eder, S; Labopin, M; Arcese, W; Or, R; Majolino, I; Bacigalupo, A; de Rosa, G; Volin, L; Beelen, D; Veelken, H; Schaap, NPM; Kuball, J; Cornelissen, J; Nagler, A; Mohty, M";s:9:"metadata7";s:17:"10.1111/ejh.12553";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:88;a:14:{s:9:"citazione";s:257:"Ronci, C., Ferraro, A.S., Lanti, A., Missiroli, F., Sinopoli, S., Del Proposto, G., et al. (2015). Platelet-rich plasma as treatment for persistent ocular epithelial defects. TRANSFUSION AND APHERESIS SCIENCE, 52(3), 300-304 [10.1016/j.transci.2014.12.027].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_258095";s:6:"handle";s:11:"2108/245540";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/01";s:9:"metadata4";N;s:9:"metadata5";s:74:"Platelet-rich plasma as treatment for persistent ocular epithelial defects";s:9:"metadata6";s:157:"Ronci, C; Ferraro, AS; Lanti, A; Missiroli, F; Sinopoli, S; Del Proposto, G; Cipriani, C; De Felici, C; Ricci, F; Ciotti, M; Cudillo, L; Arcese, W; Adorno, G";s:9:"metadata7";s:29:"10.1016/j.transci.2014.12.027";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:89;a:14:{s:9:"citazione";s:272:"Maurillo, L., Buccisano, F., Piciocchi, A., Del Principe, M.I., Sarlo, C., Di Veroli, A., et al. (2014). Minimal Residual Disease as Biomarker for Optimal Biologic Dosing of ARA-C in Patients with Acute Myeloid Leukemia. AMERICAN JOURNAL OF HEMATOLOGY [10.1002/ajh.23893].";s:4:"data";s:10:"2014-10-31";s:2:"id";s:20:"PUBBLICAZIONE_211218";s:6:"handle";s:11:"2108/101940";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:114:"Minimal Residual Disease as Biomarker for Optimal Biologic Dosing of ARA-C in Patients with Acute Myeloid Leukemia";s:9:"metadata6";s:236:"Maurillo, L; Buccisano, F; Piciocchi, A; Del Principe, MI; Sarlo, C; Di Veroli, A; Panetta, P; Irno-Consalvo, M; Nasso, D; Ditto, C; Refrigeri, M; De Angelis, G; Cerretti, R; Arcese, W; Sconocchia, G; Lo-Coco, F; Amadori, S; Venditti, A";s:9:"metadata7";s:17:"10.1002/ajh.23893";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:90;a:14:{s:9:"citazione";s:390:"Duarte, R.F., Boumendil, A., Onida, F., Gabriel, I., Arranz, R., Arcese, W., et al. (2014). Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis. JOURNAL OF CLINICAL ONCOLOGY, 32(29), 3347-3348 [10.1200/JCO.2014.57.5597].";s:4:"data";s:10:"2014-10-10";s:2:"id";s:20:"PUBBLICAZIONE_254817";s:6:"handle";s:11:"2108/248262";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:221:"Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis";s:9:"metadata6";s:165:"Duarte, RF; Boumendil, A; Onida, F; Gabriel, I; Arranz, R; Arcese, W; Poiré, X; Kobbe, G; Narni, F; Cortelezzi, A; Olavarría, E; Schmitz, N; Sureda, A; Dreger, P";s:9:"metadata7";s:24:"10.1200/JCO.2014.57.5597";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:91;a:14:{s:9:"citazione";s:299:"Tirindelli, M., Flammia, G., Bove, P., Cerretti, R., Cudillo, L., De Angelis, G., et al. (2014). Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(10), 1612-1617 [10.1016/j.bbmt.2014.06.018].";s:4:"data";s:7:"2014-10";s:2:"id";s:20:"PUBBLICAZIONE_193404";s:6:"handle";s:10:"2108/92628";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:25:"Settore MED/24 - Urologia";s:9:"metadata4";N;s:9:"metadata5";s:108:"Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation";s:9:"metadata6";s:225:"Tirindelli, M; Flammia, G; Bove, P; Cerretti, R; Cudillo, L; De Angelis, G; Picardi, A; Annibali, O; Nobile, C; Cerchiara, E; Dentamaro, T; De Fabritiis, P; Lanti, A; Ferraro, A; Sergi, F; Di Piazza, F; Avvisati, G; Arcese, W";s:9:"metadata7";s:26:"10.1016/j.bbmt.2014.06.018";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:92;a:14:{s:9:"citazione";s:334:"Kharfan-Dabaja, M.A., Labopin, M., Bazarbachi, A., Hamladji, R.M., Blaise, D., Socié, G., et al. (2014). Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT. BONE MARROW TRANSPLANTATION, 49(9), 1170-1175 [10.1038/bmt.2014.133].";s:4:"data";s:7:"2014-09";s:2:"id";s:20:"PUBBLICAZIONE_254720";s:6:"handle";s:11:"2108/248264";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:156:"Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT";s:9:"metadata6";s:174:"Kharfan-Dabaja, MA; Labopin, M; Bazarbachi, A; Hamladji, RM; Blaise, D; Socié, G; Lioure, B; Bermudez, A; Lopez-Corral, L; Or, R; Arcese, W; Fegueux, N; Nagler, A; Mohty, M";s:9:"metadata7";s:20:"10.1038/bmt.2014.133";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:93;a:14:{s:9:"citazione";s:241:"Patriarca, F., Luznik, L., Medeot, M., Zecca, M., Bacigalupo, A., Di Bartolomeo, P., et al. (2014). Experts' considerations on HLA-haploidentical stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY, 93(3), 187-197 [10.1111/ejh.12322].";s:4:"data";s:7:"2014-09";s:2:"id";s:20:"PUBBLICAZIONE_254677";s:6:"handle";s:11:"2108/248270";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:71:"Experts' considerations on HLA-haploidentical stem cell transplantation";s:9:"metadata6";s:219:"Patriarca, F; Luznik, L; Medeot, M; Zecca, M; Bacigalupo, A; Di Bartolomeo, P; Arcese, W; Corradini, P; Ciceri, F; Vago, L; Kanakry, CG; Fleischhauer, K; Martelli, MF; Bosi, A; Rambaldi, A; Cesaro, S; Russo, D; Fanin, R";s:9:"metadata7";s:17:"10.1111/ejh.12322";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:94;a:14:{s:9:"citazione";s:282:"Ruggeri, A., Labopin, M., Sormani, M.P., Sanz, G., Sanz, J., Volt, F., et al. (2014). Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. HAEMATOLOGICA, 99(9), 1509-1515 [10.3324/haematol.2014.109280].";s:4:"data";s:7:"2014-09";s:2:"id";s:20:"PUBBLICAZIONE_254726";s:6:"handle";s:11:"2108/248268";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:131:"Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen";s:9:"metadata6";s:295:"Ruggeri, A; Labopin, M; Sormani, MP; Sanz, G; Sanz, J; Volt, F; Michel, G; Locatelli, F; Diaz De Heredia, C; O'Brien, T; Arcese, W; Iori, AP; Querol, S; Kogler, G; Lecchi, L; Pouthier, F; Garnier, F; Navarrete, C; Baudoux, E; Fernandes, J; Kenzey, C; Eapen, M; Gluckman, E; Rocha, V; Saccardi, R";s:9:"metadata7";s:28:"10.3324/haematol.2014.109280";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:95;a:14:{s:9:"citazione";s:476:"Tucunduva, L., Ruggeri, A., Sanz, G., Furst, S., Cornelissen, J., Linkesch, W., et al. (2014). Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation. BRITISH JOURNAL OF HAEMATOLOGY, 166(5), 749-757 [10.1111/bjh.12970].";s:4:"data";s:7:"2014-09";s:2:"id";s:20:"PUBBLICAZIONE_254754";s:6:"handle";s:11:"2108/248266";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:255:"Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party...";s:9:"metadata6";s:232:"Tucunduva, L; Ruggeri, A; Sanz, G; Furst, S; Cornelissen, J; Linkesch, W; Mannone, L; Ribera, J; Veelken, H; Yakoub-Agha, I; González Valentín, ME; Schots, R; Arcese, W; Montesinos, P; Labopin, M; Gluckman, E; Mohty, M; Rocha, V";s:9:"metadata7";s:17:"10.1111/bjh.12970";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:96;a:14:{s:9:"citazione";s:377:"Girmenia, C., Barosi, G., Piciocchi, A., ARCESE, W., Aversa, F., Bacigalupo, A., et al. (2014). Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(8), 1080-1088 [10.1016/j.bbmt.2014.02.018].";s:4:"data";s:7:"2014-08";s:2:"id";s:20:"PUBBLICAZIONE_254641";s:6:"handle";s:11:"2108/248272";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:188:"Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)";s:9:"metadata6";s:241:"Girmenia, C; Barosi, G; Piciocchi, A; ARCESE, W; Aversa, F; Bacigalupo, A; Bandini, G; Bosi, A; Busca, A; Castagnola, E; Caselli, D; Cesaro, S; Ciceri, F; Locasciulli, A; Locatelli, F; Mikulska, M; Pagano, L; Prete, A; Raiola, A; Rambaldi, A";s:9:"metadata7";s:26:"10.1016/j.bbmt.2014.02.018";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:97;a:14:{s:9:"citazione";s:387:"Nagler, A., Labopin, M., Gorin, N., Ferrara, F., Sanz, M.A., Wu, D., et al. (2014). Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. HAEMATOLOGICA, 99(8), 1380-1386 [10.3324/haematol.2014.105197].";s:4:"data";s:7:"2014-08";s:2:"id";s:20:"PUBBLICAZIONE_254756";s:6:"handle";s:11:"2108/248276";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:238:"Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:195:"Nagler, A; Labopin, M; Gorin, N; Ferrara, F; Sanz, MA; Wu, D; Gomez, AT; Lapusan, S; Irrera, G; Guimaraes, JE; Sousa, AB; Carella, AM; Vey, N; Arcese, W; Shimoni, A; Berger, R; Rocha, V; Mohty, M";s:9:"metadata7";s:28:"10.3324/haematol.2014.105197";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:98;a:14:{s:9:"citazione";s:281:"Testi, M., Andreani, M., Locatelli, F., Arcese, W., Troiano, M., Battarra, M., et al. (2014). Influence of the HLA characteristics of Italian patients on donor search outcome in unrelated hematopoietic stem cell transplantation. TISSUE ANTIGENS, 84(2), 198-205 [10.1111/tan.12355].";s:4:"data";s:7:"2014-08";s:2:"id";s:20:"PUBBLICAZIONE_254701";s:6:"handle";s:11:"2108/248274";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:133:"Influence of the HLA characteristics of Italian patients on donor search outcome in unrelated hematopoietic stem cell transplantation";s:9:"metadata6";s:96:"Testi, M; Andreani, M; Locatelli, F; Arcese, W; Troiano, M; Battarra, M; Gaziev, J; Lucarelli, G";s:9:"metadata7";s:17:"10.1111/tan.12355";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:99;a:14:{s:9:"citazione";s:401:"Tucunduva, L., Ruggeri, A., Sanz, G., Furst, S., Socié, G., Michallet, M., et al. (2014). Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. BONE MARROW TRANSPLANTATION, 49(7), 887-894 [10.1038/bmt.2014.72].";s:4:"data";s:7:"2014-07";s:2:"id";s:20:"PUBBLICAZIONE_254711";s:6:"handle";s:11:"2108/248278";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:241:"Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:251:"Tucunduva, L; Ruggeri, A; Sanz, G; Furst, S; Socié, G; Michallet, M; Arcese, W; Milpied, N; Yakoub-Agha, I; Linkesch, W; Cornelissen, J; Mannone, L; Iori, AP; Ribera, J; Sanz, J; Montesinos, P; Purtill, D; Labopin, M; Gluckman, E; Mohty, M; Rocha, V";s:9:"metadata7";s:19:"10.1038/bmt.2014.72";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:100;a:14:{s:9:"citazione";s:219:"Sollazzo, F., Tendas, A., Conte, E., Bianchi, M.P., Niscola, P., Cupelli, L., et al. (2014). Bone marrow aspiration and biopsy-related pain management. ANNALS OF HEMATOLOGY, 93(6), 1061-1062 [10.1007/s00277-013-1926-7].";s:4:"data";s:7:"2014-06";s:2:"id";s:20:"PUBBLICAZIONE_254698";s:6:"handle";s:11:"2108/248280";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:57:"Bone marrow aspiration and biopsy-related pain management";s:9:"metadata6";s:264:"Sollazzo, F; Tendas, A; Conte, E; Bianchi, MP; Niscola, P; Cupelli, L; Mauroni, MR; Molinari, V; D'Apolito, A; Pilozzi, V; Cacciaraichi, S; Viggiani, C; Pignatelli, AC; Annibali, O; Mengarelli, A; Dentamaro, T; de Fabritiis, P; Ferrari, A; Montefusco, E; Arcese, W";s:9:"metadata7";s:25:"10.1007/s00277-013-1926-7";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:101;a:14:{s:9:"citazione";s:391:"Ruggeri, A., Sanz, G., Bittencourt, H., Sanz, J., Rambaldi, A., Volt, F., et al. (2014). Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT. LEUKEMIA, 28(4), 779-786 [10.1038/leu.2013.259].";s:4:"data";s:7:"2014-04";s:2:"id";s:20:"PUBBLICAZIONE_254758";s:6:"handle";s:11:"2108/248282";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:252:"Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT";s:9:"metadata6";s:195:"Ruggeri, A; Sanz, G; Bittencourt, H; Sanz, J; Rambaldi, A; Volt, F; Yakoub-Agha, I; Ribera, JM; Mannone, L; Sierra, J; Mohty, M; Solano, C; Nabhan, S; Arcese, W; Gluckman, E; Labopin, M; Rocha, V";s:9:"metadata7";s:20:"10.1038/leu.2013.259";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:102;a:14:{s:9:"citazione";s:302:"Labopin, M., Gorin, N., Polge, E., Socié, G., Gurman, G., Gluckman, E., et al. (2014). A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. BONE MARROW TRANSPLANTATION, 49(3), 376-381 [10.1038/bmt.2013.178].";s:4:"data";s:7:"2014-03";s:2:"id";s:20:"PUBBLICAZIONE_254853";s:6:"handle";s:11:"2108/248291";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:144:"A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality";s:9:"metadata6";s:162:"Labopin, M; Gorin, N; Polge, E; Socié, G; Gurman, G; Gluckman, E; Jindra, P; Poiré, X; Schäfer-Eckart, K; Ruutu, T; Milone, G; Arcese, W; Mohty, M; Rocha, V";s:9:"metadata7";s:20:"10.1038/bmt.2013.178";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:103;a:14:{s:9:"citazione";s:253:"Scerpa, M.C., Rossi, C., Daniele, N., Lanti, A., Adorno, G., Picardi, A., et al. (2014). A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. TRANSFUSION, 54(3), 522-531 [10.1111/trf.12307].";s:4:"data";s:7:"2014-03";s:2:"id";s:20:"PUBBLICAZIONE_254721";s:6:"handle";s:11:"2108/248288";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:114:"A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant";s:9:"metadata6";s:110:"Scerpa, MC; Rossi, C; Daniele, N; Lanti, A; Adorno, G; Picardi, A; Arcese, W; Amadori, S; Isacchi, G; Zinno, F";s:9:"metadata7";s:17:"10.1111/trf.12307";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:104;a:14:{s:9:"citazione";s:390:"Marchesi, F., Mengarelli, A., Giannotti, F., Tendas, A., Anaclerico, B., Porrini, R., et al. (2014). High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. TRANSPLANT INFECTIOUS DISEASE, 16(1), 158-164 [10.1111/tid.12162].";s:4:"data";s:7:"2014-02";s:2:"id";s:20:"PUBBLICAZIONE_254672";s:6:"handle";s:11:"2108/248293";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:221:"High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network";s:9:"metadata6";s:262:"Marchesi, F; Mengarelli, A; Giannotti, F; Tendas, A; Anaclerico, B; Porrini, R; Picardi, A; Cerchiara, E; Dentamaro, T; Chierichini, A; Romeo, A; Cudillo, L; Montefusco, E; Tirindelli, MC; De Fabritiis, P; Annino, L; Petti, MC; Monarca, B; Arcese, W; Avvisati, G";s:9:"metadata7";s:17:"10.1111/tid.12162";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:105;a:14:{s:9:"citazione";s:291:"Piñana, J.L., Sanz, J., Picardi, A., Ferrá, C., Martino, R., Barba, P., et al. (2014). Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. HAEMATOLOGICA, 99(2), 378-384 [10.3324/haematol.2013.091009].";s:4:"data";s:7:"2014-02";s:2:"id";s:20:"PUBBLICAZIONE_254766";s:6:"handle";s:11:"2108/248297";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:137:"Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia";s:9:"metadata6";s:198:"Piñana, JL; Sanz, J; Picardi, A; Ferrá, C; Martino, R; Barba, P; Gonzalez-Vicent, M; Pascual, MJ; Martín, C; Verdeguer, A; de Heredia, CD; Montesinos, P; Ribera, J; Sanz, M; Arcese, W; Sanz, G";s:9:"metadata7";s:28:"10.3324/haematol.2013.091009";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:106;a:14:{s:9:"citazione";s:290:"Eapen, M., Klein, J.P., Ruggeri, A., Spellman, S., Lee, S.J., Anasetti, C., et al. (2014). Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. BLOOD, 123(1), 133-140 [10.1182/blood-2013-05-506253].";s:4:"data";s:10:"2014-01-02";s:2:"id";s:20:"PUBBLICAZIONE_254760";s:6:"handle";s:11:"2108/248299";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:143:"Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy";s:9:"metadata6";s:259:"Eapen, M; Klein, JP; Ruggeri, A; Spellman, S; Lee, SJ; Anasetti, C; Arcese, W; Barker, JN; Baxter-Lowe, LA; Brown, M; Fernandez-Vina, MA; Freeman, J; He, W; Iori, AP; Horowitz, MM; Locatelli, F; Marino, S; Maiers, M; Michel, G; Sanz, GF; Gluckman, E; Rocha, V";s:9:"metadata7";s:28:"10.1182/blood-2013-05-506253";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:107;a:14:{s:9:"citazione";s:318:"Cunha, R., Loiseau, P., Ruggeri, A., Sanz, G., Michel, G., Iori, A.P., et al. (2014). Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis. BONE MARROW TRANSPLANTATION, 49(1), 24-29 [10.1038/bmt.2013.120].";s:4:"data";s:7:"2014-01";s:2:"id";s:20:"PUBBLICAZIONE_254816";s:6:"handle";s:11:"2108/248302";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:165:"Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis";s:9:"metadata6";s:313:"Cunha, R; Loiseau, P; Ruggeri, A; Sanz, G; Michel, G; Iori, AP; Paolaiori, A; Socié, G; Arcese, W; Picardi, A; Dias de Heredia, C; Rio, B; Locatelli, F; O'Brien, TA; Yakoub-Agha, I; Angel Diaz, M; Milpied, N; Bittencourt, H; Pedro Souza, M; Aljurf, M; Charron, D; Boudjedir, K; Labopin, M; Gluckman, E; Rocha, V";s:9:"metadata7";s:20:"10.1038/bmt.2013.120";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:108;a:14:{s:9:"citazione";s:293:"Chuna, R., Loiseau, P., Ruggeri, A., Sanz, G., Michel, G., Paolaiori, A., et al. (2014). Impact of HLA mismatch direction on outcome after umbilical cord blood transplantation for hematological malignant disorders: a retrospective eurocord-EBMT analysis. BONE MARROW TRANSPLANTATION, 120, 1-6.";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_212772";s:6:"handle";s:11:"2108/101270";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:165:"Impact of HLA mismatch direction on outcome after umbilical cord blood transplantation for hematological malignant disorders: a retrospective eurocord-EBMT analysis.";s:9:"metadata6";s:296:"Chuna, R; Loiseau, P; Ruggeri, A; Sanz, G; Michel, G; Paolaiori, A; Sociè, G; Arcese, W; Picardi, A; Dias de Heredia, C; Rio, B; Locatelli, F; O'Brien, T; Yakoub Agha, I; Diaz, M; Milpied, M; Bittencourt, H; Pedro Souza, M; Aljurf, M; Charron, D; Boudjedir, K; Labopin, M; Gluckman, E; Rocha, V";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:109;a:14:{s:9:"citazione";s:257:"Cudillo, L., Ceresoli, E., Sarmati, L., Mariotti, B., Viscione, M., De Majo, A., et al. (2014). Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. BONE MARROW TRANSPLANTATION, 49(4), 595-596.";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_198258";s:6:"handle";s:10:"2108/95088";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:116:"Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report.";s:9:"metadata6";s:111:"Cudillo, L; Ceresoli, E; Sarmati, L; Mariotti, B; Viscione, M; De Majo, A; Di Veroli, A; Andreoni, M; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:110;a:14:{s:9:"citazione";s:323:"Girmenia, C., Raiola, A., Piciocchi, A., Algarotti, A., Stanzani, M., CUDILLO, L., et al. (2014). Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(6), 872.";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_205314";s:6:"handle";s:10:"2108/97688";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:167:"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO";s:9:"metadata6";s:502:"Girmenia, C; Raiola, A; Piciocchi, A; Algarotti, A; Stanzani, M; CUDILLO, L; Pecoraro, C; Guidi, S; Iori, A; Montante, B; Chiusolo, P; Lanino, E; Carella, A; Zucchetti, E; Bruno, B; Irrera, G; Patriarca, F; Baronciani, D; Musso, M; Prete, A; Risitano, A; Russo, D; Mordini, N; Pastore, D; Vacca, A; Onida, F; Falcioni, S; Pisapia, G; Milone, G; Vallisa, D; Olivieri, A; Bonini, A; Castagnola, E; Sica, S; Majolino, I; Bosi, A; Busca, A; ARCESE, W; Bandini, G; Bacigalupo, A; Rambaldi, A; Locasciulli, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:111;a:14:{s:9:"citazione";s:388:"Marchesi, F., Mengarelli, A., Giannotti, F., Tendas, A., Anaclerico, B., Porrini, R., et al. (2014). High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. TRANSPLANT INFECTIOUS DISEASE, 16, 158 [doi: 10.1111/tid.12162].";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_205312";s:6:"handle";s:10:"2108/97687";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:222:"High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.";s:9:"metadata6";s:260:"Marchesi, F; Mengarelli, A; Giannotti, F; Tendas, A; Anaclerico, B; Porrini, R; Picardi, A; Cerchiara, E; Dentamaro, T; Chierichini, A; Romeo, A; Cudillo, L; Montefusco, E; Tirindelli, M; DE FABRITIIS, P; Annino, L; Petti, M; Monarca, B; Arcese, W; Avvisati, G";s:9:"metadata7";s:22:"doi: 10.1111/tid.12162";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:112;a:14:{s:9:"citazione";s:242:"Piñana, J.L., Sanz, J., Picardi, A., Ferrá, C., Rodrigo Martino, R., Barba, P., et al. (2014). Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. HAEMATOLOGICA, 99, 378-392.";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_212750";s:6:"handle";s:11:"2108/101268";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:117:"Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia.";s:9:"metadata6";s:209:"Piñana, JL; Sanz, J; Picardi, A; Ferrá, C; Rodrigo Martino, R; Barba, P; Gonzalez-Vicent, M; Pascual, MJ; Martín, C; Verdeguer, A; Diaz de Heredia1, C; Montesinos, P; Ribera, JM; Sanz, M; Arcese, W; Sanz, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:113;a:14:{s:9:"citazione";s:251:"Scerpa, M., Rossi, C., Daniele, N., Lanti, A., Adorno, G., Picardi, A., et al. (2014). A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. TRANSFUSION, 54(3), 522-531 [10.1111/trf.12307].";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_165939";s:6:"handle";s:11:"2108/102731";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:115:"A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant.";s:9:"metadata6";s:109:"Scerpa, M; Rossi, C; Daniele, N; Lanti, A; Adorno, G; Picardi, A; Arcese, W; Amadori, S; Isacchi, G; Zinno, F";s:9:"metadata7";s:17:"10.1111/trf.12307";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:114;a:14:{s:9:"citazione";s:333:"Calabrese, E., Zorzi, F., Visconti, E., De Angelis, G., Cerretti, R., Del Vecchio Blanco, G., et al. (2013). Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation. DIGESTIVE AND LIVER DISEASE, 45(11), 899-904 [10.1016/j.dld.2013.04.004].";s:4:"data";s:7:"2013-11";s:2:"id";s:20:"PUBBLICAZIONE_178408";s:6:"handle";s:10:"2108/86678";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:34:"Settore MED/12 - Gastroenterologia";s:9:"metadata4";N;s:9:"metadata5";s:149:"Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation";s:9:"metadata6";s:177:"Calabrese, E; Zorzi, F; Visconti, E; De Angelis, G; Cerretti, R; Del Vecchio Blanco, G; Picardi, A; Cudillo, L; Postorino, M; Franceschini, L; Biancone, L; Arcese, W; Pallone, F";s:9:"metadata7";s:25:"10.1016/j.dld.2013.04.004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:115;a:14:{s:9:"citazione";s:386:"Todisco, E., Ciceri, F., Oldani, E., Boschini, C., Micò, C., Vanlint, M.T., et al. (2013). The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo. LEUKEMIA, 27(10), 2086-2091 [10.1038/leu.2013.208].";s:4:"data";s:7:"2013-10";s:2:"id";s:20:"PUBBLICAZIONE_254715";s:6:"handle";s:11:"2108/248340";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:240:"The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo";s:9:"metadata6";s:367:"Todisco, E; Ciceri, F; Oldani, E; Boschini, C; Micò, C; Vanlint, MT; Donnini, I; Patriarca, F; Alessandrino, PE; Bonifazi, F; Arcese, W; Barberi, W; Marenco, P; Terruzzi, E; Cortelazzo, S; Santarone, S; Proia, A; Corradini, P; Tagliaferri, E; Falcioni, S; Irrera, G; Dallanegra, L; Castagna, L; Santoro, A; Camboni, A; Sacchi, N; Bosi, A; Bacigalupo, A; Rambaldi, A";s:9:"metadata7";s:20:"10.1038/leu.2013.208";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:116;a:14:{s:9:"citazione";s:325:"Sanz, J., Picardi, A., Hernández Boluda, J.C., Martín, C., Ferrá, C., Nozzoli, C., et al. (2013). Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(9), 1387-1392 [10.1016/j.bbmt.2013.07.004].";s:4:"data";s:7:"2013-09";s:2:"id";s:20:"PUBBLICAZIONE_254746";s:6:"handle";s:11:"2108/248344";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:128:"Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation";s:9:"metadata6";s:268:"Sanz, J; Picardi, A; Hernández Boluda, JC; Martín, C; Ferrá, C; Nozzoli, C; Gonzalez-Vicent, M; Rambaldi, A; Valcarcel, D; Verdeguer, A; Serrano, D; de Heredia, CD; Pascual, MJ; de Paz, R; Montesinos, P; Bartolozzi, B; Algarotti, A; Sanz, MA; Arcese, W; Sanz, GF";s:9:"metadata7";s:26:"10.1016/j.bbmt.2013.07.004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:117;a:14:{s:9:"citazione";s:248:"Porrovecchio, R., Babakir-Mina, M., Rapanotti, M., Arcese, W., Perno, C., & Ciotti, M. (2013). Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients. JOURNAL OF MEDICAL VIROLOGY, 85(6), 1122-1124 [10.1002/jmv.23565].";s:4:"data";s:7:"2013-06";s:2:"id";s:20:"PUBBLICAZIONE_158904";s:6:"handle";s:10:"2108/75675";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:85:"Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients";s:9:"metadata6";s:78:"Porrovecchio, R; Babakir-Mina, M; Rapanotti, M; Arcese, W; Perno, C; Ciotti, M";s:9:"metadata7";s:17:"10.1002/jmv.23565";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:118;a:14:{s:9:"citazione";s:355:"Tendas, A., Pignatelli, A.C., Sollazzo, F., Veggia, B., Conte, E., D'Apolito, A., et al. (2013). Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 45(4), e2-e3 [10.1016/j.jpainsymman.2012.12.007].";s:4:"data";s:7:"2013-04";s:2:"id";s:20:"PUBBLICAZIONE_254666";s:6:"handle";s:11:"2108/248352";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:167:"Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party";s:9:"metadata6";s:207:"Tendas, A; Pignatelli, AC; Sollazzo, F; Veggia, B; Conte, E; D'Apolito, A; Di Veroli, A; Molinari, V; Mauroni, M; Annibali, O; Pilozzi, V; Cacciaraichi, S; Viggiani, C; Niscola, P; de Fabritiis, P; Arcese, W";s:9:"metadata7";s:33:"10.1016/j.jpainsymman.2012.12.007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:119;a:14:{s:9:"citazione";s:367:"Maramattom, L.V., Hari, P.N., Burns, L.J., Carreras, J., Arcese, W., Cairo, M.S., et al. (2013). Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), 173-179 [10.1016/j.bbmt.2012.11.016].";s:4:"data";s:7:"2013-02";s:2:"id";s:20:"PUBBLICAZIONE_254683";s:6:"handle";s:11:"2108/248337";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:179:"Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research";s:9:"metadata6";s:294:"Maramattom, LV; Hari, PN; Burns, LJ; Carreras, J; Arcese, W; Cairo, MS; Costa, LJ; Fenske, TS; Lill, M; Freytes, CO; Gale, RP; Gross, TG; Hale, GA; Hamadani, M; Holmberg, LA; Hsu, JW; Inwards, DJ; Lazarus, HM; Marks, DI; Maloney, DG; Maziarz, RT; Montoto, S; Rizzieri, DA; Wirk, B; Gajewski, JL";s:9:"metadata7";s:26:"10.1016/j.bbmt.2012.11.016";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:120;a:14:{s:9:"citazione";s:285:"Di Bartolomeo, P., Santarone, S., De Angelis, G., Picardi, A., Cudillo, L., Cerretti, R., et al. (2013). Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. BLOOD, 121(5), 849-857 [10.1182/blood-2012-08-453399].";s:4:"data";s:10:"2013-01-31";s:2:"id";s:20:"PUBBLICAZIONE_254658";s:6:"handle";s:11:"2108/248354";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:124:"Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies";s:9:"metadata6";s:248:"Di Bartolomeo, P; Santarone, S; De Angelis, G; Picardi, A; Cudillo, L; Cerretti, R; Adorno, G; Angelini, S; Andreani, M; De Felice, L; Rapanotti, MC; Sarmati, L; Bavaro, P; Papalinetti, G; Di Nicola, M; Papola, F; Montanari, M; Nagler, A; Arcese, W";s:9:"metadata7";s:28:"10.1182/blood-2012-08-453399";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:121;a:14:{s:9:"citazione";s:343:"Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., et al. (2013). Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. BLOOD, 121(3), 440-446 [10.1182/blood-2012-08-448613].";s:4:"data";s:10:"2013-01-17";s:2:"id";s:20:"PUBBLICAZIONE_254792";s:6:"handle";s:11:"2108/248356";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:193:"Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:229:"Roos-Weil, D; Dietrich, S; Boumendil, A; Polge, E; Bron, D; Carreras, E; Iriondo Atienza, A; Arcese, W; Beelen, DW; Cornelissen, JJ; Kröger, N; Milone, G; Rossi, G; Jardin, F; Peters, C; Rocha, V; Sureda, A; Mohty, M; Dreger, P";s:9:"metadata7";s:28:"10.1182/blood-2012-08-448613";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:122;a:14:{s:9:"citazione";s:274:"Tendas, A., Sollazzo, F., Niscola, P., Cupelli, L., Mauroni, M.R., D'Apolito, A., et al. (2013). Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score. SUPPORTIVE CARE IN CANCER, 21(1), 5-6 [10.1007/s00520-012-1550-4].";s:4:"data";s:7:"2013-01";s:2:"id";s:20:"PUBBLICAZIONE_254645";s:6:"handle";s:11:"2108/248333";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:109:"Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score";s:9:"metadata6";s:201:"Tendas, A; Sollazzo, F; Niscola, P; Cupelli, L; Mauroni, MR; D'Apolito, A; Pilozzi, V; Cacciaraichi, S; Viggiani, C; Pignatelli, AC; Annibali, O; Mengarelli, A; Dentamaro, T; de Fabritiis, P; Arcese, W";s:9:"metadata7";s:25:"10.1007/s00520-012-1550-4";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:123;a:14:{s:9:"citazione";s:283:"Di Bartolomeo, P., Santarone, S., De Angelis, G., Picardi, A., Cudillo, L., Cerretti, R., et al. (2013). Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies. BLOOD, 121, 849-857 [10.1182/blood-2012-08-453399].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_215865";s:6:"handle";s:11:"2108/102873";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:125:"Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies";s:9:"metadata6";s:247:"Di Bartolomeo, P; Santarone, S; De Angelis, G; Picardi, A; Cudillo, L; Cerretti, R; Adorno, G; Angelini, S; Andreani, M; De Felice, L; Rapanotti, M; Sarmati, L; Bavaro, P; Papalinetti, G; Di Nicola, M; Papola, F; Montanari, M; Nagler, A; Arcese, W";s:9:"metadata7";s:28:"10.1182/blood-2012-08-453399";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:124;a:14:{s:9:"citazione";s:320:"Sanz, J., Picardi, A., Hernández Boluda, J., Martín, C., Ferrá, C., Nozzoli, C., et al. (2013). Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19, 1387-1392 [10.1016/j.bbmt.2013.07.004].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_212770";s:6:"handle";s:11:"2108/101269";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:128:"Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation";s:9:"metadata6";s:270:"Sanz, J; Picardi, A; Hernández Boluda, J; Martín, C; Ferrá, C; Nozzoli, C; Gonzalez Vicent, M; Rambaldi, A; Valcarcel, D; Verdeguer, A; Serrano, D; Díaz de Heredia, C; Pascual, M; de Paz, R; Montesinos, P; Bartolozzi, B; Algarotti, A; Sanz, M; Arcese, W; Sanz, G";s:9:"metadata7";s:26:"10.1016/j.bbmt.2013.07.004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:125;a:14:{s:9:"citazione";s:264:"Sergiacomi, G., Gaspari, E., Taglieri, A., Meschini, A., Gisone, V., Cudillo, L., et al. (2013). 3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. LA RADIOLOGIA MEDICA, 118(1), 101-111 [10.1007/s11547-012-0796-8].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_141672";s:6:"handle";s:10:"2108/68924";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:100:"3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations.";s:9:"metadata6";s:99:"Sergiacomi, G; Gaspari, E; Taglieri, A; Meschini, A; Gisone, V; Cudillo, L; Arcese, W; Simonetti, G";s:9:"metadata7";s:25:"10.1007/s11547-012-0796-8";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:126;a:14:{s:9:"citazione";s:240:"Ramadan, S., Di Veroli, A., Camboni, A., Breccia, M., Iori, A., Aversa, F., et al. (2012). Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era. HAEMATOLOGICA [10.3324/haematol.2012.065714].";s:4:"data";s:10:"2012-06-11";s:2:"id";s:20:"PUBBLICAZIONE_139950";s:6:"handle";s:10:"2108/68260";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:102:"Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era";s:9:"metadata6";s:135:"Ramadan, S; Di Veroli, A; Camboni, A; Breccia, M; Iori, A; Aversa, F; Cupelli, L; Papayannidis, C; Bacigalupo, A; Arcese, W; Lo-Coco, F";s:9:"metadata7";s:28:"10.3324/haematol.2012.065714";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:127;a:14:{s:9:"citazione";s:253:"Iori, A., Valle, V., Piciocchi, A., Meloni, G., Torelli, G., Vitale, A., et al. (2012). Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia. ANNALS OF HEMATOLOGY, 91(6), 941-948 [10.1007/s00277-011-1392-z].";s:4:"data";s:7:"2012-06";s:2:"id";s:20:"PUBBLICAZIONE_139951";s:6:"handle";s:10:"2108/68262";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:98:"Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia";s:9:"metadata6";s:216:"Iori, A; Valle, V; Piciocchi, A; Meloni, G; Torelli, G; Vitale, A; Testi, A; Barberi, W; Ricci, R; Milano, F; Lucarelli, B; Screnci, M; Perrone, M; Laurenti, L; Natalino, F; Perrone, S; Sacchi, N; Arcese, W; Foà, R";s:9:"metadata7";s:25:"10.1007/s00277-011-1392-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:128;a:14:{s:9:"citazione";s:326:"Rigacci, L., Puccini, B., Dodero, A., Iacopino, P., Castagna, L., Bramanti, S., et al. (2012). Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. ANNALS OF HEMATOLOGY, 91(6), 931-939 [10.1007/s00277-011-1395-9].";s:4:"data";s:7:"2012-06";s:2:"id";s:20:"PUBBLICAZIONE_139719";s:6:"handle";s:10:"2108/68168";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:164:"Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study";s:9:"metadata6";s:190:"Rigacci, L; Puccini, B; Dodero, A; Iacopino, P; Castagna, L; Bramanti, S; Ciceri, F; Fanin, R; Rambaldi, A; Falda, M; Milone, G; Guidi, S; Martelli, M; Mazza, P; Oneto, R; Bosi, A; Arcese, W";s:9:"metadata7";s:25:"10.1007/s00277-011-1395-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:129;a:14:{s:9:"citazione";s:280:"Tendas, A., Sollazzo, F., Bruno, A., Cupelli, L., Niscola, P., Pignatelli, A., et al. (2012). Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant. SUPPORTIVE CARE IN CANCER, 20(5), 891-892 [10.1007/s00520-012-1411-1].";s:4:"data";s:7:"2012-05";s:2:"id";s:20:"PUBBLICAZIONE_139963";s:6:"handle";s:10:"2108/68289";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:114:"Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant";s:9:"metadata6";s:113:"Tendas, A; Sollazzo, F; Bruno, A; Cupelli, L; Niscola, P; Pignatelli, A; Dentamaro, T; de Fabritiis, P; Arcese, W";s:9:"metadata7";s:25:"10.1007/s00520-012-1411-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:130;a:14:{s:9:"citazione";s:316:"Bruno, A., De Meis, I., Cantoni, F., Siniscalchi, A., Velotta, V., Tendas, A., et al. (2012). High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant. BONE MARROW TRANSPLANTATION, 47, 249-249.";s:4:"data";s:7:"2012-04";s:2:"id";s:20:"PUBBLICAZIONE_141799";s:6:"handle";s:10:"2108/68992";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:179:"High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant";s:9:"metadata6";s:289:"Bruno, A ; De Meis, I ; Cantoni, F ; Siniscalchi, A ; Velotta, V ; Tendas, A ; Cupelli, L ; Dentamaro, T ; Piccioni, D ; Del Poeta, G ; Ballatore, G ; Tamburini, A ; Suppo, G ; Del Proposto, G ; Adorno, G ; Isacchi, G ; Arcese, W ; Amadori, S ; Perrotti, AP ; de Fabritiis, P ; Caravita, T";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:131;a:14:{s:9:"citazione";s:307:"Rambaldi, A., Bacigalupo, A., Fanin, R., Ciceri, F., Bonifazi, F., Falda, M., et al. (2012). Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients. LEUKEMIA, 47, 47-47 [10.1038/leu.2012.55].";s:4:"data";s:10:"2012-03-01";s:2:"id";s:20:"PUBBLICAZIONE_141671";s:6:"handle";s:10:"2108/68923";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:170:"Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients";s:9:"metadata6";s:325:"Rambaldi, A; Bacigalupo, A; Fanin, R; Ciceri, F; Bonifazi, F; Falda, M; Lambertenghi-Deliliers, G; Benedetti, F; Bruno, B; Corradini, P; Alessandrino, P; Iacopino, P; Arcese, W; Scimè, R; Raimondi, R; Sica, S; Castagna, L; Lamparelli, T; Oneto, R; Lombardini, L; Pollichieni, S; Algarotti, A; Carobbio, A; Sacchi, N; Bosi, A";s:9:"metadata7";s:19:"10.1038/leu.2012.55";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:132;a:14:{s:9:"citazione";s:262:"Buccisano F,, Maurillo L, ., Del Principe MI,, Del Poeta G,, Sconocchia G,, Lo-Coco F,, et al. (2012). Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. BLOOD, 119, 332-341 [10.1182/blood-2011-08-363291].";s:4:"data";s:4:"2012";s:2:"id";s:19:"PUBBLICAZIONE_91172";s:6:"handle";s:10:"2108/52976";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:104:"Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.";s:9:"metadata6";s:120:"Buccisano F,; Maurillo L, ;Del Principe MI,; Del Poeta G,; Sconocchia G,; Lo-Coco F,; Arcese W, ;Amadori S,; Venditti A.";s:9:"metadata7";s:28:"10.1182/blood-2011-08-363291";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:133;a:14:{s:9:"citazione";s:255:"Canossi, A., Aureli, A., Del Beato, T., Arcese, W., Papola, F., Santarone, S., et al. (2012). Assessment of donor-derived kir by sequential cDNA genotyping in non t cell depleted haploidentical stem cell transplanted patients. TISSUE ANTIGENS, 79(6), 410.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_141796";s:6:"handle";s:10:"2108/68989";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:131:"Assessment of donor-derived kir by sequential cDNA genotyping in non t cell depleted haploidentical stem cell transplanted patients";s:9:"metadata6";s:115:"Canossi, A; Aureli, A; Del Beato, T; Arcese, W; Papola, F; Santarone, S; Arriga, R; Di Bartolomeo, P; Sconocchia, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:134;a:14:{s:9:"citazione";s:323:"Cudillo, L., Di Veroli, A., Mariotti, B., Ceresoli, E., PICARDI, A., Cerretti, R., et al. (2012). Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma. Paper presented at 38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, SWITZERLAND.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_142281";s:6:"handle";s:10:"2108/69196";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:97:"Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma";s:9:"metadata6";s:160:"Cudillo, L; Di Veroli, A; Mariotti, B; Ceresoli, E; PICARDI, A; Cerretti, R; De Angelis, G; Rizzo, M; Pisani, F; CANTONETTI, M; Lombardo, G; Scala, E; ARCESE, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:135;a:14:{s:9:"citazione";s:264:"Lanini, S., Garbuglia, A., Puro, V., Solmone, M., Martini, L., Arcese, W., et al. (2012). Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device. PLOS ONE, 7(3), e33122-e33122 [10.1371/journal.pone.0033122].";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_139946";s:6:"handle";s:10:"2108/68255";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:111:"Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device";s:9:"metadata6";s:135:"Lanini, S; Garbuglia, A; Puro, V; Solmone, M; Martini, L; Arcese, W; Nanni Costa, A; Borgia, P; Piselli, P; Capobionchi, M; Ippolito, G";s:9:"metadata7";s:28:"10.1371/journal.pone.0033122";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:136;a:14:{s:9:"citazione";s:412:"Marchesi, F., Giannotti, F., Avvisati, G., Petti, M., Pimpinelli, F., Paba, P., et al. (2012). The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. AMERICAN JOURNAL OF HEMATOLOGY, 87(2), 213-217 [10.1002/ajh.22214].";s:4:"data";s:4:"2012";s:2:"id";s:19:"PUBBLICAZIONE_85112";s:6:"handle";s:10:"2108/51806";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:248:"The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network";s:9:"metadata6";s:197:"Marchesi, F; Giannotti, F; Avvisati, G; Petti, M; Pimpinelli, F; Paba, P; Dessanti, M; Cerretti, R; Tirindelli, M; Picardi, A; D'Andrea, M; Spadea, A; Ensoli, F; Perno, Cf; Mengarelli, A; Arcese, W";s:9:"metadata7";s:17:"10.1002/ajh.22214";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:137;a:14:{s:9:"citazione";s:164:"Arcese, W., Mangione, I., & Picardi, A. (2011). Algorithm for donor selection in 2011. CURRENT OPINION IN HEMATOLOGY, 18(6), 401-407 [10.1097/MOH.0b013e32834ba838].";s:4:"data";s:7:"2011-11";s:2:"id";s:19:"PUBBLICAZIONE_91136";s:6:"handle";s:10:"2108/52969";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:37:"Algorithm for donor selection in 2011";s:9:"metadata6";s:34:"Arcese, W; Mangione, I; Picardi, A";s:9:"metadata7";s:28:"10.1097/MOH.0b013e32834ba838";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:138;a:14:{s:9:"citazione";s:391:"Marchesi, F., Giannotti, F., Avvisati, G., Petti, M., Pimpinelli, F., Paba, P., et al. (2011). The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. ANNALS OF HEMATOLOGY [doi: 10.1002/ajh.22214].";s:4:"data";s:7:"2011-10";s:2:"id";s:19:"PUBBLICAZIONE_91138";s:6:"handle";s:10:"2108/52970";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:249:"The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network.";s:9:"metadata6";s:197:"Marchesi, F; Giannotti, F; Avvisati, G; Petti, M; Pimpinelli, F; Paba, P; Dessanti, M; Cerretti, R; Tirindelli, M; Picardi, A; D'Andrea, M; Spadea, A; Ensoli, F; Perno, Cf; Mengarelli, A; Arcese, W";s:9:"metadata7";s:22:"doi: 10.1002/ajh.22214";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:139;a:14:{s:9:"citazione";s:260:"Tendas, A., Boschetto, C., Baraldi, L., Caiazza, E., Cupelli, L., Lentini, R., et al. (2011). Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease. INDIAN JOURNAL OF PALLIATIVE CARE, 17(2), 159-161 [10.4103/0973-1075.84540].";s:4:"data";s:7:"2011-05";s:2:"id";s:20:"PUBBLICAZIONE_140957";s:6:"handle";s:10:"2108/68589";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:88:"Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease";s:9:"metadata6";s:226:"Tendas, A; Boschetto, C; Baraldi, L; Caiazza, E; Cupelli, L; Lentini, R; Trawinska, M; Palombi, M; Ales, M; Morino, L; Giovannini, M; Scaramucci, L; Cartoni, C; Dentamaro, T; ARCESE, W; DE FABRITIIS, P; Niscola, P; Mandelli, F";s:9:"metadata7";s:23:"10.4103/0973-1075.84540";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:140;a:14:{s:9:"citazione";s:250:"Ferrannini, M., Vischini, G., De Angelis, G., Giannakakis, K., & Arcese, W. (2011). Spontaneous bilateral kidney rupture during autologous stem cell transplantation in a patient affected by amyloidosis. NDT PLUS, 4(1), 56-59 [10.1093/ndtplus/sfq168].";s:4:"data";s:7:"2011-02";s:2:"id";s:20:"PUBBLICAZIONE_254866";s:6:"handle";s:11:"2108/248358";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:117:"Spontaneous bilateral kidney rupture during autologous stem cell transplantation in a patient affected by amyloidosis";s:9:"metadata6";s:68:"Ferrannini, M; Vischini, G; De Angelis, G; Giannakakis, K; Arcese, W";s:9:"metadata7";s:22:"10.1093/ndtplus/sfq168";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:141;a:14:{s:9:"citazione";s:297:"Arcese, W., Picardi, A., Locatelli, F., Pinto, R.M., De Fabritiis, P., Dentamaro, T., et al. (2011). The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . BONE MARROW TRANSPLANTATION, 46.";s:4:"data";s:4:"2011";s:2:"id";s:20:"PUBBLICAZIONE_215859";s:6:"handle";s:11:"2108/102874";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:163:"The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network .";s:9:"metadata6";s:238:"Arcese, W; Picardi, A; Locatelli, F; Pinto, RM; De Fabritiis, P; Dentamaro, T; Mangione, I; Avvisati, G; Tirindelli, MC; Petti, C; Mengarelli, A; Annino, L; Chierichini, A; Montefusco, E; Ferrari, A; Cudillo, L; Cerretti, R; De Angelis, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:142;a:14:{s:9:"citazione";s:242:"Lanti A, Spurio SD, Ferraro AS, D’Alessandro E, Chiru OM, Fiorelli E, et al. (2011). Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network. BONE MARROW TRANSPLANTATION, 46.";s:4:"data";s:4:"2011";s:2:"id";s:20:"PUBBLICAZIONE_215855";s:6:"handle";s:11:"2108/103767";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:116:"Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network";s:9:"metadata6";s:176:"Lanti A; Spurio SD; Ferraro AS; D’Alessandro E; Chiru OM; Fiorelli E; Massarelli R; Cudillo L; Picardi A; Ceresoli E; Mariotti B; Provenzano I; Adorno G; Isacchi G; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:143;a:14:{s:9:"citazione";s:243:"Picardi, A., Lanti, A., Ferraro, A.S., Di Veroli, A., Cudillo, L., Cerretti, R., et al. (2011). Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease. BONE MARROW TRANSPLANTATION, 46(Supp. 1).";s:4:"data";s:4:"2011";s:2:"id";s:20:"PUBBLICAZIONE_205453";s:6:"handle";s:10:"2108/97828";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:104:"Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease";s:9:"metadata6";s:161:"Picardi, A; Lanti, A; Ferraro, AS; Di Veroli, A; Cudillo, L; Cerretti, R; Mirabile, M; Provenzano, I; De Angelis, G; Giannotti, F; Adorno, G; Ronci, C; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:144;a:14:{s:9:"citazione";s:293:"Santarone, S., Di Bartolomeo, P., De Angelis, G., Picardi, A., Bavaro, P., Di Bartolomeo, E., et al. (2011). Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies. BONE MARROW TRANSPLANTATION, 46(supp. 1), 349-349.";s:4:"data";s:4:"2011";s:2:"id";s:20:"PUBBLICAZIONE_205452";s:6:"handle";s:10:"2108/97829";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:132:"Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies";s:9:"metadata6";s:187:"Santarone, S; Di Bartolomeo, P; De Angelis, G; Picardi, A; Bavaro, P; Di Bartolomeo, E; Olioso, P; Di Nicola, M; De Felice, L; Cudillo, L; Cerretti, R; Angelini, S; Mirabile, M; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:145;a:14:{s:9:"citazione";s:385:"Duarte, R.F., Canals, C., Onida, F., Gabriel, I.H., Arranz, R., Arcese, W., et al. (2010). Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. JOURNAL OF CLINICAL ONCOLOGY, 28(29), 4492-4499 [10.1200/JCO.2010.29.3241].";s:4:"data";s:10:"2010-10-10";s:2:"id";s:20:"PUBBLICAZIONE_254834";s:6:"handle";s:11:"2108/248330";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:217:"Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:152:"Duarte, RF; Canals, C; Onida, F; Gabriel, IH; Arranz, R; Arcese, W; Ferrant, A; Kobbe, G; Narni, F; Deliliers, GL; Olavarría, E; Schmitz, N; Sureda, A";s:9:"metadata7";s:24:"10.1200/JCO.2010.29.3241";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:146;a:14:{s:9:"citazione";s:303:"Di Veroli, A., Ramadan, S.M., Divona, M., Cudillo, L., Giannì, L., Wieland, S., et al. (2010). Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene. BRITISH JOURNAL OF HAEMATOLOGY, 151(1), 99-101 [10.1111/j.1365-2141.2010.08308.x].";s:4:"data";s:7:"2010-10";s:2:"id";s:19:"PUBBLICAZIONE_46712";s:6:"handle";s:10:"2108/12290";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:123:"Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene";s:9:"metadata6";s:122:"Di Veroli, A; Ramadan, SM; Divona, M; Cudillo, L; Giannì, L; Wieland, S; Giannotti, F; Mirabile, M; Arcese, W; Lo-Coco, F";s:9:"metadata7";s:32:"10.1111/j.1365-2141.2010.08308.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:147;a:14:{s:9:"citazione";s:320:"Zinno, F., Landi, F., Aureli, V., Caniglia, M., Pinto, R.M., Rana, I., et al. (2010). Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures. TRANSFUSION AND APHERESIS SCIENCE, 43(2), 173-178 [10.1016/j.transci.2010.07.005].";s:4:"data";s:7:"2010-10";s:2:"id";s:20:"PUBBLICAZIONE_254852";s:6:"handle";s:11:"2108/248328";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:150:"Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures";s:9:"metadata6";s:121:"Zinno, F; Landi, F; Aureli, V; Caniglia, M; Pinto, RM; Rana, I; Balduino, G; Miele, MJ; Picardi, A; Arcese, W; Isacchi, G";s:9:"metadata7";s:29:"10.1016/j.transci.2010.07.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:148;a:14:{s:9:"citazione";s:274:"Dragoni, F., Iori, A., Pignoloni, P., Minotti, C., Chiarotti, F., Mazzucconi, M., et al. (2010). Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study. BRITISH JOURNAL OF HAEMATOLOGY, 150(4), 492-494 [10.1111/j.1365-2141.2010.08230.x].";s:4:"data";s:7:"2010-08";s:2:"id";s:20:"PUBBLICAZIONE_139945";s:6:"handle";s:10:"2108/68258";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:92:"Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study";s:9:"metadata6";s:123:"Dragoni, F; Iori, A; Pignoloni, P; Minotti, C; Chiarotti, F; Mazzucconi, M; Mengarelli, A; Arcese, W; Foà, R; Avvisati, G";s:9:"metadata7";s:32:"10.1111/j.1365-2141.2010.08230.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:149;a:14:{s:9:"citazione";s:228:"Picardi, A., & Arcese, W. (2010). Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. TRANSFUSION AND APHERESIS SCIENCE, 42(3), 289-297 [10.1016/j.transci.2010.03.004].";s:4:"data";s:7:"2010-06";s:2:"id";s:20:"PUBBLICAZIONE_254805";s:6:"handle";s:11:"2108/248325";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:110:"Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective";s:9:"metadata6";s:21:"Picardi, A; Arcese, W";s:9:"metadata7";s:29:"10.1016/j.transci.2010.03.004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:150;a:14:{s:9:"citazione";s:284:"Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383 [10.1002/ajh.21685].";s:4:"data";s:7:"2010-05";s:2:"id";s:20:"PUBBLICAZIONE_254709";s:6:"handle";s:11:"2108/248320";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:117:"Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis";s:9:"metadata6";s:162:"Sarmati, L; Beltrame, A; Dori, L; Maffongelli, G; Cudillo, L; De Angelis, G; Picardi, A; Ottaviani, L; Cefalo, MG; Venditti, A; Amadori, S; Arcese, W; Andreoni, M";s:9:"metadata7";s:17:"10.1002/ajh.21685";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:151;a:14:{s:9:"citazione";s:284:"Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383 [10.1002/ajh.21685].";s:4:"data";s:7:"2010-05";s:2:"id";s:19:"PUBBLICAZIONE_35338";s:6:"handle";s:10:"2108/39936";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:117:"Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis";s:9:"metadata6";s:161:"Sarmati, L; Beltrame, A; Dori, L; Maffongelli, G; Cudillo, L; De Angelis, G; Picardi, A; Ottaviani, L; Cefalo, M; Venditti, A; Amadori, S; Arcese, W; Andreoni, M";s:9:"metadata7";s:17:"10.1002/ajh.21685";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:152;a:14:{s:9:"citazione";s:222:"Arcese, W., Buccisano, F., Cerretti, R., & Picardi, A. (2010). Cord blood transplantation in adults with acute myeloid leukaemia. BAILLIERE'S BEST PRACTICE IN CLINICAL HAEMATOLOGY, 23, 197-206 [10.1016/j.beha.2010.05.007].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_62683";s:6:"handle";s:10:"2108/16477";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:66:"Cord blood transplantation in adults with acute myeloid leukaemia.";s:9:"metadata6";s:48:"Arcese, W; Buccisano, F; Cerretti, R; Picardi, A";s:9:"metadata7";s:26:"10.1016/j.beha.2010.05.007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:153;a:14:{s:9:"citazione";s:327:"Buccisano, F., Maurillo, L., Spagnoli, A., Del Principe, M.I., Fraboni, D., Panetta, P., et al. (2010). Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia. BLOOD, 116, 2295-2303.";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_35143";s:6:"handle";s:10:"2108/39982";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:199:"Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia";s:9:"metadata6";s:280:"Buccisano, F; Maurillo, L; Spagnoli, A; Del Principe, MI; Fraboni, D; Panetta, P; Ottone, T; Consalvo, MI; Lavorgna, S; Bulian, P; Ammatuna, E; Angelini, DF; Diamantini, A;Campagna, S; Ottaviani, L; Sarlo, C; Gattei, V; Del Poeta, G; Arcese, W; Amadori, S; Lo Coco, F; Venditti, A";s:9:"metadata7";s:28:"10.1182/blood-2009-12-258178";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:154;a:14:{s:9:"citazione";s:355:"Cudillo, L., Cerretti, R., Picardi, A., Mirabile, M., Giannotti, F., De Angelis, G., et al. (2010). Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. BONE MARROW TRANSPLANTATION, 45.";s:4:"data";s:4:"2010";s:2:"id";s:20:"PUBBLICAZIONE_215842";s:6:"handle";s:11:"2108/103783";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:222:"Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage.";s:9:"metadata6";s:179:"Cudillo, L; Cerretti, R; Picardi, A; Mirabile, M; Giannotti, F; De Angelis, G; Mariotti, B; Ceresoli, E; Di Veroli, A: Petti, MC; Pisani, F; Postorino, M; Cantonetti, M; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:155;a:14:{s:9:"citazione";s:264:"DRAGONI, F., IORI ANNA, P., PIGNOLONI, P., MINOTTI, C., CHIAROTTI, F., MAZZUCCONI MARIA, G., et al. (2010). Antiphospholipid Antibodies and Thrombotic Complications In Patients With Paroxysmal Nocturnal Hemoglobinuria. BRITISH JOURNAL OF HAEMATOLOGY, 150, 492-494.";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_64662";s:6:"handle";s:10:"2108/68599";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:110:"Antiphospholipid Antibodies and Thrombotic Complications In Patients With Paroxysmal Nocturnal Hemoglobinuria.";s:9:"metadata6";s:133:"DRAGONI, F; IORI ANNA, P; PIGNOLONI, P; MINOTTI, C; CHIAROTTI, F; MAZZUCCONI MARIA, G; MENGARELLI, A; ARCESE, W; FOÀ, R; AVVISATI, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:156;a:14:{s:9:"citazione";s:321:"GORIN, N., LABOPIN, M., REIFFERS, J., MILPIED, N., BLAISE, D., WITZ, F., et al. (2010). Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. BLOOD, 116, 3157-3162 [10.1182/blood-2009-11-252197].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_64659";s:6:"handle";s:10:"2108/68932";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:179:"Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.";s:9:"metadata6";s:158:"GORIN, N; LABOPIN, M; REIFFERS, J; MILPIED, N; BLAISE, D; WITZ, F; DE WITTE, T; MELONI, G; ATTAL, M; BERNAL, T; ROCHA, V; ACUTE LEUKEMIA WORKING, P; ARCESE, W";s:9:"metadata7";s:28:"10.1182/blood-2009-11-252197";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:157;a:14:{s:9:"citazione";s:336:"Kyriakou, C., Canals, C., Sibon, D., Cahn, Y., Kazmi, M., Arcese, W., et al. (2010). High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation. JOURNAL OF CLINICAL ONCOLOGY, 28, 2227-2232 [10.1200/JCO.2009.24.4905].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_64665";s:6:"handle";s:10:"2108/57425";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:178:"High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation";s:9:"metadata6";s:171:"Kyriakou, C; Canals, C; Sibon, D; Cahn, Y; Kazmi, M; Arcese, W; Kolbe, K; Gorin, N; Thomson, K; Milpied, N; Niederwieser, D; Indrak, K; Corradini, P; Sureda, A; Schmitz, N";s:9:"metadata7";s:24:"10.1200/JCO.2009.24.4905";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:158;a:14:{s:9:"citazione";s:299:"Mary, E., Vanderson, R., Guillermo, S., Andromachi, S., Mei-Jie, Z., Arcese, W., et al. (2010). Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis. THE LANCET ONCOLOGY, 11, 653-660 [10.1016/S1470-2045(10)70127-3].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_64655";s:6:"handle";s:10:"2108/57426";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:137:"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis.";s:9:"metadata6";s:433:"Mary, E; Vanderson, R; Guillermo, S; Andromachi, S; Mei-Jie, Z; Arcese, W; Anne, S; Richard E, C; Nelson, C; Adrian P, G; Luis, I; Mary J, L; David I, M; Samir, N; Annalisa, R; Robert Soiff, E; Mary M, H; Eliane, G; John E, W; On Behalf Of The Center For International, B; Marrow Transplant, R; The Acute Leukemia Working, P; Eurocord The European Group For, B; Marrow, T; And The National Cord Blood Program Of The New York Blood, C";s:9:"metadata7";s:29:"10.1016/S1470-2045(10)70127-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:159;a:14:{s:9:"citazione";s:225:"Picardi, A., & Arcese, W. (2010). Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. TRANSFUSION AND APHERESIS SCIENCE, 42, 289-297 [10.1016/j.transci.2010.03.004].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_62684";s:6:"handle";s:10:"2108/16479";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:110:"Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective";s:9:"metadata6";s:21:"Picardi, A; Arcese, W";s:9:"metadata7";s:29:"10.1016/j.transci.2010.03.004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:160;a:14:{s:9:"citazione";s:301:"Picardi, A., De Fabritiis, P., Dentamaro, T., De Rossi, G., Caniglia, M., Petti, M.C., et al. (2010). The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network. BONE MARROW TRANSPLANTATION, 45.";s:4:"data";s:4:"2010";s:2:"id";s:20:"PUBBLICAZIONE_215846";s:6:"handle";s:11:"2108/103779";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:165:"The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network";s:9:"metadata6";s:342:"Picardi, A; De Fabritiis, P; Dentamaro, T; De Rossi, G; Caniglia, M; Petti, MC; Mengarelli, A; Annino, L; Chierichini, A; Monarca, B; Ferrari, A; Avvisati, G; Tirindelli, M; Mangione, I; Pinto, R; Montefusco, E; Annibali, O; Cupelli, L; Cudillo, L; Cerretti, R; De Angelis, G; Giannotti, F; Di Veroli, A; Provenzano, I; Mirabile, M; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:161;a:14:{s:9:"citazione";s:302:"Picardi, A., Lanti, A., Cudillo, L., Cerretti, R., Dentamaro, T., DE ANGELIS, G., et al. (2010). Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. TRANSFUSION, 50(2), 501-506 [10.1111/j.1537-2995.2009.02439.x].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_64663";s:6:"handle";s:10:"2108/68926";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:140:"Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant";s:9:"metadata6";s:111:"Picardi, A; Lanti, A; Cudillo, L; Cerretti, R; Dentamaro, T; DE ANGELIS, G; Ferraro, A; DI VEROLI, A; Arcese, W";s:9:"metadata7";s:32:"10.1111/j.1537-2995.2009.02439.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:162;a:14:{s:9:"citazione";s:264:"Picardi, A., Lanti, A., Cudillo, L., Cerretti, R., Dentamaro, T., De Angelis, G., et al. (2010). Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. TRANSFUSION, 50, 501-506.";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_62685";s:6:"handle";s:10:"2108/16480";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:141:"Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant.";s:9:"metadata6";s:123:"Picardi, A; Lanti, A; Cudillo, L; Cerretti, R; Dentamaro, T; De Angelis, G; Ferraro, A; Di Veroli, A; Adorno, G; Arcese, W.";s:9:"metadata7";s:32:"10.1111/j.1537-2995.2009.02439.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:163;a:14:{s:9:"citazione";s:285:"ROMEO, A., CHIERICHINI, A., SPAGNOLI, A., VITTORI, M., VACCA, M., GOZZER, M., et al. (2010). Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. TRANSFUSION, 50, 2432-2446 [10.1111/j.1537-2995.2010.02723.x].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_64658";s:6:"handle";s:10:"2108/68930";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:129:"Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.";s:9:"metadata6";s:180:"ROMEO, A; CHIERICHINI, A; SPAGNOLI, A; VITTORI, M; VACCA, M; GOZZER, M; SPADEA, A; ANACLERICO, B; DESSANTI, M; D'ANDREA, M; TOGLIA, G; ANNINO, L; PETTI, M; MENGARELLI, A; ARCESE, W";s:9:"metadata7";s:32:"10.1111/j.1537-2995.2010.02723.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:164;a:14:{s:9:"citazione";s:325:"Tirindelli, M.C., Flammia, M., Cudillo, L., Dentamaro, T. .P., Annibali, O., Tendas, A., et al. (2010). Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant. BONE MARROW TRANSPLANTATION, 45(Supp. 2), 12-12.";s:4:"data";s:4:"2010";s:2:"id";s:20:"PUBBLICAZIONE_205450";s:6:"handle";s:10:"2108/97831";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:171:"Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant";s:9:"metadata6";s:219:"Tirindelli, MC; Flammia, M; Cudillo, L; Dentamaro, T Picardi, A; Annibali, O; Tendas, A; Cupelli, L; Nobile, C; Marchesi, F; Cerretti, R; Mirabile, M; De Angelis, G; Girardi, K; De Fabritiis, P; Avvisati, G; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:165;a:14:{s:9:"citazione";s:318:"Zinno, F., Landi, F., Aureli, V., Caniglia, M., Pinto, R., Rana, I., et al. (2010). Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures. TRANSFUSION AND APHERESIS SCIENCE, 43(2), 173-178 [10.1016/j.transci.2010.07.005].";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_62686";s:6:"handle";s:10:"2108/16482";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:150:"Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures";s:9:"metadata6";s:119:"Zinno, F; Landi, F; Aureli, V; Caniglia, M; Pinto, R; Rana, I; Balduino, G; Miele, M; Picardi, A; Arcese, W; Isacchi, G";s:9:"metadata7";s:29:"10.1016/j.transci.2010.07.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:166;a:14:{s:9:"citazione";s:295:"Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), 488-492 [10.1016/j.ijid.2009.01.020].";s:4:"data";s:7:"2009-11";s:2:"id";s:20:"PUBBLICAZIONE_115490";s:6:"handle";s:10:"2108/59311";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/08 - Anatomia Patologica";s:9:"metadata4";N;s:9:"metadata5";s:108:"A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient";s:9:"metadata6";s:108:"Beltrame, A; Sarmati, L; Cudillo, L; Cerretti, R; Picardi, A; Anemona, L; Fontana, C; Andreoni, M; Arcese, W";s:9:"metadata7";s:26:"10.1016/j.ijid.2009.01.020";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:167;a:14:{s:9:"citazione";s:297:"Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), e488-e492 [10.1016/j.ijid.2009.01.020].";s:4:"data";s:7:"2009-11";s:2:"id";s:20:"PUBBLICAZIONE_254680";s:6:"handle";s:11:"2108/248318";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:108:"A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient";s:9:"metadata6";s:108:"Beltrame, A; Sarmati, L; Cudillo, L; Cerretti, R; Picardi, A; Anemona, L; Fontana, C; Andreoni, M; Arcese, W";s:9:"metadata7";s:26:"10.1016/j.ijid.2009.01.020";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:168;a:14:{s:9:"citazione";s:244:"Babakir-Mina, M., Ciccozzi, M., Alteri, C., Polchi, P., Picardi, A., Greco, F., et al. (2009). Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. JOURNAL OF MEDICAL VIROLOGY, 81(9), 1668-1673.";s:4:"data";s:7:"2009-09";s:2:"id";s:19:"PUBBLICAZIONE_82380";s:6:"handle";s:10:"2108/26930";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:101:"Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders";s:9:"metadata6";s:118:"Babakir-Mina, M; Ciccozzi, M; Alteri, C; Polchi, P; Picardi, A; Greco, F; Lucarelli, G; Arcese, W; Perno, C; Ciotti, M";s:9:"metadata7";s:17:"10.1002/jmv.21559";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:169;a:14:{s:9:"citazione";s:291:"Crocchiolo, R., Zino, E., Vago, L., Oneto, R., Bruno, B., Pollichieni, S., et al. (2009). Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. BLOOD, 114(7), 1437-1444 [10.1182/blood-2009-01-200378].";s:4:"data";s:10:"2009-08-13";s:2:"id";s:20:"PUBBLICAZIONE_141037";s:6:"handle";s:10:"2108/68620";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:143:"Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation";s:9:"metadata6";s:225:"Crocchiolo, R; Zino, E; Vago, L; Oneto, R; Bruno, B; Pollichieni, S; Sacchi, N; Sormani, M; Marcon, J; Lamparelli, T; Fanin, R; Garbarino, L; Miotti, V; Bandini, G; Bosi, A; Ciceri, F; Bacigalupo, A; Fleischhauer, K; Arcese,W";s:9:"metadata7";s:28:"10.1182/blood-2009-01-200378";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:170;a:14:{s:9:"citazione";s:236:"Cesaro, S., Hirsch, H., Faraci, M., Owoc-Lempach, J., Beltrame, A., Tendas, A., et al. (2009). Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. CLINICAL INFECTIOUS DISEASES, 49(2), 233-240 [10.1086/599829].";s:4:"data";s:10:"2009-07-15";s:2:"id";s:20:"PUBBLICAZIONE_139949";s:6:"handle";s:10:"2108/68259";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:77:"Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study";s:9:"metadata6";s:273:"Cesaro, S; Hirsch, H; Faraci, M; Owoc-Lempach, J; Beltrame, A; Tendas, A; Baltadakis, I; Dalle, J; Koc, Y; Toporski, J; Styczynski, J; Yesilipek, M; Heinz, W; Caniglia, M; Rascon, J; Fauser, A; Michallet, M; Lopez-Corral, L; Neuburger, S; Tridello, G; Einsele, H; Arcese, W";s:9:"metadata7";s:14:"10.1086/599829";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:171;a:14:{s:9:"citazione";s:291:"Cudillo, L., Cerretti, R., Baliva, G., De Angelis, G., Postorino, M., Picardi, A., et al. (2009). Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion. BONE MARROW TRANSPLANTATION, 43(4), 347-348 [10.1038/bmt.2008.333].";s:4:"data";s:7:"2009-02";s:2:"id";s:20:"PUBBLICAZIONE_254690";s:6:"handle";s:11:"2108/248314";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:124:"Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion";s:9:"metadata6";s:124:"Cudillo, L; Cerretti, R; Baliva, G; De Angelis, G; Postorino, M; Picardi, A; Mirabile, M; Lanti, A; Cantonetti, M; Arcese, W";s:9:"metadata7";s:20:"10.1038/bmt.2008.333";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:172;a:14:{s:9:"citazione";s:302:"Tirindelli, M., Flammia, G., Sergi, F., Cerretti, R., Cudillo, L., Picardi, A., et al. (2009). Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation. TRANSFUSION, 49(1), 170-175 [10.1111/j.1537-2995.2008.01934.x].";s:4:"data";s:7:"2009-01";s:2:"id";s:20:"PUBBLICAZIONE_139944";s:6:"handle";s:10:"2108/68270";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:142:"Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation";s:9:"metadata6";s:133:"Tirindelli, M; Flammia, G; Sergi, F; Cerretti, R; Cudillo, L; Picardi, A; Postorino, M; Annibali, O; Greco, R; Avvisati, G; Arcese, W";s:9:"metadata7";s:32:"10.1111/j.1537-2995.2008.01934.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:173;a:14:{s:9:"citazione";s:304:"Tirindelli, M.C., Flammia, G., Sergi, F., Cerretti, R., Cudillo, L., Picardi, A., et al. (2009). Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation. TRANSFUSION, 49(1), 170-175 [10.1111/j.1537-2995.2008.01934.x].";s:4:"data";s:7:"2009-01";s:2:"id";s:20:"PUBBLICAZIONE_254824";s:6:"handle";s:11:"2108/248311";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:142:"Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation";s:9:"metadata6";s:134:"Tirindelli, MC; Flammia, G; Sergi, F; Cerretti, R; Cudillo, L; Picardi, A; Postorino, M; Annibali, O; Greco, R; Avvisati, G; Arcese, W";s:9:"metadata7";s:32:"10.1111/j.1537-2995.2008.01934.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:174;a:14:{s:9:"citazione";s:161:"Arcese, W., Cudillo, L., & Picardi, A. (2009). Il Trapianto di Cellule Stminali Emopoietiche.. In Il Trapianto di Cellule Stminali Emopoietiche. (pp. 1-11). SEU.";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_62687";s:6:"handle";s:10:"2108/18405";s:9:"metadata1";s:19:"Contributo in libro";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:46:"Il Trapianto di Cellule Stminali Emopoietiche.";s:9:"metadata6";s:33:"Arcese, W; Cudillo,L; Picardi, A.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:175;a:14:{s:9:"citazione";s:264:"Babakir Mina, M., Ciccozzi, M., Alteri, C., Polchi, P., Picardi, A., Greco, F., et al. (2009). Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. JOURNAL OF MEDICAL VIROLOGY, 81(9), 1668-1673 [10.1002/jmv.21559].";s:4:"data";s:4:"2009";s:2:"id";s:18:"PUBBLICAZIONE_9132";s:6:"handle";s:10:"2108/36857";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:34:"Settore MED/05 - Patologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:101:"Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders";s:9:"metadata6";s:119:"Babakir Mina, M; Ciccozzi, M; Alteri, C; Polchi, P; Picardi, A; Greco, F; Lucarelli, G; Arcese, W; Perno, Cf; Ciotti, M";s:9:"metadata7";s:17:"10.1002/jmv.21559";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:176;a:14:{s:9:"citazione";s:210:"Buccisano, F., Maurillo, L., Spagnoli, A., Del Principe, M., Ceresoli, E., Lo Coco, F., et al. (2009). Monitoring of minimal residual disease in acute myeloid leukemia. CURRENT OPINION IN ONCOLOGY, 21, 582-588.";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_35156";s:6:"handle";s:10:"2108/39410";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:64:"Monitoring of minimal residual disease in acute myeloid leukemia";s:9:"metadata6";s:116:"Buccisano, F; Maurillo, L; Spagnoli, A; Del Principe, M; Ceresoli, E; Lo Coco, F; Arcese, W; Amadori, S; Venditti, A";s:9:"metadata7";s:28:"10.1097/CCO.0b013e3283311856";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:177;a:14:{s:9:"citazione";s:291:"Cudillo, L., Cerretti, R., Baliva, G., De Angelis, G., Postorino, M., Picardi, A., et al. (2009). Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion. BONE MARROW TRANSPLANTATION, 43(4), 347-348 [10.1038/bmt.2008.333].";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_93680";s:6:"handle";s:10:"2108/36871";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:124:"Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion";s:9:"metadata6";s:124:"Cudillo, L; Cerretti, R; Baliva, G; De Angelis, G; Postorino, M; Picardi, A; Mirabile, M; Lanti, A; Cantonetti, M; Arcese, W";s:9:"metadata7";s:20:"10.1038/bmt.2008.333";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:178;a:14:{s:9:"citazione";s:204:"Cudillo, L., Cerretti, R., Picardi, A., Mirabile, M., Giannotti, F., Mariotti, B., et al. (2009). Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. HAEMATOLOGICA, 94(s4).";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_205448";s:6:"handle";s:11:"2108/107222";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:83:"Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas.";s:9:"metadata6";s:126:"Cudillo, L; Cerretti, R; Picardi, A; Mirabile, M; Giannotti, F; Mariotti, B; Pisani, F; Postorino, M; Cantonetti, M; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:179;a:14:{s:9:"citazione";s:285:"Lupattelli, M., Marchetti, G., POSTORINO, M., Franceschini, L., Romeo, N., CUDILLO, L., et al. (2009). Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. NUTRITIONAL THERAPY & METABOLISM, 27, 39-45.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_215801";s:6:"handle";s:11:"2108/107223";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:137:"Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation.";s:9:"metadata6";s:103:"Lupattelli, M; Marchetti, G; POSTORINO, M; Franceschini, L; Romeo, N; CUDILLO, L; ARCESE, W; BOLLEA, MR";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:180;a:14:{s:9:"citazione";s:225:"Ottaviani, L., Sarlo, C., Ceresoli, E., Cefalo, M., Zottolo, R., Campagna, S., et al. (2009). Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia. HAEMATOLOGICA, 94.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_215815";s:6:"handle";s:11:"2108/107224";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:111:"Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia";s:9:"metadata6";s:204:"Ottaviani, L; Sarlo, C; Ceresoli, E; Cefalo, M; Zottolo, R; Campagna, S; Mirabile, M; De Angelis, G; Del Principe, MI; Buccisano, F; Cudillo, L; Picardi, A; Cerretti, R; Arcese, W; Amadori, S; Venditti, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:181;a:14:{s:9:"citazione";s:358:"PICARDI, A., DE FABRITIIS, P., Dentamaro, T., De Rossi, G., Caniglia, M., Pinto Petti, M., et al. (2009). The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. HAEMATOLOGICA, 94.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_215822";s:6:"handle";s:11:"2108/107258";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:233:"The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network.";s:9:"metadata6";s:272:"PICARDI, A; DE FABRITIIS, P; Dentamaro, T; De Rossi, G; Caniglia, M; Pinto Petti, M; Mengarelli, A; Annino, L; Chierichini, ; Monarca, B; Montefusco, E; Avvisati, G; Tirindelli, M; Mangione, I; CUDILLO, L; Cerretti, R; De Angelis, G; Di Veroli, A; Provenzano, I; ARCESE, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:182;a:14:{s:9:"citazione";s:261:"Picardi, A., Spagnoli, A., Caniglia, M., Pinto, R., Dentamaro, T., Mangione, I., et al. (2009). Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant. BONE MARROW TRANSPLANTATION, 43(Supp. 1).";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_205449";s:6:"handle";s:10:"2108/97847";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:122:"Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant";s:9:"metadata6";s:166:"Picardi, A; Spagnoli, A; Caniglia, M; Pinto, R; Dentamaro, T; Mangione, I; Cudillo, L; Cupelli,L; Zinno, F; Bruno, A; Del Proposto, G; Kloger, G; Lecchi, L; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:183;a:14:{s:9:"citazione";s:241:"Vischini, G., Cudillo, L., Ferrannini, M., Di Daniele, N., Cerretti, R., & Arcese, W. (2009). Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report. JN. JOURNAL OF NEPHROLOGY, 22, 160-163.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_111263";s:6:"handle";s:10:"2108/56598";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:27:"Settore MED/14 - Nefrologia";s:9:"metadata4";N;s:9:"metadata5";s:107:"Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report.";s:9:"metadata6";s:77:"Vischini, G; Cudillo, L; Ferrannini, M; Di Daniele, N; Cerretti, R; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:184;a:14:{s:9:"citazione";s:294:"Maurillo, L., Buccisano, F., Del Principe, M.I., Del Poeta, G., Spagnoli, A., Panetta, P., et al. (2008). Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia. JOURNAL OF CLINICAL ONCOLOGY, 26(30), 4944-4951 [10.1200/JCO.2007.15.9814].";s:4:"data";s:10:"2008-10-20";s:2:"id";s:19:"PUBBLICAZIONE_20061";s:6:"handle";s:10:"2108/43567";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:111:"Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia";s:9:"metadata6";s:243:"Maurillo, L; Buccisano, F; Del Principe, MI; Del Poeta, G; Spagnoli, A; Panetta, P; Ammatuna, E; Neri, B; Ottaviani, L; Sarlo, C; Venditti, D; Quaresima, M;Cerretti, R; Rizzo, M; De Fabritiis, P; Lo Coco, FL; Arcese, W; Amadori, S; Venditti, A";s:9:"metadata7";s:24:"10.1200/JCO.2007.15.9814";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:185;a:14:{s:9:"citazione";s:332:"Alessandrino, E., Della Porta, M., Bacigalupo, A., Van Lint, M., Falda, M., Onida, F., et al. (2008). WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). BLOOD, 112(3), 895-902 [10.1182/blood-2008-03-143735].";s:4:"data";s:10:"2008-08-01";s:2:"id";s:20:"PUBBLICAZIONE_141059";s:6:"handle";s:10:"2108/68624";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:174:"WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)";s:9:"metadata6";s:220:"Alessandrino, E; Della Porta, M; Bacigalupo, A; Van Lint, M; Falda, M; Onida, F; Bernardi, M; Iori, A; Rambaldi, A; Cerretti, R; Marenco, P; Pioltelli, P; Malcovati, L; Pascutto, C; Oneto, R; Fanin, R; Bosi, A; Arcese, W";s:9:"metadata7";s:28:"10.1182/blood-2008-03-143735";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:186;a:14:{s:9:"citazione";s:259:"Iori, A., Arcese, W., Milano, F., Calabrese, E., Torelli, G., Barberi, W., et al. (2007). Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up. HAEMATOLOGICA, 92(8), 1051-1058 [10.3324/haematol.11271].";s:4:"data";s:7:"2007-08";s:2:"id";s:20:"PUBBLICAZIONE_139947";s:6:"handle";s:10:"2108/68256";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:110:"Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up";s:9:"metadata6";s:220:"Iori, A; Arcese, W; Milano, F; Calabrese, E; Torelli, G; Barberi, W; Mascolo, M; De Felice, L; Screnci, M; Lucarelli, B; Malandruccolo, L; Perrone, M; Salvatori, S; Laurenti, L; Iannella, E; Ricci, R; Moleti, M; Foà, R";s:9:"metadata7";s:22:"10.3324/haematol.11271";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:187;a:14:{s:9:"citazione";s:248:"Screnci, M., Salvatori, S., Carmini, D., & Arcese, W. (2007). Does the volume reduction manipulation before cryopreservation influence cord blood cell recovery pretransplant?. TRANSFUSION MEDICINE, 17(3), 208-209 [10.1111/j.1365-3148.2007.00749.x].";s:4:"data";s:7:"2007-06";s:2:"id";s:20:"PUBBLICAZIONE_141176";s:6:"handle";s:10:"2108/68668";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:112:"Does the volume reduction manipulation before cryopreservation influence cord blood cell recovery pretransplant?";s:9:"metadata6";s:47:"Screnci, M; Salvatori, S; Carmini, D; Arcese, W";s:9:"metadata7";s:32:"10.1111/j.1365-3148.2007.00749.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:188;a:14:{s:9:"citazione";s:342:"Sanz, M., Labopin, M., Gorin, N., de la Rubia, J., Arcese, W., Meloni, G., et al. (2007). Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. BONE MARROW TRANSPLANTATION, 39(8), 461-469 [10.1038/sj.bmt.1705620].";s:4:"data";s:7:"2007-04";s:2:"id";s:20:"PUBBLICAZIONE_141137";s:6:"handle";s:10:"2108/68642";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:181:"Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation";s:9:"metadata6";s:195:"Sanz, M; Labopin, M; Gorin, N; de la Rubia, J; Arcese, W; Meloni, G; Bacigalupo, A; Alessandrino, P; Carreras, E; Iriondo, A; Novitzky, N; Jacobs, P; Bandini, G; Lo-Coco, F; Frassoni, F; Rocha, V";s:9:"metadata7";s:22:"10.1038/sj.bmt.1705620";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:189;a:14:{s:9:"citazione";s:376:"Herr, A., Labopin, M., Blaise, D., Milpied, N., Potter, M., Michallet, M., et al. (2007). HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia. LEUKEMIA, 21(1), 129-135 [10.1038/sj.leu.2404461].";s:4:"data";s:7:"2007-01";s:2:"id";s:20:"PUBBLICAZIONE_141116";s:6:"handle";s:10:"2108/68635";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:234:"HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia";s:9:"metadata6";s:228:"Herr, A; Labopin, M; Blaise, D; Milpied, N; Potter, M; Michallet, M; Heit, W; Ferrara, F; Esteve, J; Arcese, W; Ehninger, G; Rowe, J; Kobbe, G; Rosselet, A; Bunjes, D; Rio, B; Brune, M; Nagler, A; Gorin, N; Frassoni, F; Rocha, V";s:9:"metadata7";s:22:"10.1038/sj.leu.2404461";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:190;a:14:{s:9:"citazione";s:188:"Arcese, W., Rocha, V., Labopin, M., Sanz, G., Iori, A., de Lima, M., et al. (2006). Unrelated cord blood transplants in adults with hematologic malignancies. HAEMATOLOGICA, 91(2), 223-230.";s:4:"data";s:7:"2006-02";s:2:"id";s:20:"PUBBLICAZIONE_139952";s:6:"handle";s:10:"2108/68263";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:72:"Unrelated cord blood transplants in adults with hematologic malignancies";s:9:"metadata6";s:129:"Arcese, W; Rocha, V; Labopin, M; Sanz, G; Iori, A; de Lima, M; Sirvent, A; Busca, A; Asano, S; Ionescu, I; Wernet, P; Gluckman, E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:191;a:14:{s:9:"citazione";s:205:"Arcese, W., Picardi, A., Cerretti, R., Cudillo, L., DE ANGELIS, G., Franceschini, L., et al. (2006). The therapeutic use of cord blood. CELL PRESERVATION TECHNOLOGY, 4(3), 161-168 [10.1089/cpt.2006.4.161].";s:4:"data";s:4:"2006";s:2:"id";s:20:"PUBBLICAZIONE_321898";s:6:"handle";s:11:"2108/190359";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:33:"The therapeutic use of cord blood";s:9:"metadata6";s:106:"Arcese, W; Picardi, A; Cerretti, R; Cudillo, L; DE ANGELIS, G; Franceschini, L; De Felice, L; Postorino, M";s:9:"metadata7";s:22:"10.1089/cpt.2006.4.161";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:192;a:14:{s:9:"citazione";s:331:"Van Lint, M., Milone, G., Leotta, S., Uderzo, C., Scime, R., Dallorso, S., et al. (2006). Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. BLOOD, 107(10), 4177-4181 [10.1182/blood-2005-12-4851].";s:4:"data";s:4:"2006";s:2:"id";s:18:"PUBBLICAZIONE_7882";s:6:"handle";s:10:"2108/57360";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:184:"Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin";s:9:"metadata6";s:186:"Van Lint, M; Milone, G; Leotta, S; Uderzo, C; Scime, R; Dallorso, S; Locasciulli, A; Guidi, S; Mordini, N; Sica, S; CUDILLO, L; Fagioli, F; Selleri, C; Bruno, B; ARCESE, W; Bacigalupo, A";s:9:"metadata7";s:26:"10.1182/blood-2005-12-4851";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:193;a:14:{s:9:"citazione";s:283:"De Felice, L., Tatarelli, C., Mascolo, M., Gregorj, C., Agostini, F., Fiorini, R., et al. (2005). Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. CANCER RESEARCH, 65(4), 1505-1513 [10.1158/0008-5472.CAN-04-3063].";s:4:"data";s:10:"2005-02-15";s:2:"id";s:20:"PUBBLICAZIONE_139960";s:6:"handle";s:10:"2108/68276";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:117:"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells";s:9:"metadata6";s:145:"De Felice, L; Tatarelli, C; Mascolo, M; Gregorj, C; Agostini, F; Fiorini, R; Gelmetti, V; Pascale, S; Padula, F; Petrucci, M; Arcese, W; Nervi, C";s:9:"metadata7";s:29:"10.1158/0008-5472.CAN-04-3063";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:194;a:14:{s:9:"citazione";s:220:"Caronna, R., Cardi, M., Arcese, W., Iori, A., Martelli, M., Catinelli, S., et al. (2005). Gastrointestinal surgical emergencies in patients treated for hemathological malignancies. I SUPPLEMENTI DI TUMORI, 4(3), 141-145.";s:4:"data";s:4:"2005";s:2:"id";s:20:"PUBBLICAZIONE_141711";s:6:"handle";s:10:"2108/68954";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:89:"Gastrointestinal surgical emergencies in patients treated for hemathological malignancies";s:9:"metadata6";s:170:"Caronna, R; Cardi, M; Arcese, W; Iori, A; Martelli, M; Catinelli, S; Mangioni, S; Corelli, S; Priore, F; Tarantino, E; Frantellizzi, V; Spera, G; Borrini, F; Chirletti, P";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:195;a:14:{s:9:"citazione";s:310:"Locasciulli, A., Bruno, B., Rambaldi, A., Saracco, P., Dufour, C., Finelli, C., et al. (2004). Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. HAEMATOLOGICA, 89(9), 1054-1061.";s:4:"data";s:7:"2004-09";s:2:"id";s:20:"PUBBLICAZIONE_139957";s:6:"handle";s:10:"2108/68271";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:181:"Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study";s:9:"metadata6";s:144:"Locasciulli, A; Bruno, B; Rambaldi, A; Saracco, P; Dufour, C; Finelli, C; Sica, S; Varotto, S; Arcese, W; Locatelli, F; Soligo, D; Bacigalupo, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:196;a:14:{s:9:"citazione";s:291:"Raimondi, R., Soli, M., Lamparelli, T., Bacigalupo, A., Arcese, W., Belloni, M., et al. (2004). ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. BONE MARROW TRANSPLANTATION, 34(4), 321-329 [10.1038/sj.bmt.1704579].";s:4:"data";s:7:"2004-08";s:2:"id";s:20:"PUBBLICAZIONE_141181";s:6:"handle";s:10:"2108/68679";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:124:"ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature";s:9:"metadata6";s:88:"Raimondi, R; Soli, M; Lamparelli, T; Bacigalupo, A; Arcese, W; Belloni, M; Rodeghiero, F";s:9:"metadata7";s:22:"10.1038/sj.bmt.1704579";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:197;a:14:{s:9:"citazione";s:290:"Iori, A., Cerretti, R., De Felice, L., Screnci, M., Mengarelli, A., Romano, A., et al. (2004). Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. BONE MARROW TRANSPLANTATION, 33(11), 1097-1105 [10.1038/sj.bmt.1704500].";s:4:"data";s:7:"2004-06";s:2:"id";s:20:"PUBBLICAZIONE_141179";s:6:"handle";s:10:"2108/68676";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:121:"Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation";s:9:"metadata6";s:248:"Iori, A; Cerretti, R; De Felice, L; Screnci, M; Mengarelli, A; Romano, A; Caniglia, M; Cerilli, L; Gentile, G; Moleti, M; Giona, F; Agostini, F; Pasqua, I; Perrone, M; Pinto, M; Grapulin, L; Testi, A; Martino, P; De Rossi, G; Mandelli, F; Arcese, W";s:9:"metadata7";s:22:"10.1038/sj.bmt.1704500";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:198;a:14:{s:9:"citazione";s:253:"Gluckman, E., Rocha, V., Arcese, W., Michel, G., Sanz, G., Chan, K., et al. (2004). Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. EXPERIMENTAL HEMATOLOGY, 32(4), 397-407 [10.1016/j.exphem.2004.01.002].";s:4:"data";s:7:"2004-04";s:2:"id";s:20:"PUBBLICAZIONE_139948";s:6:"handle";s:10:"2108/68257";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:96:"Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice";s:9:"metadata6";s:337:"Gluckman, E; Rocha, V; Arcese, W; Michel, G; Sanz, G; Chan, K; Takahashi, T; Ortega, J; Filipovich, A; Locatelli, F; Asano, S; Fagioli, F; Vowels, M; Sirvent, A; Laporte, J; Tiedemann, K; Amadori, S; Abecassis, M; Bordigoni, P; Diez, B; Shaw, P; Vora, A; Caniglia, M; Garnier, F; Ionescu, I; Garcia, J; Koegler, G; Rebulla, P; Chevret, S";s:9:"metadata7";s:28:"10.1016/j.exphem.2004.01.002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:199;a:14:{s:9:"citazione";s:446:"Ringdén, O., Labopin, M., Gorin, N., Le Blanc, K., Rocha, V., Gluckman, E., et al. (2004). Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. JOURNAL OF CLINICAL ONCOLOGY, 22(3), 416-423 [10.1200/JCO.2004.06.102].";s:4:"data";s:10:"2004-02-01";s:2:"id";s:20:"PUBBLICAZIONE_139953";s:6:"handle";s:10:"2108/68264";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Bloo...";s:9:"metadata6";s:143:"Ringdén, O; Labopin, M; Gorin, N; Le Blanc, K; Rocha, V; Gluckman, E; Reiffers, J; Arcese, W; Vossen, J; Jouet, J; Cordonnier, C; Frassoni, F";s:9:"metadata7";s:23:"10.1200/JCO.2004.06.102";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:200;a:14:{s:9:"citazione";s:273:"Letizia, C., Celi, M., Iori, A., Verrelli, C., Caliumi, C., Diacinti, D., et al. (2004). Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia. ANNALI ITALIANI DI MEDICINA INTERNA, 19(3), 175-183.";s:4:"data";s:4:"2004";s:2:"id";s:20:"PUBBLICAZIONE_139961";s:6:"handle";s:10:"2108/68288";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:130:"Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia";s:9:"metadata6";s:90:"Letizia, C; Celi, M; Iori, A; Verrelli, C; Caliumi, C; Diacinti, D; Arcese, W; D'Erasmo, E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:201;a:14:{s:9:"citazione";s:264:"Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., et al. (2004). Transplants of Umbilical Cord Blood or Bone Marrow from Unrelated donors in Adult with Acute Leukemia. NEW ENGLAND JOURNAL OF MEDICINE, 351, 2276-2285 [10.1056/NEJMoa041469].";s:4:"data";s:4:"2004";s:2:"id";s:20:"PUBBLICAZIONE_112201";s:6:"handle";s:10:"2108/57422";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:101:"Transplants of Umbilical Cord Blood or Bone Marrow from Unrelated donors in Adult with Acute Leukemia";s:9:"metadata6";s:241:"Rocha, V; Labopin, M; Sanz, G; Arcese, W; Schwerdtfeger, R; Bosi, A; Jacobsen, N; Ruutu, T; de Lima, M; Finke, J; Frassoni, F; Gluckman, E Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry.";s:9:"metadata7";s:20:"10.1056/NEJMoa041469";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:202;a:14:{s:9:"citazione";s:246:"Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K., Filipovich, A., et al. (2003). Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. BLOOD, 102(13), 4290-4297 [10.1182/blood-2003-04-1288].";s:4:"data";s:10:"2003-12-15";s:2:"id";s:20:"PUBBLICAZIONE_139956";s:6:"handle";s:10:"2108/68269";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:100:"Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis";s:9:"metadata6";s:329:"Michel, G; Rocha, V; Chevret, S; Arcese, W; Chan, K; Filipovich, A; Takahashi, T; Vowels, M; Ortega, J; Bordigoni, P; Shaw, P; Yaniv, I; Machado, A; Pimentel, P; Fagioli, F; Verdeguer, A; Jouet, J; Diez, B; Ferreira, E; Pasquini, R; Rosenthal, J; Sievers, E; Messina, C; Iori, A; Garnier, F; Ionescu, I; Locatelli, F; Gluckman, E";s:9:"metadata7";s:26:"10.1182/blood-2003-04-1288";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:203;a:14:{s:9:"citazione";s:337:"Gorin, N., Labopin, M., Rocha, V., Arcese, W., Beksac, M., Gluckman, E., et al. (2003). Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. BLOOD, 102(8), 3043-3051 [10.1182/blood-2003-03-0665].";s:4:"data";s:10:"2003-10-15";s:2:"id";s:20:"PUBBLICAZIONE_139954";s:6:"handle";s:10:"2108/68265";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:193:"Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow";s:9:"metadata6";s:158:"Gorin, N; Labopin, M; Rocha, V; Arcese, W; Beksac, M; Gluckman, E; Ringden, O; Ruutu, T; Reiffers, J; Bandini, G; Falda, M; Zikos, P; Willemze, R; Frassoni, F";s:9:"metadata7";s:26:"10.1182/blood-2003-03-0665";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:204;a:14:{s:9:"citazione";s:322:"Lo-Coco, F., Romano, A., Mengarelli, A., Diverio, D., Iori, A., Moleti, M., et al. (2003). Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease. LEUKEMIA, 17(10), 1930-1933 [10.1038/sj.leu.2403078].";s:4:"data";s:7:"2003-10";s:2:"id";s:20:"PUBBLICAZIONE_141751";s:6:"handle";s:10:"2108/68969";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:176:"Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease";s:9:"metadata6";s:119:"Lo-Coco, F; Romano, A; Mengarelli, A; Diverio, D; Iori, A; Moleti, M; De Santis, S; Cerretti, R; Mandelli, F; Arcese, W";s:9:"metadata7";s:22:"10.1038/sj.leu.2403078";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:205;a:14:{s:9:"citazione";s:221:"Cwynarski, K., Roberts, I., Iacobelli, S., van Biezen, A., Brand, R., Devergie, A., et al. (2003). Stem cell transplantation for chronic myeloid leukemia in children. BLOOD, 102(4), 1224-1231 [10.1182/blood-2002-12-3637].";s:4:"data";s:10:"2003-08-15";s:2:"id";s:20:"PUBBLICAZIONE_139955";s:6:"handle";s:10:"2108/68267";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:66:"Stem cell transplantation for chronic myeloid leukemia in children";s:9:"metadata6";s:177:"Cwynarski, K; Roberts, I; Iacobelli, S; van Biezen, A; Brand, R; Devergie, A; Vossen, J; Aljurf, M; Arcese, W; Locatelli, F; Dini, G; Niethammer, D; Niederwieser, D; Apperley, J";s:9:"metadata7";s:26:"10.1182/blood-2002-12-3637";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:206;a:14:{s:9:"citazione";s:288:"Dini, G., Valsecchi, M., Micalizzi, C., Busca, A., Balduzzi, A., Arcese, W., et al. (2003). Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. BONE MARROW TRANSPLANTATION, 32(3), 325-331 [10.1038/sj.bmt.1704132].";s:4:"data";s:7:"2003-08";s:2:"id";s:20:"PUBBLICAZIONE_141190";s:6:"handle";s:10:"2108/68683";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:125:"Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission";s:9:"metadata6";s:258:"Dini, G; Valsecchi, M; Micalizzi, C; Busca, A; Balduzzi, A; Arcese, W; Cesaro, S; Prete, A; Rabusin, M; Mazzolari, E; Di Bartolomeo, P; Sacchi, N; Pession, A; Giorgiani, G; Lanino, E; Lamparelli, T; Favre, C; Bosi, A; Manzitti, C; Galimberti, S; Locatelli, F";s:9:"metadata7";s:22:"10.1038/sj.bmt.1704132";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:207;a:14:{s:9:"citazione";s:283:"Del Giudice, I., Iori, A., Mengarelli, A., Testi, A., Romano, A., Cerretti, R., et al. (2003). Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. ANNALS OF HEMATOLOGY, 82(3), 189-192 [10.1007/s00277-002-0590-0].";s:4:"data";s:7:"2003-03";s:2:"id";s:20:"PUBBLICAZIONE_141177";s:6:"handle";s:10:"2108/68673";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:121:"Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature";s:9:"metadata6";s:108:"Del Giudice, I; Iori, A; Mengarelli, A; Testi, A; Romano, A; Cerretti, R; Macrì, F; Iacobini, M; Arcese, W";s:9:"metadata7";s:25:"10.1007/s00277-002-0590-0";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:208;a:14:{s:9:"citazione";s:296:"Mengarelli, A., Iori, A., Romano, A., Cerretti, R., Cerilli, L., De Propris, M., et al. (2003). One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. HAEMATOLOGICA, 88(3), 315-323.";s:4:"data";s:7:"2003-03";s:2:"id";s:20:"PUBBLICAZIONE_139958";s:6:"handle";s:10:"2108/68272";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:168:"One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation";s:9:"metadata6";s:130:"Mengarelli, A; Iori, A; Romano, A; Cerretti, R; Cerilli, L; De Propris, M; Fenu, S; Moleti, M; De Felice, L; Girelli, G; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:209;a:14:{s:9:"citazione";s:400:"Locasciulli, A., Bruno, B., Alessandrino, E., Meloni, G., Arcese, W., Bandini, G., et al. (2003). Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. BONE MARROW TRANSPLANTATION, 31(4), 295-300 [10.1038/sj.bmt.1703826].";s:4:"data";s:7:"2003-02";s:2:"id";s:20:"PUBBLICAZIONE_141185";s:6:"handle";s:10:"2108/68681";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:231:"Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation";s:9:"metadata6";s:149:"Locasciulli, A; Bruno, B; Alessandrino, E; Meloni, G; Arcese, W; Bandini, G; Cassibba, V; Rotoli, B; Morra, E; Majolino, I; Alberti, A; Bacigalupo, A";s:9:"metadata7";s:22:"10.1038/sj.bmt.1703826";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:210;a:14:{s:9:"citazione";s:357:"Ringdén, O., Labopin, M., Bacigalupo, A., Arcese, W., Schaefer, U., Willemze, R., et al. (2002). Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. JOURNAL OF CLINICAL ONCOLOGY, 20(24), 4655-4664 [10.1200/JCO.2002.12.049].";s:4:"data";s:10:"2002-12-15";s:2:"id";s:20:"PUBBLICAZIONE_141192";s:6:"handle";s:10:"2108/68684";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:182:"Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia";s:9:"metadata6";s:148:"Ringdén, O; Labopin, M; Bacigalupo, A; Arcese, W; Schaefer, U; Willemze, R; Koc, H; Bunjes, D; Gluckman, E; Rocha, V; Schattenberg, A; Frassoni, F";s:9:"metadata7";s:23:"10.1200/JCO.2002.12.049";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:211;a:14:{s:9:"citazione";s:341:"Rocha, V., Labopin, M., Gluckman, E., Powles, R., Arcese, W., Bacigalupo, A., et al. (2002). Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. JOURNAL OF CLINICAL ONCOLOGY, 20(21), 4324-4330 [10.1200/JCO.2002.11.058].";s:4:"data";s:10:"2002-11-01";s:2:"id";s:20:"PUBBLICAZIONE_139993";s:6:"handle";s:10:"2108/68294";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:172:"Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey";s:9:"metadata6";s:132:"Rocha, V; Labopin, M; Gluckman, E; Powles, R; Arcese, W; Bacigalupo, A; Reiffers, J; Iriondo, A; Ringdén, O; Ruutu, T; Frassoni, F";s:9:"metadata7";s:23:"10.1200/JCO.2002.11.058";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:212;a:14:{s:9:"citazione";s:350:"Testi, A., Del Giudice, I., Arcese, W., Moleti, M., Giona, F., Basso, G., et al. (2002). A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. BRITISH JOURNAL OF HAEMATOLOGY, 118(3), 741-747 [10.1046/j.1365-2141.2002.03706.x].";s:4:"data";s:7:"2002-09";s:2:"id";s:20:"PUBBLICAZIONE_139992";s:6:"handle";s:10:"2108/68293";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:176:"A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group";s:9:"metadata6";s:300:"Testi, A; Del Giudice, I; Arcese, W; Moleti, M; Giona, F; Basso, G; Biondi, A; Conter, V; Messina, C; Rondelli, R; Micozzi, A; Micalizzi, C; Barisone, E; Locatelli, F; Dini, G; Aricò, M; Casale, F; Comis, M; Ladogana, S; Lippi, A; Mura, R; Pinta, M; Santoro, N; Valsecchi, M; Masera, G; Mandelli, F";s:9:"metadata7";s:32:"10.1046/j.1365-2141.2002.03706.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:213;a:14:{s:9:"citazione";s:323:"Dini, G., Cancedda, R., Giorgiani, G., Porta, F., Messina, C., Uderzo, C., et al. (2002). Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO). HAEMATOLOGICA, 87(8 Suppl), 51-57.";s:4:"data";s:7:"2002-08";s:2:"id";s:20:"PUBBLICAZIONE_139959";s:6:"handle";s:10:"2108/68275";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:197:"Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO)";s:9:"metadata6";s:242:"Dini, G; Cancedda, R; Giorgiani, G; Porta, F; Messina, C; Uderzo, C; Pession, A; Fagioli, F; La Nasa, G; Arcese, W; Pollichieni, S; Zecca, M; Lanino, E; Mazzolari, E; Cesaro, S; Balduzzi, A; Rondelli, R; Vassallo, E; Cappelli, B; Locatelli, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:214;a:14:{s:9:"citazione";s:256:"Guglielmi, C., Arcese, W., Dazzi, F., Brand, R., Bunjes, D., Verdonck, L., et al. (2002). Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. BLOOD, 100(2), 397-405 [10.1182/blood.V100.2.397].";s:4:"data";s:10:"2002-07-15";s:2:"id";s:20:"PUBBLICAZIONE_139996";s:6:"handle";s:10:"2108/68297";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:114:"Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose";s:9:"metadata6";s:216:"Guglielmi, C; Arcese, W; Dazzi, F; Brand, R; Bunjes, D; Verdonck, L; Schattenberg, A; Kolb, H; Ljungman, P; Devergie, A; Bacigalupo, A; Gomez, M; Michallet, M; Elmaagacli, A; Gratwohl, A; Apperley, J; Niederwieser, D";s:9:"metadata7";s:24:"10.1182/blood.V100.2.397";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:215;a:14:{s:9:"citazione";s:295:"Mengarelli, A., Iori, A., Cerretti, R., Cerilli, L., Romano, A., & Arcese, W. (2002). Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy. HAEMATOLOGICA, 87(7), 782-784.";s:4:"data";s:7:"2002-07";s:2:"id";s:20:"PUBBLICAZIONE_139995";s:6:"handle";s:10:"2108/68295";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:177:"Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy";s:9:"metadata6";s:69:"Mengarelli, A; Iori, A; Cerretti, R; Cerilli, L; Romano, A; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:216;a:14:{s:9:"citazione";s:207:"Bonifazi, F., Bandini, G., & Arcese, W. (2002). Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow transplantation. HAEMATOLOGICA, 87(5), 449-452.";s:4:"data";s:7:"2002-05";s:2:"id";s:20:"PUBBLICAZIONE_139989";s:6:"handle";s:10:"2108/68290";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:127:"Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow transplantation";s:9:"metadata6";s:34:"Bonifazi, F; Bandini, G; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:217;a:14:{s:9:"citazione";s:272:"Mengarelli, A., Iori, A., Guglielmi, C., Romano, A., Cerretti, R., Torromeo, C., et al. (2002). Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. HAEMATOLOGICA, 87(1), 52-58.";s:4:"data";s:7:"2002-01";s:2:"id";s:20:"PUBBLICAZIONE_139991";s:6:"handle";s:10:"2108/68291";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:146:"Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia";s:9:"metadata6";s:143:"Mengarelli, A; Iori, A; Guglielmi, C; Romano, A; Cerretti, R; Torromeo, C; Micozzi, A; Fenu, S; Laurenti, L; Donato, V; De Felice, L; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:218;a:14:{s:9:"citazione";s:266:"Rocha, V., Cornish, J., Sievers, E., Filipovich, A., Locatelli, F., Peters, C., et al. (2001). Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. BLOOD, 97(10), 2962-2971 [10.1182/blood.V97.10.2962].";s:4:"data";s:10:"2001-05-15";s:2:"id";s:20:"PUBBLICAZIONE_141238";s:6:"handle";s:10:"2108/68714";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:116:"Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia";s:9:"metadata6";s:338:"Rocha, V; Cornish, J; Sievers, E; Filipovich, A; Locatelli, F; Peters, C; Remberger, M; Michel, G; Arcese, W; Dallorso, S; Tiedemann, K; Busca, A; Chan, K; Kato, S; Ortega, J; Vowels, M; Zander, A; Souillet, G; Oakill, A; Woolfrey, A; Pay, A; Green, A; Garnier, F; Ionescu, I; Wernet, P; Sirchia, G; Rubinstein, P; Chevret, S; Gluckman, E";s:9:"metadata7";s:25:"10.1182/blood.V97.10.2962";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:219;a:14:{s:9:"citazione";s:235:"Dini, G., Cancedda, R., Locatelli, F., Bosi, A., Bandini, G., Alessandrino, E., et al. (2001). Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO). HAEMATOLOGICA, 86(5), 451-456.";s:4:"data";s:7:"2001-05";s:2:"id";s:20:"PUBBLICAZIONE_141194";s:6:"handle";s:10:"2108/68685";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:108:"Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO)";s:9:"metadata6";s:330:"Dini, G; Cancedda, R; Locatelli, F; Bosi, A; Bandini, G; Alessandrino, E; Porta, F; Uderzo, C; Messina, C; Fagioli, F; Arcese, W; Marenco, P; Fanin, R; Falda, M; Soligo, D; La Nasa, G; Giardini, C; Pession, A; Scimè, R; Di Bartolomeo, P; Bruno, B; Garbarino, L; Lamparelli, T; Giorgiani, G; Lanino, E; Manzitti, C; Bacigalupo, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:220;a:14:{s:9:"citazione";s:276:"de Fabritiis, P., Iori, A., Mengarelli, A., Gozzer, M., Ferrazza, G., De Propris, M., et al. (2001). CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF. TRANSFUSION, 41(2), 190-195 [10.1046/j.1537-2995.2001.41020190.x].";s:4:"data";s:7:"2001-02";s:2:"id";s:20:"PUBBLICAZIONE_141241";s:6:"handle";s:10:"2108/68716";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:107:"CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF";s:9:"metadata6";s:100:"de Fabritiis, P; Iori, A; Mengarelli, A; Gozzer, M; Ferrazza, G; De Propris, M; Romano, A; Arcese, W";s:9:"metadata7";s:35:"10.1046/j.1537-2995.2001.41020190.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:221;a:14:{s:9:"citazione";s:278:"Locasciulli, A., Arcese, W., Locatelli, F., Di Bona, E., & Bacigalupo, A. (2001). Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. THE LANCET, 357(9249), 43-44 [10.1016/S0140-6736(00)03574-1].";s:4:"data";s:10:"2001-01-06";s:2:"id";s:20:"PUBBLICAZIONE_141336";s:6:"handle";s:10:"2108/68753";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:133:"Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group";s:9:"metadata6";s:66:"Locasciulli, A; Arcese, W; Locatelli, F; Di Bona, E; Bacigalupo, A";s:9:"metadata7";s:29:"10.1016/S0140-6736(00)03574-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:222;a:14:{s:9:"citazione";s:266:"Mengarelli, A., Iori, A., Guglielmi, C., Perrone, M., Gozzer, M., Girmenia, C., et al. (2000). Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies. LEUKEMIA, 14(12), 2052-2058 [10.1038/sj.leu.2401947].";s:4:"data";s:7:"2000-12";s:2:"id";s:20:"PUBBLICAZIONE_141329";s:6:"handle";s:10:"2108/68747";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:116:"Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies";s:9:"metadata6";s:153:"Mengarelli, A; Iori, A; Guglielmi, C; Perrone, M; Gozzer, M; Girmenia, C; Cimino, G; Testi, A; Ricci, R; De Felice, L; Girelli, G; Mandelli, F; Arcese, W";s:9:"metadata7";s:22:"10.1038/sj.leu.2401947";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:223;a:14:{s:9:"citazione";s:251:"Dini, G., Cancedda, R., Locatelli, F., Bosi, A., Bandini, G., Alessandrino, E., et al. (2000). Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO). HAEMATOLOGICA, 85(11 Suppl), 30-36.";s:4:"data";s:7:"2000-11";s:2:"id";s:20:"PUBBLICAZIONE_141324";s:6:"handle";s:10:"2108/68741";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:119:"Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO)";s:9:"metadata6";s:330:"Dini, G; Cancedda, R; Locatelli, F; Bosi, A; Bandini, G; Alessandrino, E; Porta, F; Uderzo, C; Messina, C; Fagioli, F; Arcese, W; Marenco, P; Fanin, R; Falda, M; Soligo, D; La Nasa, G; Giardini, C; Pession, A; Scimè, R; Di Bartolomeo, P; Bruno, B; Garbarino, L; Lamparelli, T; Giorgiani, G; Lanino, E; Manzitti, C; Bacigalupo, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:224;a:14:{s:9:"citazione";s:376:"Locatelli, F., Bruno, B., Zecca, M., Van-Lint, M., McCann, S., Arcese, W., et al. (2000). Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. BLOOD, 96(5), 1690-1697.";s:4:"data";s:10:"2000-09-01";s:2:"id";s:20:"PUBBLICAZIONE_141334";s:6:"handle";s:10:"2108/68750";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomiz...";s:9:"metadata6";s:152:"Locatelli, F; Bruno, B; Zecca, M; Van-Lint, M; McCann, S; Arcese, W; Dallorso, S; Di Bartolomeo, P; Fagioli, F; Locasciulli, A; Lawler, M; Bacigalupo, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:225;a:14:{s:9:"citazione";s:281:"Girmenia, C., Iori, A., Bernasconi, S., Testi, A., Moleti, M., Arcese, W., et al. (2000). Listeriosis in recipients of allogeneic bone marrow transplants from unrelated donors. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 19(9), 711-714 [10.1007/s100960000343].";s:4:"data";s:7:"2000-09";s:2:"id";s:20:"PUBBLICAZIONE_141331";s:6:"handle";s:10:"2108/68749";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:85:"Listeriosis in recipients of allogeneic bone marrow transplants from unrelated donors";s:9:"metadata6";s:79:"Girmenia, C; Iori, A; Bernasconi, S; Testi, A; Moleti, M; Arcese, W; Martino, P";s:9:"metadata7";s:21:"10.1007/s100960000343";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:226;a:14:{s:9:"citazione";s:370:"Guglielmi, C., Arcese, W., Hermans, J., Bacigalupo, A., Bandini, G., Bunjes, D., et al. (2000). Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. BLOOD, 95(11), 3328-3334.";s:4:"data";s:10:"2000-06-01";s:2:"id";s:20:"PUBBLICAZIONE_141328";s:6:"handle";s:10:"2108/68746";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:247:"Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:211:"Guglielmi, C; Arcese, W; Hermans, J; Bacigalupo, A; Bandini, G; Bunjes, D; Carreras, E; Devergie, A; Frassoni, F; Goldman, J; Gratwohl, A; Kolb, H; Iori, A; Niederwieser, D; Prentice, H; de Witte, T; Apperley, J";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:227;a:14:{s:9:"citazione";s:335:"Frassoni, F., Labopin, M., Powles, R., Mary, J., Arcese, W., Bacigalupo, A., et al. (2000). Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. THE LANCET, 355(9213), 1393-1398 [10.1016/S0140-6736(00)02137-1].";s:4:"data";s:10:"2000-04-22";s:2:"id";s:20:"PUBBLICAZIONE_141370";s:6:"handle";s:10:"2108/68768";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:176:"Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:175:"Frassoni, F; Labopin, M; Powles, R; Mary, J; Arcese, W; Bacigalupo, A; Bunjes, D; Gluckman, E; Ruutu, T; Schaefer, U; Sierra, J; Vernant, J; Willemze, R; de Witte, T; Gorin, N";s:9:"metadata7";s:29:"10.1016/S0140-6736(00)02137-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:228;a:14:{s:9:"citazione";s:457:"Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., et al. (2000). Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). BLOOD, 95(6), 1931-1934.";s:4:"data";s:10:"2000-03-15";s:2:"id";s:20:"PUBBLICAZIONE_141363";s:6:"handle";s:10:"2108/68761";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Se...";s:9:"metadata6";s:190:"Bacigalupo, A; Bruno, B; Saracco, P; Di Bona, E; Locasciulli, A; Locatelli, F; Gabbas, A; Dufour, C; Arcese, W; Testi, G; Broccia, G; Carotenuto, M; Coser, P; Barbui, T; Leoni, P; Ferster, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:229;a:14:{s:9:"citazione";s:306:"Guardiola, P., Pasquini, R., Dokal, I., Ortega, J., van Weel-Sipman, M., Marsh, J., et al. (2000). Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. BLOOD, 95(2), 422-429.";s:4:"data";s:10:"2000-01-15";s:2:"id";s:20:"PUBBLICAZIONE_141364";s:6:"handle";s:10:"2108/68762";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:183:"Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:299:"Guardiola, P; Pasquini, R; Dokal, I; Ortega, J; van Weel-Sipman, M; Marsh, J; Ball, S; Locatelli, F; Vermylen, C; Skinner, R; Ljungman, P; Miniero, R; Shaw, P; Souillet, G; Michallet, M; Bekassy, A; Krivan, G; Di Bartolomeo, P; Heilmann, C; Zanesco, L; Cahn, J; Arcese, W; Bacigalupo, A; Gluckman, E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:230;a:14:{s:9:"citazione";s:343:"Mengarelli, A., Minotti, C., Palumbo, G., Arcieri, P., Gentile, G., Iori, A., et al. (2000). High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation. BRITISH JOURNAL OF HAEMATOLOGY, 108(1), 126-131 [10.1046/j.1365-2141.2000.01812.x].";s:4:"data";s:7:"2000-01";s:2:"id";s:20:"PUBBLICAZIONE_141368";s:6:"handle";s:10:"2108/68765";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:165:"High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation";s:9:"metadata6";s:107:"Mengarelli, A; Minotti, C; Palumbo, G; Arcieri, P; Gentile, G; Iori, A; Arcese, W; Mandelli, F; Avvisati, G";s:9:"metadata7";s:32:"10.1046/j.1365-2141.2000.01812.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:231;a:14:{s:9:"citazione";s:199:"Arcese, W., & Guglielmi, C. (2000). Survival of patients with PH+ Chronic myeloid leukemia relapsing after an allogeneic stem cell transplant.. Paper presented at The Jubilee Meeting on CML, Bologna.";s:4:"data";s:4:"2000";s:2:"id";s:20:"PUBBLICAZIONE_143285";s:6:"handle";s:10:"2108/69467";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:106:"Survival of patients with PH+ Chronic myeloid leukemia relapsing after an allogeneic stem cell transplant.";s:9:"metadata6";s:22:"Arcese, W; Guglielmi,C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:232;a:14:{s:9:"citazione";s:333:"Colombo, A., Alessandrino, E., Bernasconi, P., Arcese, G., Rabusin, M., Bacigalupo, A., et al. (1999). N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). TRANSPLANTATION, 68(9), 1414-1416 [10.1097/00007890-199911150-00031].";s:4:"data";s:10:"1999-11-15";s:2:"id";s:20:"PUBBLICAZIONE_141387";s:6:"handle";s:10:"2108/68782";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:159:"N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO)";s:9:"metadata6";s:106:"Colombo, A; Alessandrino, E; Bernasconi, P; Arcese, G; Rabusin, M; Bacigalupo, A; Bernasconi, C; Arcese, W";s:9:"metadata7";s:32:"10.1097/00007890-199911150-00031";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:233;a:14:{s:9:"citazione";s:315:"De Felice, L., Di Pucchio, T., Mascolo, M., Agostini, F., Breccia, M., Guglielmi, C., et al. (1999). Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures. BRITISH JOURNAL OF HAEMATOLOGY, 106(1), 133-141 [10.1046/j.1365-2141.1999.01519.x].";s:4:"data";s:7:"1999-07";s:2:"id";s:20:"PUBBLICAZIONE_141390";s:6:"handle";s:10:"2108/68786";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:129:"Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures";s:9:"metadata6";s:139:"De Felice, L; Di Pucchio, T; Mascolo, M; Agostini, F; Breccia, M; Guglielmi, C; Ricciardi, M; Tafuri, A; Screnci, M; Mandelli, F; Arcese, W";s:9:"metadata7";s:32:"10.1046/j.1365-2141.1999.01519.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:234;a:14:{s:9:"citazione";s:298:"Iacopino, P., Pucci, G., Arcese, W., Bosi, A., Falda, M., Locatelli, F., et al. (1999). Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO). BONE MARROW TRANSPLANTATION, 24(1), 47-51 [10.1038/sj.bmt.1701830].";s:4:"data";s:7:"1999-07";s:2:"id";s:20:"PUBBLICAZIONE_141360";s:6:"handle";s:10:"2108/68758";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:141:"Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)";s:9:"metadata6";s:150:"Iacopino, P; Pucci, G; Arcese, W; Bosi, A; Falda, M; Locatelli, F; Marenco, P; Miniero, R; Morabito, F; Rossetti, F; Sica, S; Uderzo, C; Bacigalupo, A";s:9:"metadata7";s:22:"10.1038/sj.bmt.1701830";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:235;a:14:{s:9:"citazione";s:254:"Locatelli, F., Rocha, V., Chastang, C., Arcese, W., Michel, G., Abecasis, M., et al. (1999). Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. BLOOD, 93(11), 3662-3671.";s:4:"data";s:10:"1999-06-01";s:2:"id";s:20:"PUBBLICAZIONE_141402";s:6:"handle";s:10:"2108/68795";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:134:"Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group";s:9:"metadata6";s:197:"Locatelli, F; Rocha, V; Chastang, C; Arcese, W; Michel, G; Abecasis, M; Messina, C; Ortega, J; Badell-Serra, I; Plouvier, E; Souillet, G; Jouet, J; Pasquini, R; Ferreira, E; Garnier, F; Gluckman, E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:236;a:14:{s:9:"citazione";s:310:"Arcese, W., Tura, S., Russo, D., Baccarani, M., Fanin, R., Tiribelli, M., et al. (1999). Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation. JOURNAL OF CLINICAL ONCOLOGY, 17(6), 1858-1868.";s:4:"data";s:7:"1999-06";s:2:"id";s:20:"PUBBLICAZIONE_141400";s:6:"handle";s:10:"2108/68793";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:172:"Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation";s:9:"metadata6";s:140:"Arcese, W; Tura, S; Russo, D; Baccarani, M; Fanin, R; Tiribelli, M; Rosti, G; Fiacchini, M; De Vivo, A; Bonifazi, F; Zuffa, E; Montefusco, E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:237;a:14:{s:9:"citazione";s:188:"Elia, L., Arcese, W., Torello, M., Iori, A., Guglielmi, C., Perrone, M., et al. (1999). HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants. HAEMATOLOGICA, 84(6), 530-534.";s:4:"data";s:7:"1999-06";s:2:"id";s:20:"PUBBLICAZIONE_141389";s:6:"handle";s:10:"2108/68784";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:68:"HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants";s:9:"metadata6";s:116:"Elia, L; Arcese, W; Torello, M; Iori, A; Guglielmi, C; Perrone, M; Screnci, M; Sprovieri, T; Rapanotti, M; Cimino, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:238;a:14:{s:9:"citazione";s:403:"Guardiola, P., Anderson, J., Bandini, G., Cervantes, F., Runde, V., Arcese, W., et al. (1999). Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. BLOOD, 93(9), 2831-2838.";s:4:"data";s:10:"1999-05-01";s:2:"id";s:20:"PUBBLICAZIONE_141399";s:6:"handle";s:10:"2108/68791";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Resea...";s:9:"metadata6";s:209:"Guardiola, P; Anderson, J; Bandini, G; Cervantes, F; Runde, V; Arcese, W; Bacigalupo, A; Przepiorka, D; O'Donnell, M; Polchi, P; Buzyn, A; Sutton, L; Cazals-Hatem, D; Sale, G; de Witte, T; Deeg, H; Gluckman, E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:239;a:14:{s:9:"citazione";s:177:"Arcese, W., & Iori, A. (1999). Pregnancy and secondary cancer after allogeneic bone marrow transplantation. BONE MARROW TRANSPLANTATION, 23(7), 752-752 [10.1038/sj.bmt.1701653].";s:4:"data";s:7:"1999-04";s:2:"id";s:20:"PUBBLICAZIONE_141396";s:6:"handle";s:10:"2108/68788";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:75:"Pregnancy and secondary cancer after allogeneic bone marrow transplantation";s:9:"metadata6";s:18:"Arcese, W; Iori, A";s:9:"metadata7";s:22:"10.1038/sj.bmt.1701653";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:240;a:14:{s:9:"citazione";s:264:"Arcese, W., Guglielmi, C., Iori, A., Screnci, M., Carmini, D., Testi, A., et al. (1999). Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia. BONE MARROW TRANSPLANTATION, 23(6), 549-554 [10.1038/sj.bmt.1701615].";s:4:"data";s:7:"1999-03";s:2:"id";s:20:"PUBBLICAZIONE_141598";s:6:"handle";s:10:"2108/68892";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:104:"Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia";s:9:"metadata6";s:230:"Arcese, W; Guglielmi, C; Iori, A; Screnci, M; Carmini, D; Testi, A; Moleti, M; Mengarelli, A; Del Giudice, I; Cimino, G; Elia, L; Rapanotti, M; Perrone, P; Laurenti, L; Gentile, G; Boecklin, F; Romano, A; De Felice, L; Mandelli, F";s:9:"metadata7";s:22:"10.1038/sj.bmt.1701615";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:241;a:14:{s:9:"citazione";s:448:"Cimino, G., Rapanotti, M., Elia, L., Iori, A., Guglielmi, C., Screnci, M., et al. (1999). A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. BRITISH JOURNAL OF HAEMATOLOGY, 104(4), 770-777 [10.1046/j.1365-2141.1999.01232.x].";s:4:"data";s:7:"1999-03";s:2:"id";s:20:"PUBBLICAZIONE_141600";s:6:"handle";s:10:"2108/68909";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in ...";s:9:"metadata6";s:143:"Cimino, G; Rapanotti, M; Elia, L; Iori, A; Guglielmi, C; Screnci, M; Carmini, D; De Felice, L; Moleti, M; Mengarelli, A; Mandelli, F; Arcese, W";s:9:"metadata7";s:32:"10.1046/j.1365-2141.1999.01232.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:242;a:14:{s:9:"citazione";s:237:"Dini, G., Arcese, W., Barbanti, M., Biffoni, F., Bosi, A., Lanino, E., et al. (1998). Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant. BONE MARROW TRANSPLANTATION, 22 Suppl 5, S41-S41-5.";s:4:"data";s:7:"1998-12";s:2:"id";s:20:"PUBBLICAZIONE_141761";s:6:"handle";s:10:"2108/68972";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:98:"Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant";s:9:"metadata6";s:101:"Dini, G; Arcese, W; Barbanti, M; Biffoni, F; Bosi, A; Lanino, E; Majolino, I; Menichella, G; Reali, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:243;a:14:{s:9:"citazione";s:298:"Giona, F., Annino, L., Testi, A., Rondelli, R., Arcese, W., Meloni, G., et al. (1998). Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups. LEUKEMIA & LYMPHOMA, 32(1-2), 89-95 [10.3109/10428199809059249].";s:4:"data";s:7:"1998-12";s:2:"id";s:20:"PUBBLICAZIONE_141760";s:6:"handle";s:10:"2108/68971";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:145:"Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups";s:9:"metadata6";s:88:"Giona, F; Annino, L; Testi, A; Rondelli, R; Arcese, W; Meloni, G; Moleti, M; Mandelli, F";s:9:"metadata7";s:25:"10.3109/10428199809059249";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:244;a:14:{s:9:"citazione";s:383:"Carreras, E., Bertz, H., Arcese, W., Vernant, J., Tomás, J., Hagglund, H., et al. (1998). Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. BLOOD, 92(10), 3599-3604.";s:4:"data";s:10:"1998-11-15";s:2:"id";s:20:"PUBBLICAZIONE_141765";s:6:"handle";s:10:"2108/68974";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:255:"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia W...";s:9:"metadata6";s:268:"Carreras, E; Bertz, H; Arcese, W; Vernant, J; Tomás, J; Hagglund, H; Bandini, G; Esperou, H; Russell, J; de la Rubia, J; Di Girolamo, G; Demuynck, H; Hartmann, O; Clausen, J; Ruutu, T; Leblond, V; Iriondo, A; Bosi, A; Ben-Bassat, I; Koza, V; Gratwohl, A; Apperley, J";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:245;a:14:{s:9:"citazione";s:362:"Gratwohl, A., Hermans, J., Goldman, J., Arcese, W., Carreras, E., Devergie, A., et al. (1998). Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. THE LANCET, 352(9134), 1087-1092 [10.1016/S0140-6736(98)03030-X].";s:4:"data";s:10:"1998-10-03";s:2:"id";s:20:"PUBBLICAZIONE_141766";s:6:"handle";s:10:"2108/68976";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:200:"Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation";s:9:"metadata6";s:171:"Gratwohl, A; Hermans, J; Goldman, J; Arcese, W; Carreras, E; Devergie, A; Frassoni, F; Gahrton, G; Kolb, H; Niederwieser, D; Ruutu, T; Vernant, J; de Witte, T; Apperley, J";s:9:"metadata7";s:29:"10.1016/S0140-6736(98)03030-X";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:246;a:14:{s:9:"citazione";s:307:"Van Lint, M., Uderzo, C., Locasciulli, A., Majolino, I., Scimé, R., Locatelli, F., et al. (1998). Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. BLOOD, 92(7), 2288-2293.";s:4:"data";s:10:"1998-10-01";s:2:"id";s:20:"PUBBLICAZIONE_141777";s:6:"handle";s:10:"2108/68979";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:181:"Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation";s:9:"metadata6";s:194:"Van Lint, M; Uderzo, C; Locasciulli, A; Majolino, I; Scimé, R; Locatelli, F; Giorgiani, G; Arcese, W; Iori, A; Falda, M; Bosi, A; Miniero, R; Alessandrino, P; Dini, G; Rotoli, B; Bacigalupo, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:247;a:14:{s:9:"citazione";s:303:"Muscaritoli, M., Conversano, L., Torelli, G., Arcese, W., Capria, S., Cangiano, C., et al. (1998). Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. TRANSPLANTATION, 66(5), 610-616 [10.1097/00007890-199809150-00011].";s:4:"data";s:10:"1998-09-15";s:2:"id";s:20:"PUBBLICAZIONE_141776";s:6:"handle";s:10:"2108/68977";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:135:"Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation";s:9:"metadata6";s:106:"Muscaritoli, M; Conversano, L; Torelli, G; Arcese, W; Capria, S; Cangiano, C; Falcone, C; Rossi Fanelli, F";s:9:"metadata7";s:32:"10.1097/00007890-199809150-00011";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:248;a:14:{s:9:"citazione";s:323:"Donato, V., Iacari, V., Zurlo, A., Capua, A., Tombolini, V., Banelli, E., et al. (1998). Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients. RADIOTHERAPY AND ONCOLOGY, 48(3), 267-276 [10.1016/S0167-8140(98)00069-3].";s:4:"data";s:7:"1998-09";s:2:"id";s:20:"PUBBLICAZIONE_141764";s:6:"handle";s:10:"2108/68973";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:158:"Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients";s:9:"metadata6";s:134:"Donato, V; Iacari, V; Zurlo, A; Capua, A; Tombolini, V; Banelli, E; Enrici, R; De Felice, C; Giacco, G; Iori, A; Arcese, W; Biagini, C";s:9:"metadata7";s:29:"10.1016/S0167-8140(98)00069-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:249;a:14:{s:9:"citazione";s:254:"Iori, A., Screnci, M., Guglielmi, C., Mengarelli, A., Carmini, D., Testi, A., et al. (1998). Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemia. BONE MARROW TRANSPLANTATION, 22 Suppl 1, S75-S75.";s:4:"data";s:7:"1998-07";s:2:"id";s:20:"PUBBLICAZIONE_141779";s:6:"handle";s:10:"2108/68980";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:110:"Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemia";s:9:"metadata6";s:187:"Iori, A; Screnci, M; Guglielmi, C; Mengarelli, A; Carmini, D; Testi, A; Moleti, M; Cimino, G; Perrone, P; Laurenti, L; Elia, L; Boecklin, F; Romano, A; Vulcano, F; De Felice, L; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:250;a:14:{s:9:"citazione";s:249:"Giona, F., Testi, A.M., Rondelli, R., Amadori, S., Arcese, W., Meloni, G., et al. (1997). ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse. BRITISH JOURNAL OF HAEMATOLOGY, 99(3), 671-677.";s:4:"data";s:4:"1997";s:2:"id";s:19:"PUBBLICAZIONE_15660";s:6:"handle";s:10:"2108/51000";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:110:"ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse";s:9:"metadata6";s:144:"Giona, F; Testi, AM; Rondelli, R; Amadori, S; Arcese, W; Meloni, G; Moleti, ML, Ceci, A; Pillon, M; Madon, E; Comis, M; Pession, A; Mandelli, F.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:251;a:14:{s:9:"citazione";s:193:"Vitale, A., Testi, A.m., Moleti, M.l., Vignetti, M., Arcese, W., Fenu, S., et al. (1994). Myelodysplastic syndromes in childhood: description of seven cases. ANNALS OF HEMATOLOGY, 68(5), 241-5.";s:4:"data";s:7:"1994-05";s:2:"id";s:20:"PUBBLICAZIONE_254676";s:6:"handle";s:11:"2108/212190";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:66:"Myelodysplastic syndromes in childhood: description of seven cases";s:9:"metadata6";s:116:"Vitale, A; Testi, Am; Moleti, Ml; Vignetti, M; Arcese, W; Fenu, S; Cedrone, M; De Felice, L; Amadori, S; Mandelli, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:252;a:14:{s:9:"citazione";s:206:"Gentile, G., Venditti, M., Micozzi, A., Caprioli, A., Donelli, G., Tirindelli, C., et al. (1991). Cryptosporidiosis in patients with hematologic malignancies. REVIEWS OF INFECTIOUS DISEASES, 13(5), 842-846.";s:4:"data";s:4:"1991";s:2:"id";s:20:"PUBBLICAZIONE_141845";s:6:"handle";s:10:"2108/69590";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:59:"Cryptosporidiosis in patients with hematologic malignancies";s:9:"metadata6";s:109:"Gentile, G; Venditti, M; Micozzi, A; Caprioli, A; Donelli, G; Tirindelli, C; Meloni, G; Arcese, W; Martino, P";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:253;a:14:{s:9:"citazione";s:228:"Sarmati, L., Andreoni, M., Arcese, W., Pica, F., Bianchi, A., Mauro, F., et al. (1987). L'infezione da Citomegalovirus in 16 pazienti sottoposti a trapianto di midollo. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE, 39, 935-936.";s:4:"data";s:4:"1987";s:2:"id";s:20:"PUBBLICAZIONE_142944";s:6:"handle";s:10:"2108/69409";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:80:"L'infezione da Citomegalovirus in 16 pazienti sottoposti a trapianto di midollo.";s:9:"metadata6";s:85:"Sarmati, L; Andreoni, M; Arcese, W; Pica, F; Bianchi, A; Mauro, F; Papa, G; Rocchi, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:254;a:14:{s:9:"citazione";s:223:"Petti, M., Amadori, S., Annino, L., Arcese, W., Avvisati, G., Di Lorenzo, A., et al. (1982). Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients). HAEMATOLOGICA, 67(4), 556-566.";s:4:"data";s:7:"1982-08";s:2:"id";s:20:"PUBBLICAZIONE_140956";s:6:"handle";s:10:"2108/68587";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:98:"Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients)";s:9:"metadata6";s:96:"Petti, M; Amadori, S; Annino, L; Arcese, W; Avvisati, G; Di Lorenzo, A; Gastaldi, R; Mandelli, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:255;a:14:{s:9:"citazione";s:135:"Tribalto, M., Pastore, S., Colombo, R., Arcese, W., & Mandelli, F. (1981). Smouldering multiple myeloma. HAEMATOLOGICA, 66(6), 880-882.";s:4:"data";s:7:"1981-12";s:2:"id";s:20:"PUBBLICAZIONE_140943";s:6:"handle";s:10:"2108/68585";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:28:"Smouldering multiple myeloma";s:9:"metadata6";s:59:"Tribalto, M; Pastore, S; Colombo, R; Arcese, W; Mandelli, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:256;a:14:{s:9:"citazione";s:293:"Gluckman, E., Barrett, A., Arcese, W., Devergie, A., & Degoulet, P. (1981). Bone marrow transplantation in severe aplastic anaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.). BRITISH JOURNAL OF HAEMATOLOGY, 49(2), 165-173 [10.1111/j.1365-2141.1981.tb07212.x].";s:4:"data";s:7:"1981-10";s:2:"id";s:20:"PUBBLICAZIONE_140050";s:6:"handle";s:10:"2108/68583";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:131:"Bone marrow transplantation in severe aplastic anaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.)";s:9:"metadata6";s:60:"Gluckman, E; Barrett, A; Arcese, W; Devergie, A; Degoulet, P";s:9:"metadata7";s:34:"10.1111/j.1365-2141.1981.tb07212.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}}" } ["meta_keywords"]=> array(1) { [0]=> string(1) "," } ["reserved"]=> array(1) { [0]=> string(1) "0" } ["auth_ip"]=> array(1) { [0]=> string(1) "0" } } ["_fieldBoosts":protected]=> array(6) { ["content_id"]=> bool(false) ["content_title"]=> bool(false) ["description"]=> bool(false) ["meta_keywords"]=> bool(false) ["reserved"]=> bool(false) ["auth_ip"]=> bool(false) } } }